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Summary 
Pseudomonas aeruginosa is an opportunistic human pathogen that is now the 
leading cause of morbidity and mortality in immunocompromised individuals. Those 
suffering with the genetic disease cystic fibrosis (CF) commonly encounter P. aeruginosa 
infections. P. aeruginosa infection can present itself as an acute infection, which is 
characterised by highly virulent, “free-swimming” bacteria, or as a chronic infection 
associated with the formation of surface-adhered bacterial communities known as 
biofilms. The labyrinth of interconnecting signalling networks has meant that the 
regulatory mechanisms behind biofilm formation and virulence are largely undefined. 
In this dissertation, a single nucleotide polymorphism was identified within the 
gene, fusA1, encoding elongation factor G (EF-G). The mutation introduced minor 
structural changes to the protein which were likely to have functional repercussions in 
its involvement in protein synthesis. Phenotypic analysis revealed that the mutation 
conferred changes in both resistance and sensitivity to various antibiotics, as well as 
changes in motility, exoenzyme production, quorum sensing, metabolism, synthesis of 
biofilm-associated proteins and exopolysaccharide production. Most notably was the up-
regulation of a major virulence determinant, the type three secretion system, typically 
characteristic of cells comprising an acute infection. Proteomic and transcriptomic 
profiling of the mutant strain provided an insight into the genetic basis behind these 
phenotypes, identifying the up-regulation of multidrug efflux systems and modulations 
to the chemotactic systems. This study also found links between several biological 
processes that were modulated in the mutant strain, such as crosstalk between sulfur 
metabolism, iron uptake and the oxidative stress response.  
In summary, the work presented in this dissertation highlights the susceptibility 
of fusA1 to spontaneous mutation and identifies a novel role for EF-G in bacterial 
virulence and antibiotic sensitivity, both of which have worrying implications for 
infection within the CF lung.  
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1.1   Pseudomonas aeruginosa 
1.1.1    General characteristics 
Pseudomonas aeruginosa is a Gram-negative, rod shaped bacterium that can be 
found ubiquitously within the environment. The name ‘aeruginosa’ was coined from the 
Latin word, aerūgō, meaning “copper rust”, and refers to its characteristic blue-green 
colouration (Brown, 1954).  Typically, P. aeruginosa lives as a relatively harmless 
microorganism, inhabiting a wide variety of environments, from plants, soil and aquatic 
areas, to living on nematodes and animals. It is not uncommon for P. aeruginosa to inhabit 
healthy human individuals; however, in these cases the Pseudomonas population would 
be largely outnumbered by other microbial flora. In the case of immunocompromised 
individuals or patients receiving immunosuppressive drugs, P. aeruginosa embodies an 
opportunistic human pathogen and takes advantage of the subdued immune response. 
Should the body be unable to clear an infection, it can become severe enough to result in 
the death of the patient. P. aeruginosa is particularly dreaded amongst the clinical 
community due to its ability to grow on medical equipment such as catheters, stents and 
ventilators, and has even been isolated from soaps and hydrotherapy pools. This creates 
a high risk of transmission between patients and has afforded P. aeruginosa the dubious 
accolade of being one of the most common nosocomial infective pathogens (Lister et al., 
2009; Pereira et al., 2014).  
 
1.1.2 Infection 
The ability of P. aeruginosa to adapt and persist in a wide variety of environments 
can be attributed to its large genome, consisting of 6.3 Mbp and 5,570 predicted open 
reading frames (ORFs) (Stover et al., 2000). Having one of the largest and most complex 
bacterial genomes allows this organism to have a flexible metabolism and simple 
nutritional requirements. For this reason, P. aeruginosa can colonise numerous areas of 
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the body and is often isolated from burn wounds, and the respiratory, gastrointestinal 
and urinary tracts.  
In acute burn wounds the protective layers of the skin are destroyed and the 
immune system is suppressed, making the exposed tissue open to colonisation.  
P. aeruginosa proliferates within the damaged tissue and, in some severe infections, the 
bacteria can spread into the circulatory system causing bacteraemia and septic shock (Liu 
et al., 2014). P. aeruginosa is also implicated in the development of swimmers ear, a 
bacterial infection of the external ear canal, causing inflammation and temporarily 
hearing impairment (Reid et al., 1981). As well as this, for individuals who wear contact 
lenses, P. aeruginosa is the most common cause of corneal infection and the development 
of sight-threatening corneal ulcers. This is due to its ability to survive on the lens, within 
storage solution and thrives within the ocular environment (Stapleton et al., 2012).  
However, most notably, P. aeruginosa is currently the leading cause of morbidity and 
mortality in immunocompromised patients with, for example, ventilator-associated 
pneumonia or cystic fibrosis (CF). This is because it causes irreversible damage to the 
lung tissue, reducing lung function and leading to accelerated lung failure (McCarthy et 
al., 2014; Raineri et al., 2014).  
 
1.1.3 Resistance and treatment 
The 20th century became the golden age for medical advancement and antibiotic 
discovery. However, almost no new antibiotics have been identified in the last 30 years 
and infections that were once easily treated are once again becoming a serious threat to 
modern healthcare. Over-prescribing and the use of antibiotics in the farming industry 
have led to a surge in antimicrobial resistance. In hospitals, the intense selection 
pressures, and availability of susceptible patients, provides the perfect environment for 
cultivating antimicrobial resistant ‘super-bugs’. When combined with the large growth in 
the immunocompromised population, that has occurred in the last decade, resistance is 
progressively becoming a huge health and economic burden (Lister et al., 2009; Taylor et 
al., 2014).  
Amongst the growing number of antibiotic resistant bacteria, the World Health 
Organisation ranked P. aeruginosa the number two priority pathogen for which new 
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antibiotics are urgently needed, only out-matched by the carbapenem-resistant, 
Acinetobacter baumannii (Kahlmeter et al., 2017). Treatment options for  
P. aeruginosa infection are therefore limited as not only is antibiotic treatment often 
ineffective but it can worsen the condition by killing off competing microorganisms and 
allowing the population of P. aeruginosa to expand.  
Antibiotic resistance can spread amongst bacterial populations on mobile genetic 
elements or can occur through the spontaneous mutation of genes encoding resistance 
mechanisms. P. aeruginosa already confers a high level of intrinsic resistance due to the 
production of antibiotic inactivating enzymes that target a diverse range of antibiotics 
and reduce their effectivity. Inactivation of aminoglycosides, for example, involves 
chemical modification of the drug by either phosphorylation, acetylation or adenylation. 
This means that numerous modifying enzymes, encoded by P. aeruginosa, are effective at 
rendering a single antibiotic useless and consequently result in high levels of resistance 
to that drug (Poole, 2005).  
In addition to modifying enzymes, P. aeruginosa encodes several multi-drug 
resistance (MDR) efflux pumps which reduce susceptibility to antibiotics by translocating 
drugs out of the cell. Not only do efflux pumps export antibiotics, but they also remove 
toxic substances, metabolites and quorum sensing molecules to assist environmental 
adaptation and communication between bacteria. Four efflux systems have been studied 
extensively in P. aeruginosa; MexAB-OprM, MexCD-OprJ, MexEF-OprN and MexXY-OprM 
(Soto, 2013). These are composed of a proton motive force-driven antiporter pump 
(MexB, D, F and Y), which lies within the cytoplasmic membrane, a gated outer membrane 
channel (OprM, J and N) and a linker lipoprotein (MexA, C, E and X) (Livermore, 2002). 
The first pump to be identified was the MexAB-OprM efflux pump, which remains to be 
one of the most highly expressed efflux systems. This pump also has the broadest range 
of antimicrobial targets, including fluoroquinolones, tetracyclines, chloramphenicols and 
β-lactams. The other efflux systems have a narrower range of substrates but can be 
equally important in antibiotic resistance, particularly during infection when a number 





1.2    Biofilms 
1.2.1     Life cycle and formation 
P. aeruginosa is one of the most highly studied and clinically-significant organisms 
in relation to biofilm formation (Müsken et al., 2010). Biofilms are surface-associated 
bacterial communities embedded within a self-made, extracellular polymeric matrix. 
These communities exhibit increased antibiotic resistance, increased immune evasion, 
and can prove to be extremely persistent during antimicrobial treatment (Alhede et al., 
2009). 
A number of technological advances have catalysed insight into the development 
of bacterial biofilms. In particular, the development of flow cell biofilm chambers, which 
can be monitored using laser scanning confocal microscopy, has revealed the temporal 
changes which accompany biofilm formation in vitro. These studies have revealed that 
biofilm formation follows a sequential process of attachment, growth, maturation and 
dispersal, and high-throughput screening has aided in the discovery of many of the 
fundamental genetic factors required for biofilm formation.  Moreover, details of the 
physical and chemical communication systems and “social interactions” within the 
biofilm are now being unearthed (Klausen et al., 2003; Müsken et al., 2010).  
The transition from ‘free-swimming’ planktonic growth to biofilm formation 
involves several distinct steps. In 1998, O’Toole and Kolter published the first global 
genetic screen aimed at identifying P. aeruginosa mutants that are defective in biofilm 
formation; an approach that highlighted the importance of Surface Attachment Defective 
(sad) genes. Several sad genes are required for flagellar synthesis, and the functional 
disruption of these genes blocks biofilm formation at a very early stage; surface 
attachment. This is because the flagellum is involved in overcoming surface repulsion at 
the liquid-surface interface, thereby enabling temporary surface attachment during the 
first stage of biofilm formation. Temporary surface attachment is followed by exploration 
of the surrounding surface via type IV pili (T4P)-dependent twitching motility (Müsken 
et al., 2010). This way, the surface associated bacteria come together to form 
microcolonies (Figure 1.1).  
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Figure 1.1. Biofilm formation begins when highly motile planktonic cells adhere 
to a surface. The cells undergo physical changes that involve down-regulation of motility 
apparatus and virulence factors whilst up regulating the production of an 
exopolysaccharide-rich extracellular matrix. The community matures into mushroom-
shaped structures. In response to inducing conditions, cells become motile once again 
and disseminate to colonise new ecological niches. 
 
Microcolony formation is accompanied by a reduction in motility and virulence 
gene expression (Klausen et al., 2003). Concomitant with this, the microcolonies grow in 
size to form larger cellular aggregates (Landry et al., 2006) and secrete large volumes of 
characteristic extracellular matrix. The majority of the matrix is made from a viscous 
mixture of extracellular polysaccharides, principally Psl, Pel and alginate. Proteins such 
as CdrA act as ‘spars’ between matrix components, adding strength to the structural 
scaffold, and extracellular DNA (eDNA) is present in the matrix, providing further 
structural rigidity. In continuous flow biofilms, the colonies eventually develop into 
protruding mushroom-shaped structures. However, when conditions require it, the cells 
on the periphery of the structure are capable of reverting to a planktonic phenotype 
where they begin to produce enzymes which cleave the matrix components, thereby 
6 
 
allowing cells to disseminate into the surrounding environment and colonise new niches 
(O’Toole et al., 1998; Fazli et al., 2014).  
 
1.2.2 The extracellular matrix 
1.2.2.1 Exopolysaccharides 
Of the three exopolysaccharides (Psl, Pel and alginate) secreted by P. aeruginosa, 
alginate is responsible for the mucoid phenotype which is essentially pathognomic of CF. 
Alginate is a capsule-like exopolysaccharide composed of α-D-mannuronic acid and 
glucuronic acid, producing a negatively charged copolymer (Pulcrano et al., 2012).  In 
contrast, Psl and Pel polysaccharides monopolise the matrix in non-mucoid strains, such 
as environmental and domestic laboratory strains. Pel is a glucose-rich polysaccharide 
with a particular role in pellicle formation; a ‘floating biofilm’ which forms at a liquid-air 
interface. A pellicle provides the colony access to high concentrations of oxygen and 
nutrients, and can be seen on the surface of standing cultures (Friedman and Kolter, 
2004a). The second non-mucoid polysaccharide, Psl, forms fibrous structures around  
P. aeruginosa cells creating a mesh-like scaffold to which neighbouring cells can bind 
(Wang et al., 2015). Overexpressing Psl results in cell aggregation when grown in liquid 
culture, demonstrating its role in cell-cell interactions, and causes increased adhesion of 
cells to microtitre wells during in vivo biofilm plate assays verifying its role in cell-surface 
interactions (Ma et al., 2006; Borlee et al., 2010). Together, the secreted 
exopolysaccharides play a range of roles in the matrix, by providing structure, protection 
and adhesion.  
 
1.2.2.2    CdrA 
The protein CdrA was first identified through a screen for genes transcriptionally 
induced by c-di-GMP. Here, its function as a protein component of the biofilm matrix was 
determined and it was predicted to be a rod-shaped adhesin that acts as a stabilising 
crossbar between matrix components to increase the structural integrity of the biofilm. 
CdrA is found within a two gene operon with cdrB, forming a two-partner secretion 
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system, consisting of a secreted adhesin (CdrA) and its transporter (CdrB). The over-
expression of cdrA leads to cell aggregation in liquid culture, which has been attributed 
to CdrA binding to Psl exopolysaccharides. CdrA mutants form weak biofilms in which Psl 
is no longer tightly associated with the cells, suggesting that CdrA cross-links Psl 
polysaccharides or tethers Psl to cell membranes. In doing so, this increases the stability 
of the matrix and promotes cell aggregation and microcolony formation. Strains defective 
in Psl synthesis also exhibit reduced cell-associated CdrA levels and therefore produce 
less robust biofilms (Borlee et al., 2010). 
 
1.2.3 Antibiotic resistance and targeting biofilms 
Biofilm cells are linked to enhanced antimicrobial defences, including the 
restriction of drug uptake, increasing efflux pump activity, altering drug targets, or 
directly inactivating the drug. This is thought to be due to changes in gene expression, as 
cells move from planktonic growth into biofilm development (Lambert, 2002; 
Breidenstein et al., 2011; Liao et al., 2012). The biofilm is also composed of a heterologous 
population, exhibiting mutational changes and variations in transcriptional activity. For 
example, subpopulations will often display differential tolerance levels to antimicrobial 
compounds, which makes finding an antibiotic treatment that is effective on the whole 
biofilm extremely difficult (L. Yang et al., 2007).  
The tight colony structure of the biofilm also contributes to antimicrobial 
resistance forming a diffusion barrier so that only cells within the surface layers are 
exposed to lethal concentrations of the drug. Within the surface layers, antimicrobials can 
be consumed or deactivated to prevent their toxic effects disturbing the rest of the 
microcolony (Mulcahy et al., 2014; Baker et al., 2015). Studies have suggested that the 
exopolysaccharides play an important role in this process, as they act as a protective 
capsule that effectively delays the penetration of antimicrobial agents. Through a similar 
mechanism, they assist in the evasion of the host immune system by reducing the 
penetration of antibodies, reducing macrophage induced phagocytosis and limiting the 
migration of neutrophils (Horsman et al., 2012). Therefore, it is becoming of increasing 
interest to directly target components of the biofilm matrix. Disrupting biofilm formation, 
using polysaccharide lyases and digestive enzymes, leaves the bacteria vulnerable to 
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antimicrobials and can improve the effectiveness of antibiotic treatment. Preventative 
methods could also involve targeting adhesins to inhibit initial cell attachment and arrest 
the establishment of a biofilm (Wei et al., 2013).  
 
1.2.4 Regulation of biofilm formation 
Biofilm formation is a highly regulated process which is finely tuned by a cascade 
of signals and interconnecting regulatory networks. The composition of the extracellular 
environment is most likely to be the initial catalyst for the progression of planktonic cells 
into a biofilm lifestyle (O’Toole and Kolter, 1998), although many of the downstream 
effectors remain elusive and, in most instances, the environmental cues are also unknown 
(Mulcahy et al., 2011). 
Bis-(3’-5’)-cyclic dimeric guanosine monophosphate (c-di-GMP) is a signalling 
molecule produced by bacteria to control a whole consort of biological processes. At high 
intracellular concentrations, c-di-GMP is the key regulator in activating biofilm growth. 
Intracellular pools of c-di-GMP are modulated by diguanylate cyclases (DGC), which 
synthesise the molecule, and c-di-GMP phosphodiesterases (PDE), which catabolise it. 
However, it is very difficult to predict effectors of c-di-GMP, and the signalling molecule 
affects a very diverse range of proteins (Römling et al., 2013). One such group of proteins 
are those involved in flagellar motility, which become down-regulated by c-di-GMP, 
thereby forcing the bacteria into a sessile mode of growth. Concomitant with this, the 
production of matrix components, including exopolysaccharides, adhesive pili, eDNA and 
adhesins, become up-regulated by increased c-di-GMP levels (Römling, Galperin and 
Gomelsky, 2013).  
Whilst c-di-GMP has been recognised as the main regulator of the biofilm lifestyle, 
several other pathways impact its development, including the Gac/Rsm pathway which 
is vital in balancing the expression of biofilm-associated genes with planktonic-
associated genes. In a similar manner, quorum sensing (QS) plays a role in the expression 
of exopolysaccharides, eDNA and the biosynthesis of rhamnolipids, a glycolipid 
biosurfactant which helps maintain the channelling systems that run throughout the 




1.3 P. aeruginosa and cystic fibrosis 
1.3.1 Cystic fibrosis 
CF is the most prevalent lethal autosomal recessive disorder amongst the 
Caucasian population (McCarthy et al., 2014), and is caused by mutations in the cystic 
fibrosis transmembrane conductance regulator, CFTR, gene, which encodes a chloride 
channel. CFTR is essential for maintaining periciliary liquid volume and efficient 
mucociliary clearance within the lung. As a result, CFTR mutation causes mucus to 
accumulate in the airways and inhaled microbes are not cleared effectively, leading to 
recurrent infection by pathogens. It is this recurrent infection which aggravates the 
airways causing chronic inflammation and damage to the lung tissue. The lungs become 
severely scarred as a result and eventually, function can only be recovered through 
radical procedures such as transplantation. Loss of lung function due to bacterial 
infection is therefore one of the most significant causes of deterioration in CF patients 
(Ratjen et al., 2003; McCarthy et al., 2014; Trinh et al., 2015). 
 
1.3.2 The CF lung 
The CF lung provides an idyllic environment for colonising bacteria as the thick 
mucus layer provides a protective and nutritious home for microbial communities.  This 
abnormally high accumulation of mucus occurs from hyper-reabsorption of water in the 
lung due to the faulty chloride channel, CFTR (Maiuri et al., 2017). The CFTR channel is 
also involved in bicarbonate secretion which interacts with mucins and affects their 
composition. In the CF lung, dysfunctional CFTR channels reduce bicarbonate secretion, 
causing the mucins to become thick and dense. This is due to bicarbonate-free mucins 
adhering very strongly to the surface of the airways which prevents clearance of the 
mucus and any trapped particles. Because of this, pathogens can survive in the airways 
without risk of mucociliary clearance. The reduction in bicarbonate also causes the liquid 
of the CF lung to be more acidic than in non-CF patients. A low pH deactivates many 
antimicrobial peptides and therefore reduces the effectiveness of bacterial killing during 
treatment (Cantin et al., 2015).  
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Embedded within the mucus layer are a variety of inflammatory substances, 
including polymorphonuclear leukocytes, dead host cells, serum, and bacterial products 
from the thriving microbial population. It is this complex mix, collectively known as 
sputum, that is the main nutritional resource supporting the diverse range of microbes in 
the lung (Turner et al., 2015).  
Counter-intuitively, the CF lung is in fact an oxygen-limited environment.  
P. aeruginosa is well adapted to a micro-aerobic lifestyle and thrives under these 
conditions (Ratjen and Döring, 2003). The accumulation of mucus in the CF lung reduces 
the transfer of oxygen from the lungs into the bloodstream and can result in stabilisation 
of the hypoxia inducible factor-1, a transcription factor that promotes inflammation. 
Whilst the inflammatory response can help to clear out bacteria, having an active immune 
system is not always beneficial; polymorphonuclear leukocytes recruited to infection 
sites secrete proteases which can cleave immune receptors, such as T-cell receptors, and 
host extracellular matrix, impeding bacterial cell recognition and damaging the 
surrounding host tissue (Cantin et al., 2015). Because of this, even the presence of sessile 
and low virulent biofilms have extremely damaging effects on the lung. 
 
1.3.3 Progression of a CF infection  
Alongside P. aeruginosa, the CF airways are colonised by a variety of other 
microorganisms, such as Staphylococcus aureus and Haemophilus influenzae (Figure 1.2). 
Colonisation of the lung occurs during infancy but the abundances of each microorganism 
fluctuates throughout the individual’s lifetime. The increased prevalence of P. aeruginosa 
in the lung coincided with the introduction of CF specialised centres in the 1960s, leading 
to an increase in the level of patient to patient transmission. Nowadays, contact between 
CF patients is minimised but still, by the age of 20, P. aeruginosa commonly dominates 
the microbial community of the lung and often remains with the patient for the rest of 




Figure 1.2. Prevalence of respiratory organisms in CF patients throughout their life 
(taken from the UK Cystic Fibrosis Registry annual data report 2012 (Owen and Bilton, 
2013)). 
 
There are distinct structural abnormalities of the CF lung that are present at birth 
which can affect lung function, but at this early stage there is minimal inflammation. It is 
only after accumulating a high titre of bacteria in the lungs that the immune system is 
activated, and begins to cause damage to the host tissue (Cantin et al., 2015, Alhede et al., 
2009). During infection, P. aeruginosa grows to high densities of 107-109 colony forming 
units (CFU)/mL in the CF lung, more than enough to activate the host immune response 
(Turner et al., 2015). In principle, these infections can be divided into two broad types; 
acute infections, which are associated with highly-virulent planktonic cells, that are 
extremely invasive and cause substantial tissue damage, and chronic infections, which 
are commonly-associated with biofilm formation (Alhede et al., 2009). Infection 
exacerbates the CF respiratory condition and causes a relapsing cycle of infection, 
inflammation and airway obstruction. This cycle produces prolonged tissue damage and 





1.3.4 From acute infection to chronic infection 
P. aeruginosa initially infect the CF airways as planktonic cells, where being highly 
motile and equipped with multiple toxin secretion systems, enables the pathogen to 
overcome host defences and bacterial competition. This stage is often associated with 
acute infection due to the considerable level of damage caused by the high activity of 
virulence factors and pathogenicity (Bhagirath et al., 2016). One such virulence factor, is 
the type three secretion system (T3SS), which injects multiple exotoxins into host cells, 
resulting in cytotoxicity. During respiratory infection, strains expressing the T3SS have 
been found to cause up to six-fold higher mortality (Anantharajah et al., 2016).  
Acute infection causes rapid decline in lung function, but P. aeruginosa can go on 
to establish a chronic infection through the formation of biofilms on the lung epithelium. 
With chronic infection comes pulmonary exacerbations; worsening of CF symptoms, 
including increased sputum, coughing, weight loss and adventitious sounds during 
examination of the lung (Smyth et al., 2008). So far it remains unclear exactly what 
triggers the transition from a planktonic lifestyle to biofilm growth. The lung presents a 
distinctly different environment to that outside of the body and bacteria need to 
overcome the nutrient- and oxygen-limitation, oxidative stresses and host immune 
defences. These challenges may be the first cues to influence gene expression and activate 
biofilm formation. (McCarthy et al., 2014).  
 
1.3.4 Treatment of CF infections 
CF treatment and survival rates have improved in recent years, however, over 
80% of patients still die from pulmonary obstruction, microbial lung infection and lung 
tissue damage resulting in lung failure (Milla et al., 2014). Current treatment regimes 
involve aggressive use of high dose antibiotics and combination therapy which helps 
improve lung function and survival of the patient. Diversity within the P. aeruginosa 
population creates a reservoir of antibiotic-resistant mutants, so although treatment 
often temporarily improves lung function, it is rarely effective in eradicating chronic 
infections (Mowat et al., 2011; Milla et al., 2014). Furthermore, treatment can be a long 
and repetitive process, and can potentially worsen the condition by selecting for resistant 
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cells that develop throughout the course of treatment. These resistant cells readily 
recolonise the CF airways following treatment and leads to recurrent infection, which 
drastically extends the length of patient hospitalisation (J. K. Miller et al., 2014). In 
addition to antibiotics, anti-inflammatory drugs can be used to slow host-inflicted lung 
damage and the rate of decline in lung function (Cantin et al., 2015). 
 
1.4 Virulence 
1.4.1 Virulence determinants 
Bacterial virulence is vital for the survival of pathogenic bacteria and transmission 
of infectious diseases. Virulence genes control motility, cytotoxicity and the production 
of virulence factors (Breidenstein et al., 2011). Virulence in P. aeruginosa is at its highest 
during planktonic growth to assist invasion and help establish an acute infection in new 
host tissue. Many mechanisms in the cell contribute to bacterial virulence, such as 
motility apparatus in the form of flagella and T4P which are thought to play a role in 
adhesion and movement across the lung substratum. Similarly, lectins enhance adhesion 
to epithelial cells and also reduce ciliary function in the respiratory tract (Khalifa et al., 
2011; Grishin et al., 2015).  
Numerous virulence factors are secreted into the extracellular environment, such 
as elastases which have high proteolytic activity, allowing for the deactivation of 
antibodies and cytokines, and degradation of elastin found within the pulmonary 
epithelium (Kida et al., 2008; Khalifa et al., 2011). Pyocyanin, a blue pigment contributing 
to P. aeruginosa’s colouration, is also secreted and contributes to oxidative stress in the 
host cells, disrupts calcium homeostasis, and inhibits cell respiration and growth (Lau et 
al., 2004). Alkaline protease is secreted by the T1SS and degrades complement 
components of the immune system, as well as cytokines and chemokines, preventing 
phagocytosis (Kida et al., 2008). Whilst exotoxin A, is a toxin secreted by the T2SS which 
inhibits protein synthesis to induce cell death in neighbouring host cells. Other virulence 
factors associated with acute infection include, lipopolysaccharides, which help to protect 
against serum-induced lysis, and rhamnolipids, which are extracellular glycoproteins 
that disrupt mucociliary transport, inhibit phagocytosis and are involved in motility and 
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biofilm formation (Khalifa et al., 2011). Finally, the T3SS is a major virulence factor that 
allows bacteria to inject toxins directly into neighbouring host cells and induce cell death 
by necrosis (Khalifa et al., 2011). 
Once the bacteria have become established, acute virulence factors are down-
regulated and the infection progresses to a chronic stage. During the chronic stage of 
growth, the bacteria develop immune-evasive strategies, promote the expression of 
antibiotic resistance mechanisms and form protected biofilm communities. Virulence 
determinants that are associated with chronic growth include the production of 
siderophores for iron acquisition and the secretion of a polysaccharide-rich matrix 
(Khalifa et al., 2011; Balasubramanian et al., 2013). 
 
1.4.2 Quorum sensing 
QS plays a central role in the regulation of virulence. It is a density-dependent 
bacterial communication system that regulates gene expression in response to critical 
thresholds of signalling molecules. These signals are small diffusible molecules that are 
secreted into the environment and are taken up by neighbouring cells where they bind to 
their cognate receptors. As the bacterial population grows, the concentration of 
accumulated QS signal molecules exceed a critical threshold and trigger the coordinated 
expression of a wide range of genes, most notably virulence-associated genes (Arevalo-
Ferro et al., 2003; Davenport et al., 2015). Paradoxically, QS also enhances biofilm 
formation. The mechanism by which this occurs is not known but it is postulated to work 
through the up-regulation of the psl operon (Diggle et al., 2003; Irie et al., 2010). 
P. aeruginosa utilises four QS systems, the N-acyl-homoserine lactone based 
systems (las and rhl), the alkyquinolone system (pqs), and the recently-identified 
integrated quorum sensing system (IQS) which responds to phosphate limitation (Jones 
et al., 1993; Ochsner et al., 1995; Kirisits et al., 2006; Lee et al., 2013). These interlink in 
a hierarchical manner with the rhl and pqs systems under the control of the las system 
(Figure 1.3) (Lee et al., 2015). The las pathway leads to the production of OdDHL, which 
complexes with the LasR receptor. This complex then multimerises to induce 
transcription of lasI, encoding the OdDHL synthase, and the rhl and pqs systems. The rhl 
system induces the production of N-butanoyl-L-homoserine lactone (BHL) which goes on 
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to bind RhlR and activates transcription of the BHL synthase encoding gene, rhlI. LasR-
OdDHL also upregulates pqsR expression, which in turn, upregulates the Pseudomonas 
quinolone signal (PQS) biosynthesis genes, pqsABCD and pqsH. PQS feeds back by 
promoting transcription of rhlI, whereas RhlR-BHL inhibits the pqs system. The IQS 
system is not as defined as the other pathways but IQS is thought to be a byproduct from 
the biosynthesis of the siderophore pyochelin, and its corresponding receptor has yet to 
be identified (Ye et al., 2014; Sun et al., 2016).   
 
 
Figure 1.3. The intertwined quorum sensing systems of P. aeruginosa which regulate 
gene expression via autoinducer synthases, receptor proteins and feedback regulation. 
 
Numerous environmental factors affect the activity of the QS network, for 
example, phosphate or iron depletion sees a rise in pqs and rhl activity (Bains et al., 2012; 
Lee et al., 2015), oxygen limitation is linked to the las system (Kim et al., 2005), and 
nutrient starvation sees a spike in BHL synthesis (Baysse et al., 2005). Using QS to 
respond to a diverse range of environmental stimuli allows P. aeruginosa to quickly 
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respond and adapt to changes in its surroundings. The las system controls the expression 
of various proteases, such as elastase, LasA protease and alkaline protease, as well as the 
T2SS effector protein, exotoxin A (Nouwens et al., 2003). The rhl system was named after 
its regulation of rhamnolipid production but is also required for regulation of elastase 
and LasA protease, along with the production of hydrogen cyanide, siderophores, lectin, 
and the pigmented virulence factor pyocyanin (Diggle et al., 2003; Chen et al., 2004). The 
pqs system regulates elastase and pyocyanin production but is also linked to iron 
chelation and pro-oxidant activities (Reen et al., 2011). QS, in particular the rhl system, 
negatively regulates T3S without affecting the T3S master regulatory genes, exsCEBAD 
(Bleves et al., 2005; Yahr et al., 2006).  
 
1.4.3 The type III secretion system 
In P. aeruginosa, the T3SS creates a direct link between the bacterial and host 
cytoplasm through which four effector proteins are translocated. These effector proteins 
generate pathogenic effects by disrupting the host cell cytoskeleton to promote apoptosis 
or by disrupting signalling cascades to inhibit phagocytosis (Yahr et al., 2006; Chung et 
al., 2013; Banerjee et al., 2014)  
The T3SS is encoded by over 40 genes, across 5 operons, which constitute the 
translocation apparatus, regulatory proteins, chaperones and effector proteins  
(Figure 1.4) (Brutinel et al., 2010). The syringe-like machinery is an evolutionary 
development from the bacterial flagellum. The needle complex of the T3SS is a hollow 
structure that spans both bacterial membranes and the peptidoglycan layer, transporting 
effector proteins from the cytosol to the translocation apparatus at the tip of the needle. 
The translocation apparatus comprises a translocation pore, formed by PopB and PopD, 
and a secreted protein, PcrV, which is important in pore assembly. PopB/D interact with 
the host cell membrane to deliver the effector proteins into the host cytosol (Hauser, 




Figure 1.4. The type III secretion system of P. aeruginosa. The translocation of numerous exoenzymes, which induce cytotoxicity in host 
cells, through the type III secretion apparatus is controlled by the ExsACDE regulatory cascade, which also controls the transcription of 
over 40 T3SS genes. 
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There are at least four effectors that are secreted by this system, ExoS, ExoU, ExoT 
and ExoY (Anantharajah et al., 2016). At the base of the injectosome, the ATPase activity 
of the basal body separates effector proteins from their chaperones and translocates 
them through the needle complex. ExoS and ExoT share the chaperone, SpcS, whilst 
chaperone, SpcU, interacts with ExoU. Thus far, no chaperones have been identified for 
ExoY. Chaperone proteins are also required for several of the T3S apparatus, including 
PopB and PopD, the structural needle protein, PscF, and regulatory protein ExsE (Hauser, 
2009; Anantharajah et al., 2016). 
ExoS and ExoT are GTPase-activating proteins (GAPs) that disrupt organisation of 
the actin cytoskeleton by targeting small GTPases within the host cell. This prevents the 
cell from migrating or phagocytosing and instead induces cell rounding and detachment 
from neighbouring cells. In addition to their GAP activity, ExoS and ExoT also possess 
ADP-ribosyltransferase domains. In ExoS, this domain inhibits DNA synthesis, affects 
vesicular trafficking, and causes cytotoxicity and apoptosis. ExoS is a major cause of 
pulmonary damage as it disrupts the pulmonary-vascular barrier. The ADP-
ribosyltransferase and GAP domains of ExoT work together to impair phagocytic activity 
and delay wound healing which promotes bacterial invasion (Hauser, 2009; 
Anantharajah, Mingeot-Leclercq and Van Bambeke, 2016). ExoY influences the 
production of numerous cyclic nucleotides, including cyclic adenosine monophosphate 
(cAMP). In doing so, the actin cytoskeleton is disrupted leading to cell necrosis (Yahr et 
al., 1998). And finally, considered a major exotoxin, ExoU has intrinsic phospholipase 
activity, disrupting host cell membranes and promoting necrotic cell death of epithelial 
cells, macrophages and neutrophils. ExoU can also trigger an inflammatory response and 
is associated with acute lung injury and sepsis (Hauser, 2009; Anantharajah, Mingeot-
Leclercq and Van Bambeke, 2016). 
 
1.4.4 Regulation of type III secretion 
The master regulator of T3S is the AraC family transcriptional regulator, ExsA, 
which binds to and promotes transcription of T3SS genes, including the regulation of its 
own expression. Expression of the T3SS is also coupled with secretion of ExsE, and 
involves a partner-switching mechanism between proteins, ExsA, ExsC, ExsD and ExsE 
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(Figure 1.4). Under non-inducing conditions, the binding of these proteins favours 
inhibitory complexes that prevent ExsA-induced transcription of T3SS genes. ExsA is 
bound by the anti-activator ExsD, and ExsE is sequestered by its binding partner ExsC. 
Injectosomes are still expressed at low levels under non-inducing conditions but become 
rapidly up-regulated upon incoming inducing signals. When T3S is activated, ExsE is 
secreted from the cell, releasing its partner ExsC. ExsD then favourably binds the newly-
freed ExsC, which displaces ExsA. In its unbound state, ExsA directly binds T3SS gene 
promoters and initiates transcription (Brutinel et al., 2010).  
There are 10 transcriptional units within the T3SS operons and genes, all of which 
are ExsA-dependent. Activation by ExsA is thought to arise via the monomer assembly 
model, whereby an initial ExsA monomer binds to the promoter at one site and recruits 
a second monomer to a neighbouring second site. The ExsA proteins recruit RNA 
polymerase to the promoter to initiate transcription of T3SS genes, although it is unclear 
whether just one monomer, or both, are responsible for this (Diaz et al., 2011). 
Host cell contact and calcium limitation are highly studied inducers of T3SS 
expression, however the way in which these environmental cues influence T3SS genes is 
poorly understood. So far, besides ExsA, only one other transcription factor, PsrA, has 
been found to regulate T3S. PsrA also regulates motility, polysaccharide production and 
metabolism, and is influenced by the presence of long chain fatty acids (Diaz, King and 
Yahr, 2011). Other biological and environmental changes, such as DNA damage, high salt 
and metabolic stress, have also been associated with the up-regulation of T3S. 
Unfortunately, the way in which these stimuli activate the secretory mechanism is still 
poorly understood (Balasubramanian et al., 2013).  
Virulence factor regulator (Vfr) is a global regulator of virulence gene expression, 
including regulation of T3S, and works in conjunction with its co-regulator, cAMP. Two 
adenylate cyclases, CyaA and CyaB, and the cAMP phosphodiesterase, CpdA, all work to 
modulate the levels of cAMP available to Vfr. Activated Vfr binds the exsA promoter to 
initiate transcription and so there is a positive correlation between T3SS activity and 
intracellular levels of cAMP (Diaz et al., 2011; Marsden et al., 2016). Calcium limitation 
and high salt conditions stimulate the production of cAMP to promote T3S (Diaz, King and 
Yahr, 2011). Interestingly, the biofilm promoting nucleotide, c-di-GMP, has been found to 
reduce virulence-associated phenotypes by interfering with cAMP production (Almblad 
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et al., 2015), and in some Pseudomonas species c-di-GMP regulates secretion systems 
directly via the injectosome ATPase (Trampari et al., 2015). Although the precise 
mechanism behind c-di-GMP interference remains undefined, it provides further 
evidence for the tightly regulated, inverse relationship between virulent, planktonic 
growth and biofilm formation. 
  
1.4.5 The T3SS versus biofilm formation 
The inverse expression profile of the T3SS and biofilm genes is well established. 
These two processes are meticulously regulated to meet the bacterias needs at different 
stages of colony growth. One pathway implicated in this cross-regulation is the Gac/Rsm 
system. The Gac/Rsm pathway is based on a two-component system in which a sensor 
histidine kinase, GacS, modulates the phosphorylation level of its cognate response 
regulator, GacA (Figure 1.5). The signalling activity of GacS is controlled by two sensor 
kinases, RetS and LadS, which work antagonistically to control GacS kinase activity. 
Phospho-GacA upregulates the transcription of two small RNAs, rsmY and rsmZ. Each of 
these RNA molecules can bind multiple copies of the small RNA-binding protein RsmA, 
thereby reducing the concentration of “free” (unbound) RsmA in the cell (Moscoso et al., 
2014). 
Free-RsmA can function as a repressor by binding directly to mRNA 5'UTR 
regions, promoting their degradation by RNases; for example, the T6SS is thought to be 
down-regulated in this way (Frangipani et al., 2014). Repression of the pslA transcript is 
more complex, as RsmA binds to and stabilises a stem-loop structure in which the Shine-
Dalgarno (SD) sequence is made unavailable through base-pairing with an anti-SD 
sequence, thus preventing access by the ribosome (Irie et al., 2010). RsmA can also 
function as an activator, and upregulates motility apparatus and virulence factors, 
including the T3SS. The mechanism behind this is poorly understood but may involve 
mRNA stabilization (Intile et al., 2014). RsmA also regulates rhamnolipid production, 
lipase production, quorum sensing and pyocyanin production, and is vital for balancing 





Figure 1.5. The Gac/Rsm pathway of P. aeruginosa mediates the inverse regulation of 
virulence factors and biofilm-forming genes in response to unknown signals received by 
two sensor kinases, LadS and RetS.  
 
Activation of the Gac/Rsm system is dependent on incoming stimuli detected by RetS 
and LadS. These triggering stimuli are still largely uncharacterised; however, recently 
calcium has been found to bind to the periplasmic domain (DISMED2) of LadS activating 
its kinase activity and ultimately promoting biofilm formation (Broder et al., 2016). This 
provides a mechanism by which an external stimulus can reciprocally affect the 
expression of biofilm genes as well as the T3SS. RetS also contains a DISMED2 domain 
but so far the only known environmental stimuli that activate RetS comes from 
neighbouring lysed cells. It is thought that these lysing cells release danger signals which 
bind to RetS and disrupt it’s inhibition of GacS, leading to the de-repression of the T6SS 






1.5 Siderophores  
1.5.1 Iron and cell survival  
Another component of the P. aeruginosa virulence system is the production of 
siderophores. Iron is essential for almost all of the biological processes that occur in 
bacteria, from metabolic activity and nucleic acid synthesis to electron transfer and redox 
reactions. In the environment, bioavailability of useful iron (Fe2+) is limited due to the 
formation of insoluble ferric oxide-hydroxides (Fe3+). In mammals, Fe3+ is toxic even at 
low levels, and so Fe3+ is sequestered by the iron transport protein, transferrin 
(Johnstone et al., 2015). Withholding iron supplies also serves as a defence mechanism 
against microbial colonisation, and is known as nutritional immunity (Lopez-Medina et 
al., 2015). Therefore, microbes develop specialised mechanisms to acquire iron within 
these iron-limited environments, and so not surprisingly, iron acquisition has been 
correlated with disease severity (Heinrichs et al., 1991).  
In order to obtain iron, bacteria produce small molecules known as siderophores. 
Siderophores are iron chelators that are synthesised in response to iron limitation. With 
a high affinity for iron, siderophores can effectively scavenge ferric ions, even in 
extremely iron-depleted environments. They solubilise Fe3+ and transport it back into the 
bacterial cell making the it available for use (Brandel et al., 2012; Balasubramanian et al., 
2013).  
 
1.5.2 Pyochelin and pyoverdine 
P. aeruginosa synthesises two major siderophores, pyochelin and pyoverdine, 
which specifically chelate Fe3+. These siderophores have distinct structural 
characteristics; pyoverdine is a peptide-based fluorescent siderophore, with two 
hydroxamic groups and an Fe3+ binding dihydroxyquinoline chromophore. Pyochelin, 
however, is a smaller, salicylate-based siderophore that possesses a lower affinity for iron 






Figure 1.6. Siderophores, pyochelin and pyoverdine, produced by P. aeruginosa (image 
taken from Hoegy et al., 2014). 
 
A pyoverdine precursor is synthesised in the cytoplasm via a siderosome, a non-
ribosomal peptide synthesis unit.  The precursor is exported to the periplasm where it 
matures and is secreted from the cell by the PvdR-OpmQ efflux pump. Pyoverdine 
chelates iron with a stoichiometry of 1:1, at which point the ferric-bound pyoverdine 
binds the outer membrane receptor, FpvA, and is transported back into the periplasm. 
The Fe3+ is not chaperoned straight through to the cytosol, but is instead reduced to Fe2+ 
in the periplasm and is internalised, independently of pyoverdine (Figure 1.7). Iron-free 
pyoverdine is recycled back out of the cell to sequester more Fe3+ ions (Bouvier et al., 
2015; Paulen et al., 2017).  As pyoverdine has a much higher affinity for Fe3+ than 
pyochelin it is considered the dominant siderophore for iron acquisition (Hare et al., 
2012a).  
Pyochelin is a much smaller and less complex molecule than pyoverdine. 
Biosynthesis of pyochelin occurs in the cytosol, by proteins encoded on two divergent 
operons, pchDCBA and pchEFGHI. The pyochelin uptake operon, fptABCX, is also clustered 
nearby, along with the regulatory gene, pchR. Pyochelin chelates iron with a 
stoichiometry of 2:1, PCH:Fe and is transported into the cell using the outer membrane 
receptor FptA. Unlike pyoverdine, pyochelin carries iron all the way into the cytosol, 
crossing the inner membrane via the permease, FptX. In the cell, ferric-pyochelin 
activates the PchR regulator, which initiates a positive feedback loop and induces 
expression of pyochelin biosynthesis genes (Youard et al., 2011).  Although the 
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biosynthesis and uptake of pyochelin has been studied extensively, the mechanism 
behind its secretion still remains unknown, as is the mechanism of PCH:Fe dissociation 
and siderophore recycling, which occurs in the cytoplasm (Paulen et al., 2017).  
 
 
Figure 1.7. Pyoverdine (PVD) and pyochelin (PCH) secretion and uptake pathways in  
P. aeruginosa. 
 
Translocation of ferrisiderophores into the cell by their respective outer 
membrane receptors is dependent on the TonB protein. TonB proteins complex with two 
inner membrane proteins, ExsB and ExsD, which use the proton-motive force to provide 
the energy required for active transport of siderophores across the outer membrane.  
P. aeruginosa encodes over 30 TonB-dependent outer membrane receptors, many of 
which play a central role in iron uptake and three TonB proteins with low protein 
similarity (between 30% to 40% amino acid identity). TonB1 is considered to be the 
primary TonB protein but mutants can be partially complemented by TonB2 (Shirley et 
al., 2009; Bouvier et al., 2015).  
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1.5.3 Regulation of iron uptake 
Excess free iron in the cell can lead to the formation of toxic reactive oxygen species, 
and so iron uptake must be tightly regulated. Fur, the ferric uptake regulator, is a DNA 
binding protein and key regulator in maintaining iron homeostasis. In iron-rich 
environments, Fur binds ferric iron within the cell and functions as a transcriptional 
repressor of iron uptake genes by blocking transcription, thus preventing a build-up of 
excess iron. Fur also represses the expression of iron-containing respiratory enzymes, 
anti-oxidant enzymes and the small RNA, prrF, which affects the expression of over 50 
iron-storage genes (Nguyen et al., 2014). Fur-boxes are present in the promoters of all 
siderophore biosynthesis-, regulatory- and uptake-genes. In the case of pyochelin, iron-
limited conditions cause Fur to be released from the promoter of pyochelin biosynthesis 
genes allowing expression to occur at a basal level. At this point, ferric-pyochelin activates 
the regulator, PchR, and together they rapidly promote the up-regulation of the pyochelin 
biosynthesis operons (Youard et al., 2011).  
 
1.5.4 Siderophores and virulence 
The role of siderophores and iron acquisition in infection and virulence has been 
documented across many bacterial species. In P. aeruginosa, Fe3+ uptake is essential for 
infection in mouse pneumonia models, and mutants defective in pyoverdine, pyochelin 
and TonB all exhibit lower levels of virulence (Minandri et al., 2016).  Binding of ferric-
pyoverdine to the membrane receptor, FpvA, initiates a signalling cascade from the cell 
surface into the cytoplasm via FpvR, an anti-sigma factor. This cascade induces the 
activation of FvpI and PvdS sigma factors (Figure 1.7). FvpI specifically promotes 
expression of the fvpA receptor gene, whereas PvdS coordinates the expression of 
numerous genes involved in pyoverdine biosynthesis and transport, and also controls 
two virulence factors, PrpL and exotoxin A (Minandri et al., 2016).  PrpL is an 
extracellular endoprotease and can degrade host iron-binding proteins, such as 
lactoferrin and transferrin, and exotoxin A inhibits protein synthesis (Wilderman et al., 
2001). The role of siderophores in virulence make them a major influence in acute 
infection. However, they appear to be far less important during chronic infection with one 
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study finding that one-third of P. aeruginosa isolates from the CF lung no longer produce 
pyoverdine (De Vos et al., 2001).  
Fur-mediated regulation of the T3SS and T6SS, has been demonstrated in 
Bordetella pertussis, B. bronchiseptica, E. coli and Edwarsiella tarda, where iron starvation 
leads to the repression of T6SS genes and the up-regulation of T3SS genes. This highlights 
that iron depletion can act as a nutritional stressor which triggers the expression of 
virulence determinants and promotes bacterial pathogenicity. Due to the conservation of 
the T3SS and T6SS across bacterial species this activation may also occur in P. aeruginosa 
(Brickman et al., 2011; Brunet et al., 2011; Chakraborty et al., 2011; Kurushima et al., 
2012).  
Manipulation of siderophores has recently opened up a new method for targeting 
bacteria with antimicrobial agents. P. aeruginosa can bind siderophores from other 
Pseudomonas species, allowing them to ‘piggy-back’ off these strains and reduce their 
own energy costs. Because of this promiscuity in the outer membrane receptors, 
antibiotic-siderophore conjugates are being tested as potential vectors to deliver 
antibiotics into the cell via the bacteria’s own translocation machinery, aptly named the 
Trojan Horse strategy (Bouvier et al., 2015; Paulen et al., 2017).   
 
1.6 Elongation factor G 
1.6.1 Ribosomal translation 
Cell growth and survival relies almost entirely on efficient protein synthesis. At 
the centre of protein synthesis is the ribosome, where amino acids are bonded together 
to form polypeptide chains in relation to an mRNA transcript. In P. aeruginosa, the 
ribosome is made up of 57 highly conserved ribosomal proteins and 3 ribosomal RNAs 
(rRNAs); 23S, 16S, and 5S (Wilson, 2014; Valot et al., 2015). Together these comprise the 
70S ribosome, which can be further divided into the small (30S) and large (50S) subunits 
(Wilson, 2014).   
Four main processes occur during protein synthesis; initiation, elongation, 
termination and recycling. Firstly, with the assistance of three initiation factors, the 
ribosome binds to an mRNA transcript and positions the start codon and an initiator tRNA 
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within the P-site of the ribosome. The P-site is one of 3 binding pockets that accommodate 
tRNA within the ribosome. Following the initiator tRNA, the relevant, charged tRNA, that 
corresponds to the mRNA codon sequence, is positioned in the A-site (Aminoacyl-tRNA 
binding site), and progressively moves to the P-site (Peptidyl-tRNA binding site) and 
finally into the E-site (tRNA Exit site) before being released from the ribosome (Figure 
1.8) (Zhou et al., 2014). Elongation factor Tu (EF-Tu) helps to incorporate aminoacylated-
tRNA into the A-site of the ribosome in a template-dependent manner through base-
pairing between the tRNA and mRNA transcript. A peptide bond is formed between the 
neighbouring amino acids within the A- and P-sites, at which point, elongation factor G 
(EF-G) orchestrates the translocation of tRNAs from the A- to P-site and from the P-site 
to E-site of the ribosome. This process is repeated and the polypeptide chain elongates 
through an exit tunnel located within the large subunit. The mRNA is also moved through 
the ribosome until a stop codon is encountered; at which point release factors hydrolyse 
the peptidyl-tRNA bond and the polypeptide chain is released. The ribosomal units then 




Figure 1.8. Structural conformation of elongation factor G when bound to the ribosome 
and during translocation of aminoacyl-tRNA from the A-site to the P-site of the ribosome 
(image taken from Lin et al., 2015). 
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EF-G is essential for protein synthesis. The precise mechanism by which EF-G catalyses 
tRNA translocation is still not fully understood but the top of the aminoacyl-tRNA is 
predicted to move first, followed by subsequent movement of the anticodon end of the 
tRNA, coupled with mRNA translocation in the small ribosomal subunit. During the 
elongation steps the ribosome undergoes several conformational changes to 
accommodate these dynamic movements and EF-G also experiences its own structural 
rearrangements which mediate binding, GTPase activity and disassociation from the 
ribosome (Salsi et al., 2015).  
 
1.6.2 Elongation factor G 
EF-G is comprised of five domains; domain I is the site for GTP binding and 
hydrolysis and domain IV docks into the A-site of the ribosome where it interacts with 
the mRNA transcript promoting translocation (Salsi et al., 2014). In its cytosolic form,  
EF-G adopts a compacted structure where domains I and V are folded closely to one 
another. EF-G binds the ribosome in its compact form but during translocation it 
subsequently undergoes inter-domain rearrangements to take on an elongated 
conformation, thought to aid positioning of domain IV within A-site of the ribosome 
(Figure 1.8) (Connell et al., 2007; Lin et al., 2015).  
P. aeruginosa synthesises two paralogous EF-G proteins which are encoded by two 
distinct genes, fusA1 and fusA2, positioned separately within the genome (4.77 Mbp and 
2.27 Mbp, respectively) (Winsor et al., 2016).  The amino acid sequence of the two 
paralogues is highly conserved, with a shared identity of 84%, however it is likely that 
these two proteins have distinct roles. EF-G1B, encoded by fusA2, is predicted to have 
greater involvement in elongation and polypeptide synthesis than EF-G1A, encoded by 
fusA1. However, EF-G1A is predicted to have a more dominant role in ribosomal recycling 
and association with ribosomal recycling factors (Palmer et al., 2013).  
FusA was named after EF-G’s ability to bind fusidic acid and the observed 
resistance resulting from fusA mutation. Fusidic acid is a steroid-like antibiotic which 
inhibits protein synthesis by disrupting peptide elongation. It typically has a low affinity 
for EF-G, but when EF-G is bound to the ribosome fusidic acid forms a strong complex 
with the protein. Once bound, fusidic acid locks EF-G into the post-translocation site, 
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blocking any more GTPase activity and preventing dissociation of EF-G from the post-
translocation ribosome, thus arresting the continuation of peptide elongation (Borg et al., 
2015). EF-G1B encoded by fusA2 is more sensitive to the effects of fusidic acid than  
EF-G1A, and so is most likely to be responsible for the emergence of fusidic acid 
resistance upon mutation (Palmer et al., 2013). 
 
1.6.3 Regulating protein synthesis 
Protein synthesis is one of the most fundamental steps in gene expression. 
Coordinating the ribosome with mRNA, translation factors and tRNA defines protein 
abundance and ensures that the protein requirements of the cell are met. Within one cell 
there is little correlation between mRNA and protein levels, suggesting that protein 
abundance is predominantly controlled at the translational step (Liu et al., 2016; 
Rodnina, 2016). Even on a single transcript, rates of protein synthesis vary considerably, 
with periods of rapid synthesis followed by interspersed pausing. Pauses in elongation 
may be determined by regulatory signals encoded on the mRNA, but often, it is due to the 
availability of cellular resources such as aminoacyl-tRNA and translation factors. 
Prolonged pauses are termed ‘ribosomal stalling’ and can result from numerous hold ups, 
but the most common is often peptide-mediated stalling from unsuccessful peptidyl 
transfer. Ribosome stalling can result in multiple ribosomes queuing along the mRNA 
transcript which then slows translation across numerous other ribosomes. Stalled 
ribosomes need to be disassembled and recycled rapidly to prevent downstream effects 
on the quality and composition of the cellular proteome (Keiler, 2015; Rodnina, 2016). 
 
1.6.4 Ribosome-targeting antibiotics 
Because the ribosome plays such a central role in cell survival it is an obvious 
target for antimicrobial agents. The majority of ribosomal-targeted drugs interfere with 
the elongation phase of protein synthesis and include aminoglycosides, 
chloramphenicols, fusidic acid and tetracyclines. These antibiotic binding sites are 
typically located at positions of mRNA-tRNA interaction which disrupt their association 
(Wilson, 2014).  
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Resistance to the major classes of ribosome-targeting antibiotics occurs through 
the up-regulation of efflux systems to remove the drug from the cell, and through 
mutations in the genes encoding ribosomal proteins and rRNA, which prevent antibiotic 
binding (Kotra et al., 2000). The bacterial genome contains duplications of rRNA operons, 
with P. aeruginosa possessing four copies (Bodilis et al., 2012). This means that antibiotic 
resistance through rRNA mutation is very rare and would require a recurring mutation 
across all four operons. However, ribosome-associated proteins are usually only found in 
single copy within the genome, so resistance to antibiotics through mutation to these 
genes is far more common. Such mutations often cause conformational adjustments in 
the rRNA which consequently affects antibiotic binding (Wilson, 2014).  
One group of ribosome-targeting antibiotics are the aminoglycosides. 
Aminoglycosides are hydrophilic sugars with an affinity for nucleic acids. 
Aminoglycosides irreversibly bind to the 16S rRNA within the small subunit of the 
ribosome and interfere with tRNA selection. It seems that different aminoglycosides, such 
as gentamicin, kanamycin and paromomycin, all bind to the A-site decoding region in a 
common manner. Aminoglycosides alter the conformation of the A-site and disrupt 
interactions between tRNA and mRNA, leading to erratic base pairing and rapid 
termination of peptide synthesis leading to cell death (Kotra, Haddad and Mobashery, 
2000). Resistance to aminoglycosides has been seen to emerge from methylation of the 
16S rRNA, up-regulation of antibiotic-modifying enzymes, and the up-regulation of efflux 











1.7 Objectives of this study  
During the inital stages of this project I observed a mutation in the gene, fusA1, 
which encodes EF-G. This mutation conveyed resistance to gentamicin and a reduction in 
the expression of a biofilm-associated gene, cdrA.  
Having identified this interesting mutation, the research aims of this study were 
to investigate the involvement of EF-G in biofilm formation and develop the 
understanding of its role in antibiotic resistance. This aim raises the following project 
objectives: 
 To characterise the position of the fusA1 mutation and determine its effect on the 
structure of EF-G.  
 To measure the effect that the mutated EF-G protein has on biofilm formation, 
along with assessing the impact it has on bacterial virulence. 
 Synthesise data from proteomic and transcriptomic analysis to establish the 



















2 Materials and methods 
2.1 Bacterial strains  
Bacterial strains used in this study can be found in Table 2.1. Bacterial strains were 
stored at -80oC in 25% (v/v) glycerol solution. Viable bacteria could be stored on media 
agar plates at room temperature for up to two weeks.  
 
Table 2.1. List of bacterial strains. 
Strain Genotype Reference 
Pseudomonas aeruginosa 
PAO1 Wild type B. Iglewski, University of 
Rochester, USA 
PAPcdr PAO1, Mini-CTX-PcdrA::lacZ, Tcr This study 
FUS443 PAPcdr derivative, containing a cytosine to 
thymidine substitution in fusA1 at gene 
position 1328 (of 2121 bp)  
This study 
FUS443C FUS443, expressing fusA1 in trans from a 
pUCP20 expression vector 
This study 
PpqsA::lux  PAO1, pqsA mutant containing a 
PpqsA::luxCDABE gene fusion 
Fletcher et al., 2007 
 
Escherichia coli 
DH5α (F-) supE44 ΔlacU169 (φ80lacZΔM15) ΔargF 
hsdR17 recA1 endA1 thi-1 relA1 
Gibco, BRL 
JM109 endA1 recA  gyrA96 thi hsdR17 (rk–, mk+) relA1 
supE44 Δ(lac-proAB) 
(F´ traD36, proAB, laqIqZΔM15) 
Yanisch-Perron et al., 1985 
β2163  (F-) RP4-2-Tc::Mu_dapA::(erm-pir), Kmr Emr Demarre et al., 2005 







2.2 Growth conditions 
Unless otherwise stated, bacterial cultures were grown in M9 minimal media 
supplemented with 0.5% (w/v) glucose and incubated at 37oC.  
 
2.2.1 Overnight cultures 
A single bacterial colony was used to inoculate 10 mL of growth media in a  
25 mL universal tube. The culture was grown at 37oC for approximately 16 h on a rotating 
wheel. If appropriate, antibiotic selection was maintained throughout incubation. 
Unless otherwise stated, experiments were conducted in triplicate using three 
biological replicates deriving from three independent bacterial colonies.  
 
2.2.2 Planktonic cultures 
For planktonic growth, overnight cultures were used to inoculate 50 mL of media 
in 250 mL conical flasks to a starting optical density (OD600) of 0.05, for growth in LB, or 
0.1, for growth in M9 minimal media. Cultures were incubated at 37oC in a shaking water 
bath at 210 rpm for aeration of the culture. If appropriate, antibiotic selection was 
maintained throughout growth.  
 
2.2.3 Growth on solid media 
Colonies were grown in 10 cm diameter Petri-dishes containing 25mL growth 
media with 1.5% (w/v) agar and incubated at 37oC overnight.  
For growing cells from frozen stocks, frozen cells were defrosted on the surface of 
the agar at room temperature. A sterile inoculation loop was used to spread the cells 






2.2.4 Growth media 
Growth media and constituents are listed in Table 2.2. Media, solutions and 
glassware were sterilised by autoclaving at 121oC for 15 min. 
 
Table 2.2. Growth media and solutions.  
Growth media Components per litre 
LB broth (Lennox) 10 g peptone 
5 g yeast extract 
5 g sodium chloride 
1X glucose M9 minimal media  
 
200 mL 5X M9 minimal salts (Difco) solution 
0.2% (w/v) magnesium sulfate 
0.01% (w/v) calcium chloride 
0.5% (w/v) glucose 
For solid agar plates  Growth media containing 1.5% (w/v) agar 
Congo Red solid media 37 g Brain-Heart infusion broth 
50 g sucrose 
0.8 g Congo Red 
Congo Red liquid media M9 minimal media  
0.8 g Congo Red 
 
Solutions 
M9 Minimal Salts, 5X  
(BD Difco) 
33.9 g disodium phosphate 
15 g monopotassium phosphate 
2.5 g sodium chloride 
5 g ammonium chloride 
Phosphate buffered saline (PBS) 10 g phosphate buffered saline tablets (Dulbecco A)  
Lysis buffer 100 mM Tris-HCl 
50 mM sodium chloride 
20 mM EDTA 
10% (v/v) glycerol 
1 mM DTT 




Table 2.2 continued  
Protein loading dye 50 mM Tris-HCl 
2% (w/v) SDS 
0.1% (w/v) bromophenol blue 
10% (v/v) glycerol 
10 mM dithiothreitol 
Stacking buffer, 5 X 60 g Tris-HCl 
0.5% (w/v) SDS 
pH 6.8 
Resolving buffer, 5 X 151 g Tris-HCl 
0.5% (w/v) SDS 
pH 8.8 
SDS-PAGE running buffer 15 g glycine 
3 g Tris-HCl 
0.1% (w/v) SDS 
pH 8.3 
Protein purification buffer 50 mM sodium phosphate 
200 mM sodium chloride 
10% (v/v) glycerol 
10 mM imidazole 
pH 8.0 
Elution buffer 50 mM sodium phosphate 
200 mM sodium chloride 
10% (v/v) glycerol 
250 mM imidazole 
pH 8.0 
Dialysis buffer 50 mM Tris-HCl 
100 mM sodium chloride 
5% (v/v) glycerol 
pH 7.4 
TAE buffer  40 mM Tris-HCl 
20 mM acetic acid 






The antibiotics used in this study are listed in Table 2.3. Antibiotics were 
solubilised in water and stored at 4oC, or in 50% (v/v) ethanol solution and stored at  
-20oC. All antibiotics were filter-sterilised using 0.2 μm membrane filters (Millipore).  
 
Table 2.3. Antibiotics and media supplements. 
Antibiotic Solvent 
Working concentration (μg/mL) 
P. aeruginosa E. coli 
Carbenicillin, Cb 50% (v/v) ethanol 250 50 
Fusaric acid 50% (v/v) ethanol >1300 - 
Fusidic acid 50% (v/v) ethanol 1750 - 
Gentamicin, Gm Water 50 10 
Kanamycin, Km Water 1000 25 
Rifampicin Water 100 - 
Tetracycline, Tc 50% (v/v) ethanol 50 10 
DAPA Water - 40 
X-gal Dimethylformamide 30 - 
Iron(III)Chloride Water 0.811 - 
 
2.3.1 Determining minimal inhibitory concentrations 
Single colonies were streaked onto M9 minimal media plates, supplemented with 
glucose and containing increasing concentrations of antibiotic.  The concentration at 
which no cells grew after 24 hours of incubation at 37oC was determined as the minimum 
inhibitory concentration.  
 
2.4 Measuring growth and harvesting planktonic cells 
Planktonic cultures were grown as described in ‘2.2.2 Planktonic cultures’. To 
measure growth of the culture, the OD600 was measured every hour using a 
spectrophotometer (Jenway 6715). If the optical density exceeded 0.9, bacterial cultures 
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were diluted in the same growth media to ensure that the readings were within the range 
of optimal sensitivity.  
In M9 minimal media, cells harvested at an OD600 of 0.2 – 0.7 represent cells in 
exponential growth. Cultures harvested at an OD600 of 0.7 - 1.2 represent cells in a late 
exponential phase of growth, and cultures exceeding an optical density of 1.2 are 
considered to have entered stationary growth.  
 
2.5 Viable cell counts 
Bacterial cultures were diluted in increasing dilution factors, from 10-3 to 10-10, in 
fresh growth media. From each dilution, 10 μL was spotted onto a media agar plate and 
incubated at 37oC overnight. Colonies were counted to determine the number of viable 
cells per mL. Comparisons were made between viable cell counts on agar plates without 
antibiotics and those supplemented with antibiotics to assess plasmid retention during 
growth.  
For measuring the retention of antibiotic resistance across bacterial generations, 
overnight cultures were diluted by 10-6, and 100 μL was plated on agar media, 
supplemented with and without antibiotics. The remaining culture was sub-cultured and 
grown for a further 24 h before repeating this process until the bacterial culture had been 
sub-cultured 3 times.  
 
2.6 Cloning techniques 
2.6.1 DNA extraction 
Genomic DNA (gDNA) was extracted from bacterial cultures using the GeneJET 
Genomic DNA Purification Kit. Plasmid DNA was extracted from bacterial cultures using 
the GeneJET Plasmid Miniprep Kit. The concentration of the extracted DNA was 
determined on a NanoDrop ND-1000 Spectrophotometer and was stored at -20oC. The 




Table 2.4. Plasmids used in this study. 
Plasmid Description Source 
pUCP20 Escherichia to Pseudomonas shuttle vector, Cbr West et al., 1994 
Mini-CTX-PcdrA::lacZ Vector for the integration of a single-copy 
chromosomal PcdrA::lacZ gene, Tcr 
Welch (unpublished) 
pFLP2 Site-specific excision vector with flippase, Cbr Becher and Schweizer, 2000 
pFLP2-cre Site-specific excision vector with cre-
recombinase, Cbr 
Welch (unpublished) 
pTnMod-OGm Self-cloning mini-transposon for stable 
integration in the genome, Gmr 
Dennis and Zykstra, 1998 
pfusA1 pUCP20 for the expression of fusA1 driven by 
the lac promoter, Cbr 
This study  
pP443L pUCP20 for the expression of fusA1 containing 
a cytosine to thymidine substitution at gene 
position 1328 (of 2121 bp), driven by the lac 
promoter, Cbr 
This study 
pSB536 BHL reporter plasmid, ahyR::luxCDABE, , Cbr    Swift et al., 1997 
pSB1142 OdDHL reporter plasmid, PlasR::luxCDABE, Tcr Winson et al., 1998 
pET19m::fusA1 Vector for inducible expression of N-terminally 
10xHis-tagged fusA1, Cbr 
This study 
pET19m::P443L Vector for inducible expression of N-terminally 




2.6.2 Polymerase chain reaction (PCR) 
PCR was performed using 50 μL of reaction mixture that contained up to 250 ng 
template DNA, 10 μM of forward and reverse primers, 10 mM dNTPs, Phusion HF buffer, 
0 – 10% (v/v) dimethyl sulfoxide (DMSO), and Phusion DNA polymerase. Reaction 
conditions were determined based on the length of the amplicon and the annealing 
temperature of the primers. Table 2.5 lists the reaction cycle recommended by the 
manufacturer for amplification using Phusion polymerase, and Table 2.6 lists the primers 




Table 2.5. Phusion PCR amplification program. 
Phusion DNA polymerase  











20 sec/kb of amplicon 




Table 2.6. Oligonucleotide primers uses in this study. 
Primer Sequence (5’ – 3’) Restriction 
sites 
Pserup CGAGTGGTTTAAGGCAACGGTCTTGA  
Pserdown AGTTCGGCCTGGTGGAACAACTCG  
fusA1 Forward ATATATCTGCAGAGGAGGTTAATTGTGGCCCGTA PstI 
fusA1 Reverse AGCCCGAAGCTTTCAACCTTGTTTTTTAAC  HindIII 
pUCP20 MCS1 GTTGTAAAACGACGGCCAGT  
pUCP20 MCS2 TTGAGTGAGCTGATACCGCT  
pslA Forward ATCGAGTACTTCCTGGTCGC  
pslA Reverse CCCAGGCGAAGAACATGATG  
pcrV Forward TCAAGGATTTTCTCAGCGGC  
pcrV Reverse AGGGTGGTCTTCTCGTTGAC  
exsA Forward GGGCGTATATGTTCTGCTCG  
exsA Reverse CTCGACTTCACTCAACAGCG  
P443L verification Forward ATATTTGAATTCGATGACGACAAGGGCATG  
P443L verification Reverse ATATTTAAGCTTGGACATGGAACGCACGTC  
pET19m::fusA1 Forward ATATATCATATGGTGGCCCGTACTAC NdeI 
pET19m::fusA1 Reverse ACGTTACATATGTCAACCTTGTTTTTT NdeI 
Orientation check Forward AGGGGAATTGTGAGCGGATA  






2.6.3 Colony PCR 
For PCR on bacterial colonies, a single colony was diluted in 100 μL of sterile dH20. 
In a 50 μL reaction, 2 μL of the diluted cells was added to the PCR mixture in place of the 
DNA template.  
 
2.6.4 Agarose gel electrophoresis  
DNA fragments were separated, based on size, by electrophoresis through agarose 
gels. Agarose was dissolved in 1x Tris-Acetate-EDTA (TAE) buffer, supplemented with 
0.4 μg/mL ethidium bromide, and allowed to set. Nucleotide samples were prepared with 
6x DNA Loading dye (Thermo Scientific) and were loaded onto 0.8% (w/v) agarose gels 
for fragments >2 kb, 1% (w/v) agarose for fragments between 0.5 – 2 kb and 2% (w/v) 
agarose gels for smaller fragments <0.5 kb. Hyperladder 1 kb (Bioline) was loaded as a 
sizing reference (200 – 10,000 bp) for DNA fragments and the samples were 
electrophoresed at 80 V for 1 h. DNA was visualised using a UV transilluminator.  
To purify DNA from within agarose gels, bands containing the desired DNA 
fragments were excised from the gel using a scalpel and the DNA was extracted from the 
agarose using the GeneJET Gel Extraction Kit. The concentration of the extracted DNA was 
determined on a NanoDrop ND-1000 Spectrophotometer and samples were stored at  
-20oC. 
 
2.6.5 Restriction digest and DNA ligation 
 DNA was digested with restriction enzymes (NEB) according to the 
manufacturer’s instruction. If treated with Shrimp Alkaline Phosphatase (NEB) this was 
added for 30 min at 37oC following the restriction digest to prevent self-religation of DNA. 
Samples were checked for successful digestion by gel electrophoresis and were gel-
purified.  
 For the ligation of fragmented DNA into cut plasmid DNA, ligation reactions were 
prepared according to the manufacturer’s instruction for T4 ligase. The reaction mixture 
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was incubated on ice for 1 h followed by 1 h at room temperature. Ligation mixture was 
stored at -20oC or used directly for transformation by electroporation. 
 
2.7 Transformation of P. aeruginosa by electroporation 
Bacterial cultures were sub-cultured for 3 hours in 10 mL fresh media to harvest 
cells during exponential growth. Cells were sedimented in a centrifuge at 3,200 x g for  
5 min, at 20oC. The cells were washed 3 times by resuspending the pellet in 10 mL of 
sterile dH20 and re-pelleting the sample. The final resuspension was in 100 μL of dH20 
and the sample was incubated for 20 min. Cells were then incubated with 0.2 – 1 μg 
plasmid DNA, or 2 μL of ligation mixture, for 10 min and transformed by electroporation 
at 2.5 kV (25 μF, 200 Ω, time constant of 5 ms). Immediately after electroporation, 1 mL 
of LB was added to the transformed cells and was incubated at 37oC for 1 hour to allow 
the cells to recover. Cells were then centrifuged at 21,000 x g for 5 min, and resuspended 
in 100 μL of growth media. The transformed cells were plated onto selective agar media 
and grown at 37oC overnight. Unless otherwise stated, all incubation and centrifugation 
steps were performed at room temperature. 
 
2.8 Transformation of E. coli by electroporation 
Bacterial cultures were grown overnight and sub-cultured for 3 hours in 10 mL of 
fresh media. Cells were centrifuged at 3,200 x g for 5 min, 4oC and the pellet washed  
3 times in pre-cooled, sterile dH20. After the final centrifugation, cells were resuspended 
in 100 μL of cold dH20 and incubated on ice for 20 min, followed by the addition of 0.2 – 
1 μg plasmid DNA and incubation on ice for 10 min. Competent cells were electroporated 
and plated onto selective agar. 
 
2.9 Construction of the PAPcdr strain 
The expression-reporter vector, mini-CTX-PcdrA::lacZ, contains a gene fusion 
between the promoter sequence of cdrAB and lacZ, and stably integrates into a neutral 
site within the genome as a single copy. Mini-CTX-PcdrA::lacZ was introduced into PAO1 
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by electroporation and transformants were selected for on 50 μg/mL tetracycline. pFLP2 
was introduced into the transformants through bi-parental conjugation with β2163 
(pFLP2), as defined in ‘2.12 bi-parental mating’. Successful conjugants were selected 
for on carbenicillin. The pFLP2 plasmid encoded a flippase gene which acted on specific 
Flp-recombinase target (FRT) sites within the mini-CTX construct to excise the 
tetracycline-resistance cassette. Transformants were streaked onto LB agar 
supplemented with 5% (w/v) sucrose to remove pFLP2 from the cell, and onto LB agar 
supplemented with tetracycline to verify successful excision of the tetracycline-
resistance cassette. Loss of pFLP2 was confirmed through carbenicillin sensitivity. 
Pserup and Pserdown primers were used to verify that mini-CTX-PcdrA::lacZ had 
been successfully incorporated into the specified neutral site within the genome. Colonies 
were streaked onto media agar containing X-gal to detect the expression of  
β-galactosidase from the PcdrA::lacZ construct, as described in ‘2.14.2 β-galactosidase 
assays’. 
 
2.10 Construction of pfusA1 and pP443L expression vectors 
The fusA1 gene was amplified from PAO1 gDNA using primers, ‘fusA1 Forward’ 
and ‘fusA1 Reverse’, and standard PCR conditions for Phusion polymerase. The PCR 
product was run on an agarose gel and the corresponding band was gel-purified. The 
amplicon and expression vector, pUCP20, were digested with restriction enzymes, PstI 
and HindIII, and the fusA1 gene was ligated into the pUCP20 vector downstream of the lac 
promoter. The construct was confirmed by PCR using primers ‘pUCP20 MCS1’ and 
‘pUCP20 MCS2’. The same method was used to create an expression vector of the mutated 
fusA1-P443L variant using gDNA extracted from the FUS443 mutant. 
 
2.11 DNA sequencing 
DNA sequences were determined through Sanger sequencing conducted by GATC 




2.12 Bi-parental mating 
The recipient P. aeruginosa strain and donor E. coli, β2163, strain were grown 
individually overnight in LB with the appropriate antibiotic selection and diaminopimelic 
acid (DAPA) supplementation for β2163.  
Bacterial cultures were normalised to an OD600 of 1 in LB and centrifuged at  
21,000 x g for 10 min at room temperature. The bacterial pellets were washed in LB to 
remove the presence of antibiotics and combined in a 1:1 ratio to a total volume of  
1 mL. The cell suspension was pelleted and resuspended in 50 μL of LB which was spotted 
onto LB agar supplemented with DAPA and incubated at 37oC for 12 - 18h. Cells were 
scraped from the agar plate and resuspended in 1 mL of PBS. The suspension was diluted 
by a dilution factor of 2 and 100 μL was plated onto LB agar supplemented with antibiotic 
selection, and incubated for 24 h at 37oC. DAPA was omitted from the dilution plates to 
prevent E. coli growth,  
 
2.13 Whole genome sequencing 
Bacterial strains were sent to MicrobesNG for whole genome sequencing on an 
Illumina HiSeq 2500 platform. Genomic DNA libraries were prepared using Nextera XT 
Library Prep Kit (Illumina) following the manufacturer’s protocol with the following 
modifications: two nanograms of DNA were used instead of one, and PCR elongation time 
was increased to 1 min from 30 seconds. DNA quantification and library preparation 
were carried out on a Hamilton Microlab STAR automated liquid handling system. Pooled 
libraries were quantified using the Kapa Biosystems Library Quantification Kit on a Roche 
light cycler 96 qPCR machine. Libraries were sequenced on the Illumina HiSeq using a 
250bp paired end protocol. Reads were adapter trimmed using Trimmomatic 0.30 with 
a sliding window quality cutoff of Q15. De novo assembly was performed on samples 
using SPAdes version 3.7, and contigs were annotated using Prokka 1.11. 
Genome alignment and analysis of gene disruptions were determined using 





2.14 Phenotypic assays 
2.14.1 Biofilm assay 
Bacterial cultures were normalised to an OD600 of 0.1 in fresh growth media and 
100 μL was added per well to a 96-well microtitre plate. Plates were sealed with sterile 
film (StarLab breathable self-adhesive film) and incubated statically at 37oC or on a 
shaking platform for 24 hours. Planktonic cells were aspirated from the wells and the 
remaining biofilm cells that were adhered to the sides of the wells were washed with  
120 μL of dH20 and stained with 100 μL of 0.1% (w/v) crystal violet for 15 min at room 
temperature. Wells were then washed 3 times with 120 μL dH20 and dried before  
re-solubilising the crystal violet in 120 μL of 30% (v/v) acetic acid for 15 min at room 
temperature. Biofilm mass was quantified by measuring absorbance at 595 nm.  
 
2.14.2 β-galactosidase assays  
2.14.2.1 Bacterial colonies 
For reporter strains containing a lacZ gene fusion, β-galactosidase activity was 
visualised by streaking or spotting 10 μL of bacterial culture onto media agar 
supplemented with 30 μg/mL X-gal (5-bromo-4-chloro-3-indolyl β-D-
galactopyranoside). β-galactosidase expression and activity was visualised through the 
production of a blue pigmented product.  
 
2.14.2.2 Planktonic cells 
For measuring β-galactosidase activity in planktonic cultures, 100 μL of cell culture 
was harvested and frozen at -80oC in a 96-well microtitre plate. The plate was defrosted 
for 30 min at 37oC and 10 μL was transferred to a fresh 96-well microtitre plate. The 
samples were frozen at -80oC for a second time to further permeabilise the cells, followed 
by thawing at room temperature. To quantitatively measure the level of  
β-galactosidase expression, 100 μL of reaction mixture (PBS solution containing  
20 mg/mL lysozyme and 250 μg/mL 4-methylumbellifryl-β-galactoside) was added to 
the cells. The reaction was measured using the Gemini XPS fluorimeter (Molecular 
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Devices) at an excitation wavelength of 360 nm and emission wavelength of 450 nm, 
every 30 sec for 30 min at 37oC, with a cut-off wavelength of 435 nm.  
 
2.14.2.3 Colony biofilms 
For quantitative measurement of β-galactosidase activity in bacterial colony 
biofilms, a sterile 0.1 μm membrane filter (Durapore) was placed on the surface of an M9 
minimal media agar plate and 10 μL of bacterial culture was spotted onto the filter. The 
plate was incubated at 37oC for 24 h and the filter was removed and submerged in 1 mL 
PBS buffer. The solution was vortexed vigorously to displace the bacterial colony from 
the filter into the solution, from which 100 μL was frozen at -80oC. The cells were 
defrosted and tested as described in ‘2.14.2.2 Planktonic cells’. 
 
2.14.3 Motility assays 
2.14.3.1 Twitching  
Agar plates for the detection of twitching motility were prepared using 10 mL of 
1.5% (w/v) LB or M9 minimal media agar into 10 cm diameter Petri-dishes. Single 
colonies were stabbed into the agar and incubated at 37oC for up to 48 h. Twitching was 
visualised through a halo of dispersion around the point of inoculation.  
 
2.14.3.2 Swimming 
Agar plates for the detection of swimming motility was prepared by pouring  
25 mL of LB or M9 minimal media containing 0.3% (w/v) Bacto agar into 10 cm diameter 
Petri-dishes and dried at room temperature for 30 min. Bacterial cultures were 
normalised to an OD600 of 1, and 3 μL of culture was dispensed at the bottom of the plate. 







For the detection of swarming motility, plates were prepared with 25 mL of LB or 
M9 minimal media containing 0.75% (w/v) Eiken agar in 10 cm diameter Petri-dishes 
and dried for 30 min at room temperature. Bacterial cultures were normalised to an 
OD600 of 1, and 5 μL was spotted onto the surface of the agar and left to soak in. Swarm 
plates were incubated at 37oC for 8 – 18 h.  
 
2.14.4 Exoenzyme assays 
2.14.4.1 Caseinase production 
Skim milk agar plates were used for the detection of caseinase activity and were 
prepared with 25 mL of 50 g/L tryptic soy agar containing 2% (w/v) skimmed milk. 
Bacterial cultures were normalised to an OD600 of 1, and 5 μL was spotted onto the agar 
and left to soak in. Plates were incubated at 37oC overnight after which caseinase activity 
could be visualised through a proteolytic halo around the bacterial culture.  
 
2.14.4.2 Gelatinase production 
Gelatinase activity was measured on 1.6% (w/v) agar plates containing 13 g/L 
Nutrient broth and 30 g/L gelatin. Bacterial cultures were normalised to an OD600 of 1, 
and 5 μL was spotted onto the agar and left to soak in. Plates were incubated at 37oC 
overnight, at which point the plates were flooded with saturated ammonium sulfate 
solution for 15 min to improve visualisation of the proteolytic halo.  
 
2.14.5 Aggregation assay 
Auto-aggregation assays were adapted from Sherlock et al. (2005). Bacterial 
cultures were sub-cultured in 10 mL of fresh media and grown at 37oC to an OD600 of 0.8. 
The cultures were left to settle at room temperature without agitation for  
3 h. From the top of the culture, 500 μL of the culture, representing the ‘non-settled’ 
fraction of the culture, was measured at OD600. The culture was then vortexed vigorously 
47 
 
to disrupt cell aggregates and the OD600 was measured. The difference between the 
optical densities was then used to determine the percentage of aggregated cells within 
the culture.  
 
2.14.6 Congo red assays 
2.14.6.1 Plate assay 
Agar plates for the detection of exopolysaccharide production were prepared with 
37 g/L Brain Heart Infusion broth supplemented with 50 g/L sucrose, and 0.8 mg/mL 
Congo Red. Bacterial cultures were normalised to an OD600 of 1 and 10 μL was spotted 
onto the surface of the agar, and incubated at 37oC for 24 h. Congo red binds to 
polysaccharides and so exopolysaccharide production was visually determined 
qualitatively through the red pigmentation of the colony.  
 
2.14.6.2 Liquid assay 
To quantitatively assess exopolysaccharide production, bacterial cultures were 
sub-cultured in fresh growth media supplemented with 10 μg/mL Congo red and 
incubated at 37oC for 24 h on a rotating wheel. The OD600 was measured and the cells 
were pelleted in a centrifuge at 3200 x g for 10 min, at room temperature. Congo red 
bound to polysaccharides was sedimented out of the solution by centrifugation and the 
optical density of the supernatant at 495 nm was determined. The OD495 was normalised 
against the culture OD600. 
 
2.14.7 Light microscopy 
Light microscopy images were obtained using an Olympus BX51 polarising 
microscope. Cells were grown overnight in the appropriate antibiotics and diluted by a 
dilution factor of 10-1. From the diluted cell suspension, 5 μL was mounted onto a glass 




2.14.8 Quorum sensing bioassay  
Overnight cultures were normalised to an OD600 of 1. In a 96-well opaque 
microtitre plate, 30 μL of P. aeruginosa culture, or supernatant, was combined with an 
equal volume of the appropriate biosensor strain. JM109 (pSB1142) was used for OdDHL 
detection (Winson et al., 1998), JM109 (pSB536) was used for BHL detection (Swift et al., 
1997) and PAO1-PpqsA::lux was used for PQS detection (Fletcher et al., 2007). Plates were 
incubated at 37oC for 3 h and bioluminescence of the cultures was measured using the 
Lucy 1 (Anthos Labtec Instruments, Austria) for single point luminometry.  
 
2.14.9 Statistical analysis 
Where appropriate, statistical analysis of phenotypic observations were 
conducted using an unpaired t-test based on a two-tailed p-value. Significance was 
denoted on figures by the presence of asterisks, where * represents a p-value of <0.05, ** 
= <0.01 and *** = <0.0001.  
 
2.15 Proteomic analysis 
2.15.1 SDS-polyacrylamide-gel electrophoresis 
Protein samples were prepared with loading dye and boiled at 95oC for 10 min. 
Samples were separated on 12% SDS-PAGE gels, prepared as described in Table 2.7. SDS-
PAGE was run at 10 V cm-1 for 1.5 h. Gels were either stained with Coomassie or used for 
western blot analysis. 
 
2.15.2 Coomassie staining 
Gels were incubated overnight in Coomassie stain (1 g/L Coomassie Brilliant  
Blue G (Sigma), 50% v/v methanol, 10% v/v acetic acid) and destained for 30 min with 
Destain I (50% v/v methanol, 7% v/v acetic acid) and twice, for 30 min, with Destain II 
(10% v/v methanol, 7% v/v acetic acid). Protein sizes were determined by comparing 
migration against a Precision Plus Protein Standard (BioRad).  
49 
 
Table 2.7. Preparations for a 12% SDS-PAGE gel. 
Gel Phase Components per 10 mL 
6% Stacking gel 2 mL 30% Bis-Acrylamide solution (Severn Biotech) 
1 mL 5 X Stacking buffer 
50 μL 20% (w/v) SDS 
100 μL 8% (w/v) APS 
5 μL Tetramethylethylenediamine  
12% Resolving gel 4 mL 30% Bis-Acrylamide solution (Severn Biotech) 
5 mL 5 X Resolving buffer 
50 μL 20% (w/v) SDS 
100 μL 8% (w/v) APS 
5 μL Tetramethylethylenediamine 
 
 
2.15.3 Western blot 
Proteins were transferred from the SDS-PAGE gel onto a polyvinylidene difluoride 
(PVDF) membrane (high fluorescence) in 7 min using the Trans-Blot Turbo Transfer 
System (BioRad) with Trans-Blot Mini Transfer Packs.  
The membrane was incubated in blocking buffer (5% w/v semi-skimmed milk 
powder) overnight, and then washed once in wash buffer (PBS and 0.1% v/v Tween 20). 
The membrane was incubated with a primary antibody, diluted in blocking buffer, for  
1 h. The membrane was washed four times in wash buffer with 5 min incubations, before 
the addition of IRDye 680RD (Li-Cor) secondary antibody diluted in blocking buffer and 
incubation for 45 min. The membrane was washed as previously stated. All incubation 
steps involved gentle agitation throughout. The protein bands were detected using an 
Odyssey CLx imaging system (Li-Cor). 
 
2.15.4 Secretome analysis 
Strains were cultured to late exponential phase (OD600 of 0.6 – 0.8) in M9 minimal 
media supplemented with glucose and harvested by pelleting the samples in a centrifuge 
at 3200 x g for 30 min at 4oC. The supernatant was filter-sterilised using 0.2 μm 
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membrane filters (Millipore) and the protein was precipitated overnight at 4oC by adding 
12.5% (w/v) trichloroacetic acid. Samples were centrifuged at 3200 x g for  
40 min at 4oC. The protein pellets were washed three times in 80% (v/v) acetone and 
sedimented for a further 15 min at 21,000 x g in 2 mL microcentrifuge tubes. The pellets 
were air dried and resuspended in urea buffer (100 mM Tris-HCl, 6 M urea, 2 M thiourea, 
pH 8.0). The protein concentration was determined using the DC protein assay (Biorad). 
Peptides were separated by SDS-PAGE and stained with Coomassie. 
 
2.15.5 Whole-cell protein extraction 
Strains were cultured to late exponential phase (OD600 of 0.6 – 0.8) in M9 minimal 
media supplemented with glucose. Cell cultures (45 mL) were harvested at 3200 x g in a 
centrifuge for 30 min at 4oC, washed in PBS and sedimented a second time. Pellets were 
resuspended in 800 μL of lysis buffer and sonicated (3x 5 sec at 15 amps, MSE microtip). 
Cells were pelleted at 21,000 x g for 30 min at 4oC. The protein concentration of the 
supernatant was determined using the DC protein assay (Biorad).   
 
2.15.6 Liquid chromatography-tandem mass spectrometry 
LC-MS/MS was performed by the Cambridge Centre for Proteomics.  Dried 
peptides were reconstituted in 100mM triethylammonium bicarbonate and labelled 
using 10-plex TMT (tandem mass tag) reagents according to the manufacturer's (Thermo 
Scientific) protocol.  Tagged peptides were fractionated by reverse-phase 
chromatographyand were identified and quantified by a high resolution Orbitrap mass 
spectrometer coupled with Dionex Ultimate 3000 RSLC nano UPLC (Thermo Fischer 
Scientific). Proteomics data sets were analysed with the empirical Bayes moderated  
T-test implemented by the limma package (Ritchie et al., 2015). P-values were corrected 
for multiple hypothesis testing using the Benjamini-Hochberg method (FDR ≤ 0.05). 
Differential expression was calculated on normalized log2 ratios (nano LC-MS/MS). The 
MS/MS fragmentation data was searched against the National Centre for Biotechnology 




2.16 Structural analysis 
2.16.1 His-tagged EF-G expression 
The fusA1 and mutated fusA1-P443L genes were amplified using ‘pET19m::fusA1 
Forward’ and ‘pET19m::fusA1 Reverse’, digested with NdeI and ligated into the vector 
pET19m. As the amplicon was only digested with one restriction enzyme, primers, 
‘Orientation check Forward’ and ‘Orientation check Reverse’, were used to ensure that 
the gene was incorporated in the correct orientation downstream of the promoter. The 
expression vector was introduced into E. coli Rosetta cells by electroporation. 
Rosetta cells were grown up in 1 L of LB supplemented with carbenicillin, and 
incubated at 37oC to an OD600 of 0.6 - 0.7. Isopropyl-β-D-thiogalactopyranoside (IPTG) 
was added to the cultures to a final concentration of 1 mM and the culture was incubated 
at 20oC for 24 hours. Cells were centrifuged at 3430 x g, for 20 min at 4oC. The cell pellet 
was resuspended in 10 mL lysis buffer and lysed by sonication (5x 30 sec at 13 amps), 
then centrifuged at 14,636 x g for 30 min, 4oC, to separate the cellular debris from the 
protein fraction within the supernatant. The supernatant was filtered through 0.45 μm 
membrane filters (Millipore). 
 
2.16.2 EF-G protein purification 
Cell lysates were loaded onto a Ni-NTA Superflow Cartridge (Qiagen) at 4oC. The 
column was equilibrated with protein purification buffer (Table 2.2) and the eluate 
profile of the sample was monitored using a high precision, multi-wavelength UV-Vis 
monitor (UPC-900) at 230, 250, 280 nm. Samples were eluted with elution buffer (Table 
2.2).   
The purified protein samples were concentrated using Vivaspin 20 columns 
(Sartorius) and dialysed by running 1 L of dialysis buffer (Table 2.2) through the Vivaspin 
columns. The concentration of the purified protein was measured on an Eppendorf 




The actual protein concentration was determined using the extinction coefficient 
for EF-G.  
𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑀) = (
𝑚𝑔 𝑚𝑙−1
𝑒𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡
) 𝑋 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 
 
2.16.3 Structural prediction using tryptophan fluorescence 
To analyse the intrinsic protein fluorescence, EF-G protein was diluted in  
2 mL dialysis buffer to a final concentration of 0.8 μM. Fluorescence was measured in a 
quartz cuvette, on a FP-8300 Spectrofluorometer (JASCO) using an excitation wavelength 
of 295 nm and an emission wavelength of 305 - 400 nm (0.5 nm intervals, 100 nm/min, 
measurement in triplicate). Fusidic acid was titrated into the protein sample producing 
increasing final concentrations of 5 μM to 100 μM. The protein was incubated with fusidic 
acid for 1 min before measuring fluorescence.  
One protein sample was tested per condition and the mean fluorescence 
measurement across three technical replicates was calculated using the Spectra Manager 
Suite (JASCO) and used to construct a fluorescence spectrum for each protein variant.  
 
2.17 Transcriptomic analysis 
2.17.1 RNA extraction 
During the isolation of bacterial RNA, work was carried out in a sterile and RNase-
free environment using RNase-free tubes and pipette tips.   
Strains were cultured in M9 minimal media supplemented with glucose and 
samples were harvested at late exponential phase (OD600 of 0.6 – 0.8) into RNA Later 
(Ambion). The samples were incubated at 4oC for 15 min and pelleted at 21,000 x g for 
20 min at 4oC.  Total RNA was extracted using the RNeasy Mini Kit (Qiagen) and digested 
twice with on-the-column DNase I digestion, following manufacturer’s guidelines. The 
concentration and purity of the RNA was measured using a NanoDrop ND-1000 
Spectrophotometer. The absence of contaminating proteins and organic compounds was 
ensured by an A260/280 ratio of 1.8 – 2.0 and A260/230 nm of 2.0 – 2.2.  
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2.17.2 Quality checking RNA 
To check for RNA degradation and DNA contamination, 2 μg of total RNA was run 
on a 1% agarose gel. Samples should have 2 clear bands representing the 23S and 16S 
ribosomal RNA. There should be no smearing below the 16S band which would indicate 
RNA degradation, and no high molecular weight bands representing gDNA or plasmid 
DNA contamination. 
Using primers ‘pslA Forward’ and ‘pslA Reverse’ for amplification of the pslA gene, 
0.5 μg of total RNA was used as the template for PCR, with gDNA as a negative control. In 
the absence of DNA contamination, no amplicon should be produced. 
 
2.17.3 cDNA synthesis and RT-PCR 
For complementary DNA (cDNA) synthesis, 1 μg of RNA was combined with 50 ng 
oligo(dT)15, 300 ng random hexamers, 1 μL dNTP mix and heated at 65oC for 5 min 
followed by incubation on ice for 2 min. To this, 4 μL of 5x SuperScript III First strand 
buffer, 1 μL 0.1 DTT and 1 μL SuperScript III Reverse transcriptase (Invitrogen) was 
added. Samples were incubated at 25oC for 5 min, followed by incubation at 50oC for 60 
min. The reaction was inactivated at 70oC for 15 min. cDNA was used as a template for 
RT-PCR following the program for a standard PCR reaction described in Table 2.5, but 
using 20 - 25 cycles.  
 
2.17.4 RNA sequencing 
Total RNA was sent to GATC Biotech for rRNA depletion and RNA-Sequencing 
using the Illumina platform (10 million reads per sample, single read, 1 x 50 bp). The 
RNA-Seq reads were processed using FastaQC and were mapped to the PAO1 genome and 
analysed using the Tuxedo Suite package. Differentially expressed genes were 
investigated. The principal component analysis plot and the volcano plots were 





3. Identification of a fusA1 mutation in P. aeruginosa  
3.1 Introduction 
Biofilms are widely recognised for harbouring antibiotic resistant bacteria that 
respond inconsistently to treatment and are excruciatingly difficult to eradicate 
completely (Milla et al., 2014).  So far, the molecular mechanisms that underpin the 
transition from planktonic growth into biofilm formation remain unclear. This is an 
important problem, as identifying global biofilm regulators may offer therapeutic 
opportunities for the treatment of chronic infection.  
A key protein component of the biofilm matrix is the secreted adhesin, CdrA (cyclic 
diguanylate-regulated two-partner secretion, partner A). The two-gene, cdrAB, operon 
encodes the secreted adhesin, CdrA, and its transporter, CdrB. CdrA adds strength to the 
structural scaffold of the matrix by binding neighbouring matrix components together. 
Expression of the cdrAB operon is positively correlated with elevated levels of c-di-GMP, 
as are a variety of other biofilm-associated genes, such as the polysaccharide biosynthesis 
operons, psl and pel. Mutations in cdrA result in thin and poorly-structured biofilms, 
whereas overexpressing cdrAB has been found to increase biofilm formation up to six-
fold (Borlee et al., 2010). Proteolytic cleavage of CdrA can initiate biofilm dissemination, 
therefore linking this protein to multiple stages of biofilm development (Cooley et al., 
2015). Expression of cdrA was found to be up to 15-fold higher in biofilm cells when 
compared with planktonic cells (Borlee et al., 2010), and clinical isolates from CF patients 
have been found to produce the adhesin in abundance (Wolfgang et al., 2003). These 
studies highlight its role in biofilm-mediated chronic infection and demonstrate the tight 
regulation of cdrA during biofilm-inducing conditions. Because of this, CdrA is an ideal 
target for monitoring the expression of biofilm-associated genes.  
In this chapter, I used a lacZ reporter construct to monitor transcription from the 
cdrA promoter. I then attempted to use random mutagenesis to identify global regulators 




3.2 CdrA expression in P. aeruginosa 
3.2.1 Creation of a cdrA transcriptional reporter 
To identify regulatory factors that might affect cdrAB transcription, a reporter 
strain was constructed to measure the activity of the cdrA promoter. This was achieved 
by use of a non-replicative mini-CTX-lacZ vector, for single-copy integration into the 
genome. The vector encodes an integrase which directs the recombination of the plasmid 
at a neutral site within the genome, located at the end of a tRNAser gene (Figure 3.1), which 
does not evoke downstream effects on neighbouring genes.  
Figure 3.1. Integration of the mini-CTX-lacZ fusion vector into a neutral site within the 
PAO1 genome followed by the excision of the tetracycline resistance cassette and 
unwanted sequences at Flp recombinase target sites (FRT).  
 
The promoter of the cdrAB operon is located directly upstream of the cdrA gene. A 
mini-CTX-lacZ construct was used which contained the cdrA gene promoter (referred to 
as PcdrA) subcloned into the multiple cloning site (MCS) of the vector, controlling 
transcription of the downstream lacZ gene. The transcriptional activity of PcdrA could 
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then be measured through the production and activity of the lacZ encoded protein,  
β-galactosidase.  
The commonly used P. aeruginosa reference strain, PAO1, was transformed by 
electroporation with the mini-CTX-PcdrA-lacZ vector. Unwanted sequences, including the 
tetracycline resistance cassette, which were located between Flp recombinase target 
sites (FRT) were excised by introducing a pFLP2 plasmid encoding Flp recombinase. 
When verifying the position of the reporter construct by PCR-amplification, I discovered 
that the frequency at which the mini-CTX vector integrated into the genome at the correct 
location was low. This may have been due to non-homologous recombination at sites 
elsewhere in the genome, or the existence of mini-CTX as a non-chromosomal plasmid 
within the cell. A reporter strain, confirmed to contain the lacZ fusion gene downstream 
of tRNAser, was used in subsequent mutagenesis screens for isolating regulators of biofilm 
formation and will henceforth be referred to as PAPcdr. 
 
3.2.2 β-galactosidase expression via PcdrA  
The activity of the cdrA promoter in the reporter construct is reflected in the 
production of β-galactosidase, encoded by the lacZ gene. Adding the β-galactosidase 
substrate, X-gal, to growth medium allowed me to measure the level of β-galactosidase 
produced by the reporter strain under different growth conditions. X-gal is hydrolysed 
by β -galactosidase to yield galactose and 5-bromo-4-chloro-3-hydroxyindole, the latter 
of which spontaneously dimerises and oxidises into an insoluble blue product (Burn, 
2012).  The level of blue pigmentation produced by a colony corresponds to the level of 
β -galactosidase synthesised and, in the case of the PcdrA-lacZ fusion, will reflect the 
activity of PcdrA. The activity of PcdrA may provide an indication of active biofilm 
formation and may be reflected in the activity of other biofilm-associated genes. PAO1 
containing an empty vector control (a promoter-less mini-CTX-lacZ construct integrated 
at tRNAser within the genome) did not produce the distinctive blue colouration in the 
presence of X-gal, verifying that pigmentation of the PAPcdr strain was a result of PcdrA 
activity. 
PAPcdr was grown on a variety of carbon sources, supplemented with X-gal, to 
assess the optimal conditions for activating expression at a basal level. M9 minimal 
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medium allowed for the greatest level of control when manipulating carbon sources and 
its pale, translucent consistency was best suited for visualisation of β-galactosidase 
activity on agar plates. Richer media, such as LB Lennox, Nutrient broth, Brain and Heart 
infusion broth and Tryptic soy broth were also assessed, but colouration of the media 
distorted colony pigmentation and so they were not used for these purposes in further 
investigations.  
Where growth on a rich solid medium, such as LB, can take between 18-24 hours, 
up to 48 hours of incubation was required for growth on minimal medium. This duration 
also varied with the carbon source and its concentration. The expression of cdrA was 
assessed in response to growth on 24 different carbon sources, each at a fixed 
concentration of 0.5% (w/v), for up to 48 hours (Table 3.1).   
 
Table 3.1. The effect of different carbon sources (0.5% w/v) on the growth and lacZ 
expression of PAPcdr on M9 minimal media supplemented with X-gal. 












Alanine Acetate Ethanol 
Arginine Manitol  Gluconic acid 












Some carbon sources, such as lactose and ribose, were not sufficient for growth 
and the reduced colony size meant that β-galactosidase expression could not be reliably 
gauged. The biofilm-inducing environment of the CF lung is highly oxygen-limited, 
however, when cultured under microaerophilic conditions the colonies grew very slowly 
across all carbon sources making it unsuitable for high throughput screening. A subset of 
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carbon sources, in which growth was unaffected under aerobic conditions, were found to 
elicit moderate to high levels of cdrA expression, appropriate for analysing changes to 
expression. However, carbon sources such as sodium fumarate, sodium succinate, 
gluconic acid and glutamic acid, induced the production of the blue-green secondary 
metabolite, pyocyanin. Secretion of pyocyanin into the surrounding media masked the 
colouration of the X-gal catabolite, producing ambiguous results. By a process of 
elimination, glucose was the best candidate for measuring PcdrA activity, as the colonies 
grew robustly, with no effect on pyocyanin production, and induced sufficient levels of 
cdrA expression for subsequent analysis.  
 
3.3 Identifying regulators of cdrA  
3.3.1 Plasposon mutagenesis 
To identify genes that potentially regulate cdrA expression, and may therefore 
impinge on biofilm formation, a mutant library was created by random transposon 
mutagenesis using the pTnMod-OGm plasposon (Dennis et al., 1998). This plasposon 
undergoes a single, stable, and non-specific integration into the PAO1 genome affecting 
the expression of any disrupted gene.  pTnMod-OGm was introduced into PAPcdr via bi-
parental conjugation and successful conjugants were isolated using gentamicin selection. 
Conjugants were screened for abnormal cdrA expression on X-gal supplemented glucose 
plates. Colonies that appeared hyper-blue (caused by an overproduction of β-
galactosidase) and those that displayed a paler pigmentation (hypo-production) were 
further analysed in planktonic culture. Activity in planktonic culture could be monitored 
by measuring the relative fluorescence of another β- galactosidase substrate, 4-
methylumbelliferyl-β-D-galactoside.  
One of the isolated transposon mutants (Tn-PAPcdr) had a pale appearance on 
solid media when compared with the progenitor strain (Figure 3.2A). The reduction in 
PcdrA activity was consistent when the strain was grown as a planktonic culture in 
glucose-supplemented minimal medium. Here, the transcriptional activity of cdrA was 




Figure 3.2. β-galactosidase activity in the PAPcdr reporter strain and activity after the 
introduction of a random transposon insertion (Tn-PAPcdr). β-galactosidase activity was 
(A) visualised by growth on X-gal supplemented solid media and (B) measured through 
the production of a fluorescent product during planktonic growth, relative to optical 
density. Statistical significance between groups was assessed by an unpaired t-test (n=3) 
(* = p <0.05, ** = p <0.01, *** = p <0.001). 
 
To identify the location of the transposon within the Tn-PAPcdr mutant genome, 
three approaches were taken. Firstly, a nested-PCR amplification technique was 
attempted, using primers to read outward from the transposon insert in conjunction with 
random hexamers. Sequencing the amplicon would identify which gene had been 
disrupted by the transposon. This method failed to amplify any flanking DNA surrounding 
the insert. Secondly, I used a replicon-cloning based technique, as described by Dennis 
and Zylstra (1998), whereby genomic DNA was fragmented and self-ligated to produce 
circularised mini-chromosomal fractions. These were introduced into E. coli and colonies 
transformed with DNA containing the insert were selected for, using gentamicin. Again, 
this method was unsuccessful and produced no viable colonies. Finally, a whole genome 






3.3.2 Whole genome sequencing 
The genome of the Tn-mutant strain and of the progenitor strain were analysed 
by whole genome sequencing, which confirmed that the mini-CTX-PcdrA::lacZ reporter 
construct had integrated correctly at the specified neutral site. Interestingly, the 
transposon was absent from the genome of the mutant strain explaining why the previous 
approaches to identification had failed. This now posed the question of how the isolated 
mutant acquired gentamicin resistance and exhibited changes in cdrA expression if not 
due to gene disruption by the plasposon insert? To answer this, the mutant genome was 
analysed for changes that might have given rise to the observed phenotypes. In doing so, 
numerous single nucleotide polymorphisms (SNP), inversions, deletions and insertions 
were identified. Closer investigation of these alterations, by PCR amplification and 
sequencing, revealed that almost all of the apparent mutations were in fact errors 
occurring from poor quality sequence reads at the end of sequence contigs, a common 
limitation with whole genome sequencing. From all the identified genome variations only 
one mutation was confirmed to be real. This was a SNP within the fusA1 gene, conferring 
a cytosine to thymidine transition (Figure 3.3). This mutation resulted in a proline to 
leucine conversion at amino acid 443 of the encoded peptide sequence. This mutant 
strain is henceforth referred to as FUS443 and the non-mutated progenitor strain, I will 
continue to call PAPcdr.  
 
 
Figure 3.3. Alignment of the fusA1 gene from PAO1 with the FUS443 mutated isolate. 
Alignment shows a cytosine to thymidine transition resulting in a proline to leucine 




3.4 Elongation factor G 
3.4.1 Computational structural analysis 
The fusA1 gene encodes elongation factor G (EF-G). As the name suggests, EF-G is 
vital in the elongation step of translation and coordinates the translocation of mRNA and 
aminoacyl-tRNA through the ribosome during extension of the peptidyl chain. The crystal 
structure of EF-G from P. aeruginosa has been determined by Nyfeler et al. (2012), and 
was used in this study to identify the position of the P443L mutation within the tertiary 
structure.  
The proline to leucine transition at amino acid 443 was positioned between an 
alpha helix and beta strand in domain III of EF-G (Figure 3.4).  Proline residues are known 
to provide flexibility to a structure and can induce kinks into the peptide chain, making 
them a common residue at turn positions within the protein.  Introducing a leucine 
residue at this position is likely to reduce these flexible properties and alter the 
conformation of the structure. Position 443 also marks an exposed residue, located 




Figure 3.4. Crystal structure of elongation factor G (determined by Nyfeler et al., 2012), 
consisting of five domains. The proline residue highlighted in red shows the position of 
the 443 proline to leucine transition in the FUS443 mutant. 
 
The GTPase activity of EF-G occurs in domain I, with switch 1 and switch 2 motifs 
situated opposite proline 443. Switch motifs undergo conformational changes that direct 
the ‘switch’ between GTP and GDP and therefore determine the GTPase activity (Vetter, 
2014). Due to the close proximity of P443L to these switch domains, it is possible that the 
dynamics of these switches are disrupted, affecting the ability to recycle GTP. To predict 
the effect that the mutation might have had on the protein structure, I used a program 
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called mCSM (Pires et al., 2014), which predicts the impact of a mutation on protein 
stability and interactions, relying on graph-based signatures. The P443L mutation was 
predicted to have a destabilising effect on the protein structure  
(-0.267 kcal/mol) and a destabilising protein-protein affinity change (-0.324 kcal/mol).  
I-TASSER was used to generate a 3D structure model of the mutated EF-G protein 
based on the changes in the amino acid sequence. The predicted structure aligned almost 
perfectly with the published EF-G structure and the turn between the alpha helix and beta 
strand was maintained with only minor steric alterations to the neighbouring residues 
(Figure 3.5).  
 
 
Figure 3.5. Alignment of the mutated EF-G protein structure (teal, with leucine residue 





EF-G has two conformations; the un-bound protein adopts a compact structure, 
but this becomes elongated when bound to the ribosome. The Nyfeler protein crystal 
structure and I-TASSER-predicted mutant structure are based on the elongated form. It 
is possible that the mutation may have structural implications on its compact form or 
during the transition between structural states.  
 
3.4.2 Intrinsic tryptophan fluorescence 
Amongst the three fluorescent amino acids (phenylalanine, tyrosine and 
tryptophan), tryptophan provides the biggest contribution to intrinsic protein 
fluorescence. Tryptophan is extremely sensitive to its microenvironment and changes to 
the fluorescent spectra often reflect changes within the protein structure therefore 
making this a simple, but highly sensitive tool, to measure changes in protein 
conformation (Ghisaidoobe et al., 2014). 
The wild type (WT) and mutated fusA1 genes from P. aeruginosa were expressed 
in E. coli and the WT EF-G and mutant EF-G proteins were purified and verified by SDS-
PAGE and Coomassie staining. EF-G has five tryptophan (Trp) residues, Trp-72, Trp-127, 
Trp-193, Trp-218 and Trp-519. Trp-218 and Trp-519 are exposed on the surface,  
Trp-193 is partially exposed and Trp-72 and Trp-127 are internalised within the protein. 
The Trp fluorescence spectra of the WT and mutant protein were measured between  
305 nm to 400 nm. The maximum emission (λmax) of the WT EF-G was 333 nm, and was 
332.5 nm for the EF-G-P443L protein. However, the fluorescence intensity at λmax was 
21.6% lower for EF-G-P443L than the WT protein (Figure 3.6A).  
Shifts in λmax are associated with changes in the exposure of tryptophan residues 
to the surrounding solvent, whilst changes to the intensity of fluorescence can be caused 
by changes in the microenvironment of the tryptophan. This suggests that the P443L 
mutation did not cause large structural rearrangements in the protein, but instead, led to 
smaller adjustments as proposed by the I-TASSER structural prediction.  
The P443L mutation in EF-G resides within the fusidic acid binding pocket. To 
investigate whether the binding of fusidic acid was affected by the mutation, various 
concentrations of fusidic acid, ranging from 0 μM to 200 μM, were added to 0.8 μM of  
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EF-G protein. The intrinsic fluorescence intensity was quenched in both the WT EF-G 
protein and the mutant variant in a dose-dependent manner by fusidic acid (Figure 3.6B). 
Quenching is a process which reduces the intensity of the fluorescence. This occurs 
through contact between an excited fluorophore and another molecule which facilitates 
non-radiative transitions to the ground state.  The addition of 200 μM of fusidic acid 
reduced the fluorescence intensity of the WT protein by 23.8% and the mutated protein 
by 26.8%.  
The efficiency of fusidic acid as a quencher was demonstrated using a Stern-
Volmer plot, where the y axis shows the decrease in emission intensity (Figure 3.6C). 
Initially, quenching occurred rapidly at low concentrations but a less steep gradient was 
observed at concentrations exceeding 40 μM of fusidic acid titration. This is typical of a 
non-linear Stern-Volmer plot and is reflective of the subpopulations of trytophans within 
EF-G which are positioned with varying accessibilities to the quencher. Similar quenching 
patterns of EF-G and EF-G-P443L suggest that the ability to bind fusidic acid is retained, 
however, the Trp fluorescence of EF-G-P443L was quenched to a greater degree 
highlighting variations in their structural composition and their interaction with fusidic 
acid.  
It is highly likely that these minor steric changes could affect the function of EF-G, 
perhaps by altering protein flexibility or its interaction with the ribosome. This could 
therefore manifest in changes to gene expression, such as that seen with PcdrA activity.
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Figure 3.6. Intrinsic tryptophan fluorescence using an excitation wavelength of 295nm and emission as recorded in figure for (A) EF-G 
and EF-G-P443L protein variants, and (B) EF-G and EF-G-P443L with increasing concentrations of fusidic acid (0-200 μM) revealing a 
reduction in fluorescence intensity. (C) Stern-Volmer plot for the interaction of EF-G protein variants with increasing concentrations of 
fusidic acid, highlighting a greater level of fluorescence quenching by fusidic acid on the EF-G-P443L protein variant.  Results represent 
one protein sample measured in triplicate.
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3.5 Characterisation of FUS443 
3.5.1 Elongation factor G and the biofilm matrix 
The FUS443 mutant was assessed for phenotypic changes to the cell, to help 
identify which signalling networks might be affected by the mutated EF-G.  
Initial tests on PcdrA activity in planktonic culture revealed that FUS443 had a 
small growth defect in minimal medium (Figure 3.2). The mutant was grown in LB to see 
if the growth defect remained when the culture was provided with a richer medium. 
Unexpectedly, the growth defect of FUS443 was even more prominent in LB, particularly 
throughout the exponential phase of growth (Figure 3.7). The initial doubling time of 
PAPcdr over the first two hours of growth was 32.5 min, whereas the doubling time was 
twice as long in FUS443 at 63.8-69.5 min, maintained over 6 hours of growth.  
 
 
Figure 3.7. Transcriptional activity of the cdrA promoter in the mutant FUS443 strain 
and progenitor strain, PAPcdr, grown in LB and measured through β-galactosidase 
activity, relative to growth. Statistical significance between groups was assessed by an 




PcdrA activity remained at a significantly lower level in the mutant strain during 
late exponential-stationary phase, at almost half of that observed in the progenitor strain. 
This suggested that the effect on cdrA expression associated with the P443L mutation in 
EF-G was nutrient-independent and occurred during both growth conditions.  
The prominent role CdrA plays in maintaining the biofilm structure meant that it 
was important to determine whether the reduced cdrA expression in FUS443 also 
impacted on the ability to form robust biofilms. Biofilm formation was measured by 
growing cultures in microtitre plates. The biofilms formed on the sides of the plastic wells 
which were stained with crystal violet and quantified by measuring the absorbance at 
595 nm. I found that the mutation had no significant effect on the formation of biofilms, 
both in minimal medium (t(22)=1.26, p=0.219) and in LB (t(30)=0.52, p=0.610) (Figure 
3.8). This result suggested that either the reduction in cdrA expression was not severe 
enough to negatively impact biofilm formation or that the biofilm was stabilised by 
compensatory mechanisms, such as the up-regulation of alternative matrix components. 
 
Figure 3.8. Biofilm formation of the FUS443 mutant and progenitor strain PAPcdr in 
microtitre plates, quantified by staining with crystal violet and measuring absorbance at 




To investigate the possibility that other matrix components were maintaining the 
biofilm in the absence of CdrA, the level of polysaccharide secretion was measured using 
the polysaccharide-binding dye Congo red. When grown on solid medium supplemented 
with Congo red, the FUS443 mutant had a dark red pigmentation, whereas the progenitor 
strain appeared paler. This indicated an increase in the production of exopolysaccharides 
in FUS443 (Figure 3.9A). In planktonic culture, polysaccharide-bound Congo red can be 
separated from the supernatant by centrifugation and provides an indication of the level 
of polysaccharide produced by the cells. The FUS443 culture supernatant had a 
significantly lower absorbance at 495 nm (t(10)=5.064, p=0.0005), indicating a decrease 
in residual free Congo red and therefore an increase in exopolysaccharide production 
when compared with the progenitor strain (Figure 3.9B). Together these findings provide 
evidence that the P443L mutation is having pleiotropic and converse effects on numerous 
biofilm-associated genes, which may explain why biofilm formation is not affected by the 
reduction in cdrA expression. 
 
Figure 3.9. Exopolysaccharide production was increased in the FUS443 mutant. (A) The 
redder pigmentation of the FUS443 colony indicated increased binding by the 
polysaccharide-binding dye, Congo red. (B) Reduced levels of Congo red in the 
supernatant of the mutant strain highlighted an increase in polysaccharide production. 
Readings were normalised relative to growth (method as described in Ma et al. 2006). 
The data represents the measurements from three biological replicates and two technical 
replicates. Statistical significance between groups was assessed by an unpaired t-test 
(n=6, *** = p <0.001). 
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3.5.2 Quorum sensing 
Quorum sensing (QS) is a bacterial system used to regulate gene expression in 
response to population density. Biofilm formation and virulence are amongst the 
phenotypes that can be regulated by this system. P. aeruginosa produces three main QS 
molecules, PQS, OdDHL and BHL. To investigate whether the mutated EF-G protein 
affected QS, bioluminescent reporter strains were used to detect the presence of QS 
molecules secreted into the medium by the P. aeruginosa strains. Initial experiments were 
conducted in LB where the reporter strains for PQS, OdDHL and BHL were co-cultured 
for three hours with PAPcdr or FUS443, and the QS levels for each were recorded. There 
was very little difference in the levels of PQS produced by the progenitor and mutant 
strain, but a significant increase in the production of BHL (t(10)=20.00, p=<0.0001) and 
OdDHL (t(10)=4.35, p=0.001) was observed in the FUS443 culture (Figure 3.10A). To 
account for differences in growth rate that could have occurred during incubation of the 
co-culture, cell-free supernatant was incubated with the reporter strains instead. In doing 
so, the differences between the mutant strain and progenitor were abolished (Figure 
3.10B). When the same experiment was conducted with bacterial co-incubation in 
minimal medium the general abundance of QS molecules was reduced in both strains. 
Intriguingly, the difference between the OdDHL levels that was observed in the LB culture 
was no longer apparent, and the difference in BHL secretion was reduced. In fact, an 
increase in PQS synthesis was observed (Figure 3.10C).  
The abundance of QS molecules differed considerably between conditions and so 
no direct comparison should be made between the different graphs. The level of QS 
signalling was greatest in the LB culture conditions. The fall in abundance seen in the 
supernatant condition is likely due to the absence of a cell culture continually 
synthesising new signalling molecules throughout the co-culture incubation period. The 
minimal media condition saw the lowest level of QS signalling, which may be due to the 
lower cell density or repression of QS systems in nutrient-limited conditions. The levels 
of OdDHL were particularly low in minimal media suggesting that the las system, which 






Figure 3.10. Secretion of quorum sensing molecules of PAPcdr and FUS443 during 
planktonic growth, measured through bioluminescence of reporter strain for PQS, OdDHL 
and BHL after (A) incubation of PAPcdr and FUS443 bacterial cultures, grown in LB, with 
reporter strains, versus (B) incubation of the reporter strains with the cell-free 
supernatant of the P. aeruginosa cultures. (C) Incubation of PAPcdr and FUS443 bacterial 
cultures, grown in minimal media, with reporter strains. Statistical significance between 
groups was assessed by an unpaired t-test (n=3) (* = p <0.05, ** = p <0.01, *** = p <0.001). 
 
The PQS reporter is a P. aeruginosa strain which is unable to synthesise its own 
PQS. The reporters for OdDHL and BHL are both E. coli strains. As the P. aeruginosa PQS-
reporter was unaffected by the use of cell culture or supernatant, it was postulated that 
the P. aeruginosa culture was out-competing the E. coli OdDHL- and BHL-reporters during 
incubation. If this was true, the data suggested that the mutant strain was less virulent 
than the progenitor strain, leading to the increased survival of E. coli and therefore a 
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higher level of bioluminescence than in the progenitor co-culture. This does not, however, 
explain why this was only observed in the LB growth condition.  
To test inter-bacterial virulence, E. coli colony counts were taken after three hours 
of co-culture with the P. aeruginosa strains in LB and compared with a culture of E. coli 
grown in the absence of P. aeruginosa. At 0 hours the E. coli culture contained a high 
density of 5.6x108 CFU. During the three hours of incubation, this was increased to 
6.5x108 CFU in the E. coli only condition and co-culture with P. aeruginosa reduced the 
CFU to 2.2x108 and 1.4x108 with PAPcdr and FUS443, respectively (Figure 3.11). Whilst 
there was evidence of some bacterial competition, an unpaired t-test concluded that there 
was no significant difference in the survival rate of E. coli when incubated with the 
progenitor or mutant strain (p=>0.05). This indicated that the two strains exhibited 
similar levels of virulence towards other bacterial species and suggested that the increase 
in QS molecules in the mutant strain was dependent upon a cell-cell interaction between 
P. aeruginosa and E. coli, specifically in LB.  
 
Figure 3.11. Colony counts of an E. coli population after three hours of co-culture with  
P. aeruginosa strains in LB show a similar level of interspecies competition when 
incubated with PAPcdr or FUS443. Values represent the average cell count of three 





3.5.3 Stability of the P443L mutation 
The growth defect elicited by the P443L mutation suggested that the mutated 
protein caused the cell to function at a sub-optimal level and was therefore costly to the 
cell. Costly mutations put pressure on the gene to revert back to its WT form or develop 
bypass mutations to counteract the cost. Because of this, I was interested to see whether 
the P443L mutation would be stable in the genome across numerous bacterial 
generations.  
A planktonic culture of the FUS443 mutant was grown overnight in the absence of 
antibiotics. It was then serially diluted and plated onto antibiotic-free minimal media 
plates and grown overnight. The same planktonic culture was also sub-cultured into 
liquid media and grown for a further 24 hours, at which point the procedure was 
repeated, until a final 72-hour culture was plated. FUS443 was gentamicin resistant and 
so 40 colonies from each plate were transferred to minimal media plates supplemented 
with gentamicin, and the emergence of gentamicin sensitive colonies was recorded 
(Table 3.2).  
 
Table 3.2. The emergence of gentamicin sensitive colonies in the FUS443 strain after growth in 
the absence of antibiotic selection. 
Duration of planktonic 
growth (hours) 
Colonies screened Gentamicin sensitive 
colonies 
24 40 0 
48 40 1 
72 40 5 
 
 
As the cells were passaged, six colonies developed gentamicin sensitivity. The 
fusA1 gene from each sensitive colony was PCR-amplified and sequenced. In all six 
colonies, the P443L mutation had been retained. This data suggested that, even in the 
absence of antibiotic selection, the P443L mutation provided some benefit to the cell and 
was worth maintaining. The gentamicin sensitivity was likely to have arisen from 
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additional mutations in the genome that counteract any negative or energetically 
expensive effects of the fusA1 mutation, including unnecessary resistance mechanisms.  
 
3.6 Complementation of the fusA1 mutation 
3.6.1 pUCP20 and cell-aggregation  
To verify that the observed phenotypes are indeed a result of the mutation in 
fusA1, a WT copy of the fusA1 gene was introduced into the mutant strain via a 
complementation vector. The complementation vector was constructed by sub-cloning 
the WT fusA1 gene into the MCS of the pUCP20 vector, placing it under the control of a lac 
promoter. The complementation vector (thus referred to as pfusA1) was introduced into 
FUS443 and the progenitor strain, PAPcdr. To control for any effects caused by the 
presence of the plasmid alone, empty pUCP20 plasmids were also introduced into the two 
strains to serve as references.  
The strains were grown in planktonic culture to assess whether the pfusA1 
plasmid reduced the growth defect observed in the mutant strain. Cultures were grown 
in the presence of carbenicillin to maintain the replication of the plasmid, however, it 
became evident that the FUS443 strain containing the empty vector formed prominent 
aggregates (Figure 3.12). An unpaired t-test concluded that the difference in aggregation 
between FUS443(pUCP20) and PAPcdr(pUCP20) was not considered to be statistically 
significant at p=<0.05, nevertheless, aggregation meant that I was unable to record an 
accurate measurement of the optical density. With the addition of pfusA1, the formation 
of cellular aggregates was reduced to a level comparable with the control strains, that did 
not contain a pUCP20 vector (and were grown in antibiotic-free media).  
The addition of antibiotic selection likely exacerbated the pre-existing growth 
defect in the mutant strain. Aggregation may have resulted from cell lysis or an altered 
cell surface which promoted cell-to-cell contacts. Polysaccharides are known to mediate 
cell contacts during the formation of microcolonies in the CF lung. FUS443 was 
recognised as an overproducer of exopolysaccharides earlier within this chapter and so 
antibiotic stress may induce the production of molecules that add to or reinforce these 




Figure 3.12. Percentage of aggregated cells within a culture of the progenitor, PAPcdr, 
and mutant, FUS443, strains in response to replication of an empty pUCP20 vector or 
pUCP20 vector expressing fusA1 (pfusA1). Percentage aggregation is calculated by the 
optical density of settled cultures and the optical density after resuspension of 
aggregates. The respective strains without pUCP20 or antibiotic selection were used as 
controls. 
 
3.6.2 Retention of the complementation vector 
Aggregation meant that planktonic cultures had to be grown in the absence of 
antibiotic selection so that accurate measurements of growth rate could be determined. 
In the absence of antibiotic pressure there was a risk that the plasmid would be discarded 
from the cell, and so to test this, colony counts were taken from antibiotic-free cultures 
that had been grown for 6.5 hours (to early-stationary phase growth) in minimal media. 
There was almost complete retention of the pfusA1 complementation plasmid in the 
mutant strain (Figure 3.13A). As expected, the greatest level of plasmid loss occurred in 
the mutant strain replicating the empty vector, which was considered to be statistically 
significant by an unpaired t-test (t(4)=3.904, p=0.018). However, the mutant strain often 
experienced lags in growth when transferred between different types of media 
composition or between liquid and solid media. Therefore, it is likely that the colony 
counts were low because the bacteria struggled to grow during the transition from an 
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antibiotic-free, liquid culture to growth on an antibiotic-supplemented, solid medium. 
Therefore, plasmid retention within the planktonic culture was likely to be greater than 
recorded.  
When grown in the absence of antibiotic selection the cells did not form 
aggregates allowing for reliable measurement of optical density. The growth defect of 
FUS443 that occurred in both LB and minimal media conditions was recovered with the 
expression of the pfusA1 vector. The rate of growth in the mutant strain was then 
comparable with the progenitor strains (Figure 3.13B) and provided evidence that the 




Figure 3.13. (A) The number of cells that retained the pUCP20 vector (Cbr) after planktonic growth in antibiotic-free minimal media for 
6.5 hours. Colony counts were calculated on plates containing (+/-) 250 μg/mL carbenicillin.  (B) Growth of PAPcdr and FUS443 in 
minimal media and LB with the expression of either the empty vector (pUCP20) or complementation vector (pfusA1). Statistical 
significance between groups was assessed by an unpaired t-test (n=3, * = p <0.05).
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3.6.3 pUCP20 disrupts cdrA expression 
β-galactosidase assays were repeated to investigate whether the lower level of 
cdrA expression observed in the FUS443 mutant was complemented by the addition of a 
functional fusA1 gene. Cells were either grown as a planktonic culture (Figure 3.14A) or 
as a colony biofilm on solid media (Figure 3.14B). Assessment of colony biofilms is similar 
to the measurement of PcdrA activity in planktonic culture, except that the cells are 
extracted from a colony grown on solid media. The control strains for PAPcdr and FUS443 
were not transformed with pUCP20.  
During both planktonic and colony biofilm growth, PcdrA activity was lower in the 
FUS443 mutant control strain than the progenitor controls, analogous with previous  
β-galactosidase experiments. Introducing the empty pUCP20 vector caused changes in  
β-galactosidase activity in both strains and in both planktonic and colony biofilm growth 
conditions. Introducing the complementation vector also produced some unexpected and 
inconsistent results that were not comparable to the control strain. This suggested that 
the regulatory system for cdrA expression is highly sensitive to changes in the cell and 
that the replication of a plasmid, alone, is enough to disrupt its normal expression. 
Despite a rise in PcdrA activity in the FUS443C strain, the inconsistency of the empty 














Figure 3.14. The effect of the pUCP20 vector and pfusA1 complementation vector on the 
transcriptional activity of the cdrA promoter, measured by β-galactosidase activity in 
minimal media (A) during planktonic growth or (B) in a colony biofilm, in comparison 
with control strains containing no plasmids. Statistical significance between groups was 
assessed by an unpaired t-test (* = p <0.05, ** = p <0.01). 
 
3.7 Phenotypic analysis of FUS443 complementation 
3.7.1 Microscopy 
On solid media, single colonies of the FUS443 strain had a slight wrinkled 
phenotype that is often associated with the production of exopolysaccharides, such as the 
pellicle forming polysaccharide, Pel (Friedman and Kolter 2004.a). Cells were grown as a 
planktonic culture and were observed under a light microscope to investigate changes in 
cell morphology. FUS443 did not appear different to the progenitor strain, however, the 
introduction of the pUCP20 vector resulted in an elongated cell-phenotype that was 
complemented by the expression of a WT fusA1 gene (Figure 3.15). As seen in the 
aggregation assays, it is likely that the added stress of maintaining the vector, in 
combination with the reduced fitness of the mutant strain, caused the cells to become 
unhealthy and to develop problems with cell division. The inability for the FUS443 cells 
to divide properly may also contribute to the reduced growth rate that was observed in 
planktonic culture. This elongated phenotype is not a direct result of the P443L mutation 
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but is a further example of the reduced fitness of the mutant strain and how additional 
pressures, such as antibiotic selection or plasmid replication, alter cellular functions and 
reduce cell viability. 
 
Figure 3.15. Light microscopy at 1000X magnification of the FUS443 mutant and 
progenitor strain, highlighting the formation of elongated cells after introducing the 
pUCP20 empty vector into FUS443. Cell length was recovered by expressing a WT fusA1 
gene in trans via pfusA1 (scale bar = 2 μM). Images are representative of the cell 
morphology observed across three biological replicates from each strain.  
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3.7.2 Protease secretion 
The secretion of proteases is extremely important in bacterial survival and the 
invasion of host tissues.  To screen for protease production, bacteria were grown on two 
types of media containing enzyme substrates; milk protein and gelatin. The proteolytic 
activity of the bacteria was observed by a hydrolytic zone of clearing as the protein in the 
media was degraded. The PAPcdr and FUS443 strains were spotted onto caseinase and 
gelatinase assay plates, along with the respective strains containing an empty vector or 
the pfusA1 complementation vector. The mutated fusA1 gene from FUS443 was also  
sub-cloned into pUCP20 (henceforth referred to as pP443L) and introduced into the 
progenitor and FUS443 strains to investigate how expression of the mutant EF-G affects 
the cell (Figure 3.16).  
Figure 3.16. The secretion of exoenzymes, caseinase and gelatinase, by PAPcdr and 
FUS443. Secretion was visualised on plates supplemented with skim milk or gelatin by a 
hydrolytic zone of clearing around the colony and revealed that FUS443 exhibited 
reduced exoenzyme secretion which was recovered by introducing the pfusA1 
complementation vector.   
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Neither the expression of the WT fusA1 gene nor the mutant gene affected the 
secretion of caseinases or gelatinases in the PAPcdr progenitor strain. This suggested that 
the endogenous WT version of EF-G had a dominant effect over the P443L variant, when 
expressed in trans. The FUS443 mutant could not grow on either of the protease plates 
indicating that protease secretion was too low for the bacteria to obtain nutrients from 
the media to support growth. Interestingly, the introduction of the pUCP20 empty vector 
induced a small increase in protease secretion but growth was still minimal. A similar 
finding was observed with the over-expression of the mutated gene via pP443L, however, 
expression of pfusA1, complemented the reduced production of both proteases, reaching 
levels comparable to the WT on both assay plates.  
 
3.7.3 Motility 
P. aeruginosa uses three main forms of motility; swimming, swarming and 
twitching. These different forms of motility are important in infection and play distinct 
roles in the formation of biofilms (Kazmierczak et al., 2015). To assess whether the P443L 
mutation impacts motility, the strains were spotted onto swim, swarm and twitch agar. 
Motility was visualised by colony expansion around the initial point of inoculation as the 
bacteria navigate outwards.  
The assay plates showed that the P443L mutation reduced motility both in type 
IV-mediated twitching and in flagellar-mediated swimming (Figure 3.17). This was 
complemented by pfusA1, suggesting that the P443L mutation was indeed causing the 
motility defect. Introducing the pP443L plasmid into the progenitor strain resulted in a 
subtle reduction in swimming motility. One explanation for this could be that the mutated 
protein is competing with the WT EF-G, preventing it from activating swimming motility 
at the normal level.  
Swarming is also flagellum dependent but requires the additional production of 
two biosurfactants; rhamnolipids and 3-hydroxyalkanoic acids (Ha et al., 2014).  The 
FUS443 mutant appeared to have increased swarming motility, however, as with some of 




Figure 3.17. Twitching, swimming and swarming motility of the PAPcdr and FUS443 strains on glucose M9 minimal media containing 
varying concentrations of agar (1.5%, 0.3% and 0.75% (w/v) for twitching, swimming and swarming assay plates respectively). Motility 
was assessed in strains containing an empty vector plasmid, pUCP20 expressing a wild type fusA1 gene (pfusA1) and pUCP20 expressing 




3.7.4 Exopolysaccharide production 
Having previously established that exopolysaccharide synthesis was increased in 
the FUS443 mutant, the Congo red assay was repeated to include the strains containing 
the pfusA1 and pP443L plasmids. On Congo red supplemented agar, the up-regulation of 
polysaccharide synthesis observed in FUS443 appeared to be complemented by the 
pfusA1 plasmid. The FUS443 -pP443L strain produced an even deeper red pigmentation, 
indicating a further increase in exopolysaccharide production (Figure 3.18A.). These 
findings were supported by the planktonic Congo red assay in which the FUS443 control 
strain (containing no vector) and FUS443 containing an empty vector removed over twice 
as much Congo red from the supernatant than the progenitor strains (Figure 3.18B). This 
suggested that polysaccharide production was doubled in the mutant strain. pfusA1 
partially complemented this phenotype in the mutant strain but still produced more 
polysaccharide than the PAPcdr strains. From this, we can conclude that the P443L 
mutation is, at least in part, responsible for a change in exopolysaccharide production. 
 
 
Figure 3.18. Congo red assay for the production of exopolysaccharides on (A) solid 
media or (B) in planktonic culture where cell-bound Congo red was sedimented and 
measurement of the remaining dye in the supernatant was taken.  Statistical significance 
between groups was assessed by an unpaired t-test (n=3) (* = p <0.05, ** = p <0.01). 
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3.8 Antibiotic resistance 
P. aeruginosa has high intrinsic resistance to a wide variety of antibiotics. The MIC 
of gentamicin for P. aeruginosa was 20 μg/mL and standard laboratory selection uses 
concentrations as high as 50 μg/mL. The FUS443 strain was initially selected from the 
plasposon screening due to its resistance to gentamicin at this concentration. Further 
investigation into the gentamicin resistant properties of this strain, by plating onto 
increasing concentrations of gentamicin, revealed that resistance was increased by  
7.5-fold (Table 3.3) and was fully complemented with the introduction of a functional 
fusA1 gene. As an aminoglycoside, gentamicin binds to the A-site of the ribosome, also 
occupied by EF-G, where it interferes with translation. It is possible that an altered 
conformation in the EF-G mutant protein disrupts the binding of aminoglycosides within 
this site and therefore prevents their cytotoxic effect. To investigate this, resistance to 
another aminoglycoside, kanamycin, was tested. P. aeruginosa has a high intrinsic level 
of kanamycin resistance, requiring concentrations as high as 1.5 mg/mL, however, this 
was further increased to over 2 mg/mL in the FUS443 strain. Again, this was fully 
complemented, suggesting that the SNP alone caused the enhanced antibiotic resistance.  
Tetracycline and chloramphenicol are also ribosome-targeting antibiotics, 
binding to the small and large ribosomal subunits, respectively. The FUS443 mutant did 
not possess any resistance to these antibiotics, nor did it confer resistance to the 
ribosome-independent antimicrobial, rifampicin. This suggests that antibiotic resistance 
occurred in a binding-site specific manner through changes within the ribosome A-site. 
Structural investigation using the intrinsic fluorescence of EF-G indicated that 
fusidic acid binding was maintained in the FUS443 mutant. In vivo, the mutation had no 
effect on sensitivity to fusidic acid (Table 3.3) confirming that the antibiotic could still 
bind the mutated EF-G protein. This also verifies that the mutation is unlikely to have 
caused large structural alterations within the fusidic acid binding pocket.  
Conversely, during the screening for antibiotic resistance, I noticed the emergence 
of fusaric acid sensitivity in the mutant strain. Whilst P. aeruginosa has high intrinsic 
resistance to fusaric acid, the mutant strain exhibited 1.6-fold increased sensitivity. Little 
is known about the mode of action of fusaric acid, but current research has not indicated 
any interaction with the ribosome. Fusaric acid sensitivity is likely to be due to 
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downstream effects induced by the P443L mutation, and not due to a direct interaction 
between the protein and antibiotic. 
All of the changes in antibiotic sensitivity or resistance mentioned here were 
completely complemented by the pfusA1 plasmid and the MIC of antibiotics for strains 
containing the p443L plasmid were consistent with the original mutant and mutant 
empty-vector control. None of the plasmid variations had an effect on the MIC of the 
progenitor strain. 
 
Table 3.3. Minimum inhibitory concentrations (MIC) of antibiotics for the FUS443 
mutant and its progenitor strain.  




Gentamicin Binds 30S ribosome and disrupts 
reading of tRNA 
20 150 
Kanamycin Binds 30S ribosome and disrupts 
reading of tRNA 
1500 >2000 
Tetracycline Binds 30S ribosome and inhibits 
incorporation of tRNA 
20 20 
Chloramphenicol Binds 50S ribosome and inhibits 
peptide bond formation 
250 250 
Rifampicin Inhibits RNA polymerase 100 100 
Fusidic acid Inhibits EF-G 1750 1750 










In the work described in this chapter I set out to identify global regulators of 
biofilm formation in P. aeruginosa, in the hope of highlighting potential targets that could 
be used to develop effective treatment for chronic infection. One mutant was found to 
contain a SNP in the EF-G-encoding gene, fusA1. This mutation impacted on a variety of 
biofilm- and virulence-associated phenotypes and whilst not predicted to drastically 
affect protein structure, the mutation clearly altered the protein function, placing the cell 
under a considerable amount of stress. This stress manifested in poor growth, 
aggregation, changes in cell morphology and alterations to cell signalling networks, such 
as QS. Whilst characterisation of the mutant provided a lot of evidence for suboptimal cell 
function, the benefits provided by the mutation, such as antibiotic resistance, meant that 
the mutation was maintained following passaging. The findings presented here highlight, 
for the first time, a role for EF-G in the regulation of biofilm- and virulence-associated 
phenotypes which may be relevant in CF chronic infections. 
 
3.9.1 Structure and function of elongation factor G 
The mutated fusA1 gene contained a non-synonymous single base substitution 
resulting in a proline to leucine conversion. Proline residues have a distinct cyclical 
structure which is important for protein folding and introducing turns and kinks. They 
are often found at the end of alpha helices or in turns, and in most cases on the protein 
surface (Gray et al., 2008; Bach et al., 2013), which is consistent with the position of the 
P443 residue in EF-G. Leucine, however, is not cyclical but possesses a branched 
hydrocarbon chain and, unlike proline, it is generally buried within the protein due to its 
hydrophobicity (Barnes et al., 2003). Computational predictions of the EF-G mutated 
protein did not indicate any significant changes to the EF-G protein structure, which was 
partially supported by analysing the intrinsic tryptophan fluorescence of the protein.  
Changes in fluorescence intensity often indicate structural alterations in the 
protein which adjust the microenvironment around the tryptophan residue. The 
wavelength of maximum emission can also shift, such as a ‘blue-shift’ as the tryptophan 
residue moves to a more nonpolar environment within the protein, or a ‘red-shift’ as the 
residue becomes more exposed to the surrounding solvent (Ghisaidoobe et al., 2014). The 
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P443L mutation caused only a very slight blue-shift in maximum emission which 
suggested that there was very minimal movement in the position of tryptophan residues 
which would affect their exposure to the solvent. There was however a large change in 
intensity, which is due to a change in quantum yield. The fluorescence quantum yield is 
the ratio of photons absorbed versus photons emitted through fluorescence, and informs 
regarding the probability that the excited state is being deactivated by fluorescence or by 
other non-radiative mechanisms (Fery-Forgues et al., 1999). In simpler terms, the 
fluorescence of the tryptophan residues is altered in response to changes in local residues 
or nearby molecules. A decrease in quantum yield has been associated with electron 
transfer by quenching, for example, via neighbouring amino acid sidechains (Ghisaidoobe 
et al., 2014). Fluorescence was quenched by the addition of fusidic acid to varying degrees 
in EF-G and the mutated form, consistent with the hypothesis that EF-G-P443L is 
structurally different from the WT form. 
With this, it appeared that the P443L mutation was not causing dramatic 
alterations to the structure, as the exposure of the multiple trytophans to the solvent was 
unchanged, but the change in quantum yield suggested minor structural changes 
throughout the protein. Interestingly, four of the five tryptophan residues were 
positioned within domain I, and the fifth was located in domain IV. Both of these domains 
play important roles in GTP hydrolysis and mRNA binding. It is conceivable that the 
minor adjustments within these domains maintained some level of function, which would 
likely have been abolished through larger structural alterations.  
EF-G adopts a series of large conformational changes throughout ribosome 
translocation. The function of EF-G relies heavily on protein flexibility, and so small 
changes can have large implications on protein function. The most dynamic movement 
occurs in domain IV, which dictates rotation of the other domains, most notably domains 
III and V. GTP and GDP exchange within domain I also mediate large conformational 
changes which bring the switch 1 region within bonding distance of domain III (Li et al., 
2011). As the majority of tryptophan residues resided in domain I, changes in 
fluorescence indicated that structural changes to this domain were likely to have 
occurred and may have disrupted such processes as guanosine phosphate exchange.  
EF-G binds the ribosome in its GTP-bound state. GTP hydrolysis occurs rapidly 
upon binding and coincides with rotation of the 30S ribosome subunit during tRNA 
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translocation. Counter-rotation of the ribosome is presumed to dissociate the deacylated-
tRNA from the E-site as well as releasing the (now GDP-bound) EF-G. Translocation can 
proceed without GTP hydrolysis, but occurs at a far slower rate, and the dissociation of 
EF-G from the ribosome is severely inhibited (Holtkamp et al., 2014). It is therefore 
possible that the growth defects observed in the FUS443 mutant were the result of poor 
guanine nucleotide exchange causing slow progression of protein synthesis.   
 
3.9.2 Variations in the phenotypic profile of FUS443 
The fusA1-P443L mutation exerted pleiotropic effects on several seemingly 
unrelated phenotypes. These could be complemented in almost all cases by the  
re-introduction of a functional fusA1 gene. The reduced growth rate of FUS443 during 
planktonic growth was an indicator that the mutant EF-G protein did not function as 
efficiently as the WT protein. Unexpectedly, the growth defect in rich media was abated 
under minimal media conditions. It is possible that the nutrient-limited environment 
triggered a stress response in the P. aeruginosa strains, which in fact could benefit its 
growth. Bacteria are well equipped to deal with environmental and internal stressors, 
and in almost all cases adaption requires a change in protein synthesis. Stress response 
systems typically shut down unnecessary pathways, or pathways which exacerbate the 
stress, so that the cell can direct more energy into growth and survival (Gottesman, 
2017). One such stress response is the nutrient-induced stringent response, mediated by 
the alarmone (p)ppGpp, which is triggered upon disruption to protein synthesis. The 
stringent response effects gene expression to promote survival during cell starvation and 
encourage persistence through environmental stress conditions (Beljantseva et al., 
2017). A stress response such as this may have directly affected EF-G or down-regulated 
some of the pathways affected by the mutated protein, therefore reducing its deleterious 
effects on the cell. In nutrient-rich conditions, these pathways remain active allowing for 
their reduced efficiency to become apparent. Alternatively, the cell may have activated 
mechanisms to compensate for the mutational defects, which are energetically-expensive 
and so reduce the amount of energy directed towards growth. 
Several virulence-factors were down-regulated in the FUS443 mutant. Reduced 
exoenzyme production meant that the mutant was unable to degrade the protein-based 
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media and so could not draw out these nutrients for growth. This would be particularly 
limiting for P. aeruginosa within the environment and would reduce the bacteria’s highly 
adaptable nature. In addition to this, swimming and twitching motility was severely 
reduced, meaning that the mutant strain was unable to explore its environment as 
efficiently as the progenitor strain. In contrast to the down-regulation of virulence 
factors, exopolysaccharide production was increased by the P443L mutation, which 
would be expected to promote biofilm formation. However, this was not the case, as 
biofilm formation was unaffected in the mutant strain. The up-regulation of 
exopolysaccharides may have been triggered as a compensatory mechanism to 
counteract the reduction in CdrA synthesis and maintains biofilm formation at a 
consistent level.  
These phenotypic studies also revealed that the WT EF-G had a dominant presence 
over any dysfunctional copies of the protein. In the cell, the WT and mutant proteins 
should have been competing for ribosome binding and so complete complementation 
was not expected. But in almost all cases the complemented strains could not be 
distinguished from the progenitor controls. It is likely that this was a result of the  
multi-copy plasmid producing greater abundance of the WT EF-G than the 
chromosomally encoded mutant form. Overexpressing the mutated fusA1 gene in trans 
saw a reduction in motility of the PAPcdr, progenitor strain. This provided evidence for 
the competition between the two EF-G forms and highlighted the sensitivity of motility 
regulation to changes in protein synthesis.  
Another distinctive phenotype which related to the fusA1 mutation was the 
dramatic up-regulation of BHL and OdDHL signalling molecules. These changes in QS 
signalling, in the FUS443 mutant, were dependent on the presence of the P. aeruginosa 
culture during incubation with the E. coli reporter strain. Any in vivo environment plays 
host to a wide variety of microbial flora, which communicate, cooperate and compete 
with one another to survive. P. aeruginosa competes with other bacterial species directly 
via the type VI secretion systems, producing toxins, siderophores and secondary 
metabolites (Beaume et al., 2015). I therefore considered that reduced virulence in 
FUS443 was responsible for increased detection of QS signal via reduced killing of the  
E. coli reporter strains. However, this theory is unlikely as similar levels of E. coli were 
recovered after incubation with either the progenitor or mutant strain.  
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In P. aeruginosa, QS regulates a diverse range of phenotypes, including virulence, 
biofilm formation and antibiotic production. QS is important for the secretion of 
exoenzymes and secreted toxins which help P. aeruginosa to dominate the microbial 
community within its environment. Strains of bacteria usually possess unique QS 
networks, which differ by stimuli and response, making QS as a therapeutic target 
difficult to work with (Laverty et al., 2014). The apparent up-regulation of QS signalling 
molecules in the mutant strain is inconsistent with the observed down-regulation of 
virulence phenotypes such as motility and protease production. It is possible that the 
spike in FUS443 QS signalling only occurs when in the presence of other microbial species 
(E. coli in this instance) to stimulate the production of the otherwise down-regulated 
virulence factors. The purpose of this may be to increase inter-bacterial competition, but 
appears to occur in a media-dependent manner. 
 
3.9.3 Antibiotic resistance 
The FUS443 mutant developed resistance to two aminoglycosides, kanamycin and 
gentamicin, with nearly a 3-fold increase in the gentamicin MIC. Aminoglycosides are a 
class of ribosome-targeting antibiotics which bind tightly to the A-site of the 30S subunit. 
Binding of aminoglycosides disrupts the correct selection of tRNA within this decoding 
site and blocks translocation of the tRNA into the P-site (Tsai et al., 2013). Typically, 
bacteria acquire aminoglycoside resistance through the expression of aminoglycoside 
acetyltransferases and phosphotransferases, or ribosomal mutation. Various studies 
have identified low-cost mutations in E. coli EF-G in response to sub-lethal concentrations 
of kanamycin (Mogre et al., 2014). These mutations spread rapidly through the 
population and were often located at the tip of domain IV which interacts with mRNA 
transcripts and the 30S subunit. Whilst the P443L mutation isolated in this study is 
located within domain III, it is possible that it has caused subsequent conformational 
changes which affect its interaction with the ribosomal A-site and disrupt aminoglycoside 
binding.  
Fusidic acid inhibits protein synthesis by binding to EF-G after GTP-hydrolysis, 
trapping it in the post-translation site and preventing further elongation. The fusidic acid 
binding pocket is situated between domains II and III, close to the switch regions which 
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control GTP hydrolysis. The P443L transition resides deep within the fusidic acid binding 
site, adjacent to residues that have been found to interact directly with the bound fusidic 
acid compound. Residue 443 of EF-G has been marked as a mutational site giving rise to 
fusidic acid resistance in Thermus thermophilus, Salmonella enterica serovar 
Typhimurium and Staphylococcus aureus (Palmer et al., 2013). However, the FUS443 P. 
aeruginosa mutant maintained fusidic acid sensitivity and binding of fusidic acid to EF-G 
did not appear to be affected by the mutation. This supports the structural predictions 
that the mutation had not significantly altered the structure of the fusidic acid binding 
pocket.  
In a study on S. aureus, an overwhelming number of fusidic acid resistant 
mutations were mapped to domain III. Hydroxyl radical probing and structural data 
showed that domain III was positioned in close proximity to protein S12 of the 30S 
ribosome (Norström et al., 2007). Whilst the FUS443 mutation in this study was 
unaffected in fusidic acid binding, the positioning of this mutation may still be key to 
changes in protein interactions with the ribosome and protein function.  
Interestingly, the FUS443 mutation also gave rise to antibiotic sensitivity. The 
progenitor strain displayed a high level of intrinsic antibiotic resistance to the myotoxin, 
fusaric acid, produced by Fusarium heterosporum. The mechanism of action for this 
antimicrobial agent is not well understood but resistance has been reported in  
P. fluorescens, a plant pathogen, that can colonise roots infected with fusarium (Quecine 
et al., 2015). Fusaric acid is reported to chelate cations, inhibit dopamine hydrolase, and 
has many similarities to the QS molecule, N-hexanoyl-L-homoserine lactone, which may 
act directly or indirectly to influence gene expression in P. aeruginosa (Tung et al., 2017). 









P. aeruginosa has posed a serious challenge to the medical community for decades 
due to the high frequency at which it acquires resistance to a wide variety of antibiotics 
(Lister et al., 2009). The unexpected and spontaneous emergence of a gentamicin 
resistant mutant, presented in this chapter, is a brazen reminder of this issue. My findings 
have shown how a SNP in EF-G, unlikely to have polar effects on downstream genes, has 
brought about resistance to multiple aminoglycosides, impacted upon several biofilm-
associated phenotypes, such as cdrA expression and the secretion of matrix 
exopolysaccharides. The SNP also affected virulence factors, including motility and 
protease production, and has caused potential changes to the cell communication 
network. The successful complementation of almost all of these characteristics strongly 
indicate the influence of the mutated EF-G protein on these systems and highlights how 
disruption to EF-G function can disturb the maintenance of a planktonic or biofilm 


















4. Proteomic analysis of FUS443 
4.1 Introduction 
The previous chapter saw the identification of a SNP in the EF-G encoding gene, 
fusA1. This mutation resulted in distinctive changes to cell morphology, affecting the 
expression of cdrA at a transcriptional level and altering the secretion of various proteins 
and polysaccharides. To investigate the global effects that the fusA1 mutation has on the 
cell, proteomic profiling of the FUS443 mutant was carried out and analysed for 
alterations to the secretome and the whole-cell proteome. Any proteomic data that has 
not been specifically defined within the tables presented in this chapter has been 
included within ‘7. Appendix’. 
 
4.2 Secretome 
P. aeruginosa secretes an abundance of proteins from the cell, such as proteases 
and exotoxins, many of which contribute to bacterial virulence. Previous findings 
highlighted a change in exoenzyme production in the FUS443 mutant and so the 
secretome was analysed to see if changes to the abundance of secreted proteins were 
large enough to be visualised by SDS-PAGE.  
The Pseudomonas Genome Database predicts that only 94 proteins are found 
extracellularly or are secreted from the cell (Winsor et al., 2016). Growth in minimal 
media restricts protein secretion further to retain resources in nutrient limited 
conditions. Previous studies have found that growth in M9 minimal media generates a 
completely different secretome profile compared with cells grown in LB, with one study 
identifying only 52 extracellular proteins from supernatants of PAO1 when grown to 
stationary phase in M9 minimal media (Scott et al., 2013). 
The FUS443 mutant (containing the empty pUCP20 vector), its progenitor, PAPcdr 
(pUCP20), and the complemented mutant, FUS443C (pfusA1) were grown in M9 minimal 
media, supplemented with glucose, to late exponential phase, at which point the 
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abundance of secreted proteins was expected to be at its greatest. Proteins within the 
supernatant were extracted and run on a 1D-SDS PAGE gel (Figure 4.1).   
 
 
Figure 4.1. Secreted proteins of the progenitor strain (PAPcdr), FUS443 mutant and the 
complemented strain (FUS443C), cultured in minimal media with glucose, were 
separated by SDS-polyacrylamide gel electrophoresis. Arrows point to protein bands that 
appear more or less intense than those of the progenitor and complemented strain. This 
figure is representative of the cell secretome observed across two biological replicates. 
 
There were minor changes in the abundance of secreted proteins across the 
different strains, indicated by the arrows on Figure 4.1. There appeared to be an increase 
in the quantity of higher molecular mass proteins at around 80 kDa in size, and also in a 
distinct band at approximately 70 kDa. The majority of secreted proteins in P. aeruginosa 
have a molecular weight of between 30 and 50 kDa and so the band at 37 kDa, which 
appeared more prominent in the mutant strain, and the band at approximately 32 kDa, 




The protein bands discussed here were only altered in the FUS443 mutant, with 
the progenitor and complemented strains having comparable protein levels. This 
suggested that the P443L mutation in EF-G was indeed affecting protein secretion or the 
synthesis of secreted proteins. There was one band at ~50 kDa in the complemented 
strain that is absent in the mutant and progenitor strains, suggesting that over-
expression of the fusA1 gene may also have had additional downstream effects that go 
beyond complementation of the P443L mutation. 
 
4.3 Proteomic profile of FUS443 
4.3.1 Sample preparation  
With changes having been observed in the secretome of FUS443, I wanted to 
investigate the effect of the fusA1 mutation on the global proteomic profile of the strain, 
and investigate any potential proteomic involvement in changes to cell physiology. 
Therefore, the whole-cell proteome of the progenitor, FUS443 mutant and complemented 
strain was analysed. Planktonic cultures were grown in M9 minimal media and were 
harvested at late exponential phase. The cell-associated protein was extracted and the 
concentrations were determined using the DC Protein Assay kit.  
Samples were first visualised on a 1D-SDS PAGE gel (Figure 4.2), where the vast 
majority of bands remained constant across all strains and across all biological replicates. 
A few subtle differences could be seen in some of the proteins below 25 kDa from the 
FUS443 cultures, but there were no clear banding patterns. The over-expression of EF-G 
(77.8 kDa) from the pfusA1 vector could be seen in the four replicates of the 
complemented strain (black arrow). pUCP20 has a high copy number in E. coli, achieved 
through the pMB1 origin of replication, whilst the encoded pRO1600 origin for 
replication in P. aeruginosa maintains this plasmid at a low copy number. Even with low 
level replication of pfusA1, the gel clearly indicated the extent to which EF-G was being 
overexpressed in the complemented strain compared with the other strains. It was also 
interesting to see that there was no obvious change in the abundance of EF-G in the 
FUS443 mutant, despite the high probability of reduced protein function. This suggested 





Figure 4.2. The total protein extracted from four biological replicates of the progenitor 
strain (PAPcdr), FUS443, and the complemented strain (FUS443C) cultured in minimal 
media with glucose were separated by SDS-polyacrylamide gel electrophoresis and 
stained with Coomassie blue. Arrow points to the over-expression of elongation factor G.  
 
To ensure that the changes in band intensity were not due to inaccurate 
measurement of the protein concentration or inconsistent loading onto the SDS-PAGE gel 
across the lanes, a duplicate gel was transferred by western blot onto a PVDF membrane 
and blotted with antibodies against the housekeeping protein, isocitrate dehydrogenase 
(ICD) (Figure 4.3). ICD, with a molecular weight of 45.6 kDa, was consistent across the 
blot. The background signal in the later lanes was likely to have been caused during 
separation through the gel and not due to errors in sample concentration. Confident that 
the protein concentrations were accurately measured, the samples were processed for 







Figure 4.3. Western blot analysis of the total protein extract from the progenitor strain 
(PAPcdr), FUS443 mutant and the complemented strain (FUS443C), using antibodies 
against ICD.  
 
4.3.2 Whole-cell proteomics 
4.3.2.1 TMT and LC/MS-MS 
Whole-cell protein extracts were sent for proteomic analysis using tandem mass 
tag (TMT) labelling and protein identification with liquid chromatography/tandem mass 
spectrometry (LC/MS-MS) at the Cambridge Centre of Proteomics. The dataset obtained 
from these samples contained 3506 proteins, from a total of 5570 predicted ORFs in the 
P. aeruginosa genome. This provided a good representation of the proteome, based on 
previously reported proteomic studies in PAO1 (Hare et al. 2012b, Park et al. 2014 and 
Guilbaud et al. 2017), and many of the absent proteins would not have been expressed in 
these growth conditions or would have been too low in abundance for detection.  
Protein quantitation values were log2 transformed to facilitate the comparison 
between conditions. Many proteins were affected by the mutation in fusA1. Of the 
proteins that had been up-regulated in response to the mutation, 177 had a log2 fold 
change (FC) of > 1, and 41 proteins had a log2 FC > 2. In contrast, 204 proteins had been 
down-regulated by a log2 FC of < -1 and 31 proteins had a log2 FC < -2 (Figure 4.4). For 
this study, modulations that were considered statistically significant had a log2 fold 





Figure 4.4. Modulation of protein abundance in the FUS443 mutant compared with the 
protein abundance of the progenitor strain. 
 
4.3.2.2 Box plots 
Box-and-whisker plots (box plots) provide a convenient way to compare protein 
expression distribution in different LC/MS runs and assess the impact of normalising 
data. The upper and lower lines of the box represent the 25th and 75th percentiles of the 
distribution and the middle line of the box represents the median value. The whiskered 
lines, that extend below and above the box, indicate the most extreme values that are not 
considered as outliers. Points that exist beyond the whiskers represent outlying values 
that are more than 1.5 times the interquartile range, from the first and third quartile.  
Figure 4.5A represents the raw distribution of protein abundance for each 
biological replicate from each condition. Global biases, which affect all peptides, are 
indicated by shifts up or down in the box plots and can be removed by normalisation of 
the data. The distributions of protein abundance are similar across all samples and any 
minor differences were corrected by normalisation of the data to each channel median 




Figure 4.5. Box plots of the log2 protein abundance distribution for nine LC-MS runs, 
composed of three replicates from each strain (PAPcdr, FUS443, FUS443C). (A) Raw data 





4.3.2.3 Principal components analysis  
 Principal components analysis (PCA) was employed to assess the similarities in 
gene expression amongst the three sample types. The PCA scores plot showed two 
clusters of data points, one containing the mutant samples and the other containing the 
progenitor and complemented samples (Figure 4.6). This indicated that the proteomic 
profile of the FUS443 mutant was distinct from the other two groups whereas the 
proteomic profiles of the progenitor and complemented strains appeared to be similar. 
This was a good indication that many of the changes occurring in the FUS443 mutant 
were a result of the fusA1 mutation.  
 
Figure 4.6. Principal component analysis of proteomic data from PAPcdr, FUS443 and 
FUS443C. Each point on the graph represents one biological replicate.  
 
4.3.2.4 Volcano plots 
Volcano plots are a way of illustrating the fold change (of log2 transformed protein 
abundance data) with the P-value (-log10 transformed) for all the quantified proteins. This 
allows for quick visualisation of global changes in the proteome and identifies proteins 
that have been highly modulated and are statistically significant in the mutant strain 
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compared with the progenitor. Data points that appear high on the Y axis have low  
P-values and are more significant.  
The volcano plot compared the combined replicates of the progenitor strain and 
the combined replicates of the FUS443 mutant strain (Figure 4.7A). Of all the proteins 
found to be up-regulated in the mutant, 129 were statistically significant, and 166 
proteins were significantly down-regulated. In comparison, the volcano plot depicting 
changes between the complemented FUS443C strain and the progenitor revealed that the 
protein abundance of these two strains were very similar (Figure 4.7B). In fact, only two 
proteins, EF-G and PscL, were significantly up-regulated in the complemented strain and 
no proteins were significantly down-regulated. This supported the PCA scores and 
together provided a clear indication that the proteomic changes induced by the P443L 
mutation in FUS443 could be recovered by complementation with a functional copy of 



















Figure 4.7. Volcano plot representing the log2 fold change (FC) of protein abundance 
against statistical significance for (A) the FUS443 mutant, and (B) the complemented 
FUS443C strain in relation to the PAPcdr progenitor strain. Several points have been 
annotated with the corresponding protein. 
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4.3.3 Modulated proteins in FUS443 
4.3.3.1 Proteins of an increased abundance 
The top 20 proteins with the greatest increased abundance in FUS443 are listed 
in Table 4.1. The log2 FC of the complemented mutant strain, FUS443C, was used to 
indicate if the modulation could be attributed to the P443L mutation.  
 
Table 4.1. List of up-regulated proteins associated with the fusA1-P443L mutation. 
Proteins associated with the T3SS are featured in the shaded boxes. A P-value of 0.000 
represents < 0.0005. 
  
  Protein 
  
Locus tag Protein function 
FUS443 FUS443C 
log2 FC P-value log2 FC P-value 
1 PscL PA1725 Type III secretion export protein 5.873 0.000 2.458 0.008 
2 PopN PA1698 Type III secretion outer membrane 
protein 
4.187 0.001 0.172 0.973 
3 PscP PA1695 Type III secretion translocation 
protein 
4.178 0.000 -0.179 0.953 
4 
 
PA3661 Hypothetical protein 4.004 0.002 -0.452 0.923 
5 PopD PA1709 Type III secretion outer membrane 
protein 
3.895 0.000 -0.113 0.903 
6 
 
PA1325 Hypothetical protein 3.667 0.000 -0.086 0.973 
7 ExoY PA2191 Adenylate cyclase 3.266 0.000 -0.193 0.881 
8 SpcS PA3842 ExoS chaperone 3.263 0.000 -0.156 0.866 
9 PcrH PA1707 Regulatory protein 3.262 0.000 -0.352 0.777 
10 ExoS PA3841 Exoenzyme S 3.261 0.000 0.157 0.861 
11 PcrG PA1705 Type III secretion regulator 3.211 0.000 -0.502 0.729 
12 PopB PA1708 Type III translocator protein 3.151 0.000 -0.055 0.973 
13 ExoT PA0044 Exoenzyme T 2.836 0.000 0.138 0.861 
14 AprX PA1245 Metalloproteinase  2.798 0.001 0.452 0.88 
15 AprA PA1249 Alkaline metalloproteinase 2.755 0.007 0.679 0.869 
16 PelA PA3064 Exopolysaccharide biosynthesis 2.725 0.000 -0.166 0.923 
17 
 
PA0630 Hypothetical protein 2.688 0.001 -0.070 0.982 
18 
 
PA0620 R-type pyocin, related to P2 phage 2.613 0.000 0.275 0.861 
19 SsuD PA3444 Hypothetical protein 2.519 0.002 1.811 0.262 




Figure 4.8. Network of interacting proteins. STRING was used to identify groups of 
interacting proteins that had been significantly up-regulated in the FUS443 mutant strain. 




Of the top 20 proteins with an increased abundance in the mutant strain, 12 
proteins were linked to T3S (shaded rows in Table 4.1). All but one of the T3SS proteins 
that were significantly up-regulated in the mutant were complemented in the FUS443C 
strain. This demonstrates that the expression of a functional fusA1 gene in trans reverses 
the changes in protein abundance associated with the mutated EF-G protein. The protein 
with the greatest fold change was PscL, a component of the T3SS found adjacent to the 
inner membrane. PscL underwent a significant log2 FC of 5.9 in the FUS443 strain, and 
the log2 FC in the complemented strain was also significant at 2.5. However, this 
corresponds to a FC of 58.6 in the mutant strain versus a 5.5 FC in the complemented 
strain, emphasising a distinct recovery in the abundance of this protein with the 
expression of fusA1. Another highly-modulated T3SS protein was PscP, a translocation 
protein of 38.5 kDa in weight. It is therefore a potential candidate for the 37 kDa band 
that was observed at an increased intensity in the FUS443 secretome (Figure 4.1). If this 
band does indeed represent PscP, together the proteomic data and secretome analysis 
support the notion that FUS443 exhibits increased levels of T3SS synthesis and secretion 
activity.  
STRING is a database of known and predicted protein-protein interactions. These 
interactions can be direct physical interactions or indirect, functional associations. The 
128 proteins that were found to be significantly up-regulated in the FUS443 mutant were 
analysed in STRING to identify clusters of associated proteins. A large number of the 
proteins could be organised into several distinct clusters representing different biological 
processes (Figure 4.8). As indicated in the top 20 modulated proteins, a dense cluster of 
interacting proteins contained those of the T3SS, such as PcrV, ExsE and ExoT. Another 
cluster was comprised of proteins associated with sulfur metabolism, such as the sulfate 
transporter, CysA, sulfate adenyltransferase, CysD and SsuD, involved in desulfonation of 
aliphatic sulfonates. TauB and TauD were also linked to this cluster as they are involved 
in metabolising taurine as a sulfur source, along with BioB, a biotin synthase which 
inserts a sulfur atom into dethiobiotin. A cluster of exopolysaccharide biosynthesis 
proteins, PelA, PelF and PslG, were up-regulated in the mutant, corroborating the 
phenotypic results in chapter three. A selection of pyochelin biosynthesis proteins were 
significantly up-regulated, as were a number of proteins encoded by the bacteriophage-
like R2-type pyocin gene cluster; PA0618, PA0620, PA0622. R-type pyocins cause 
membrane depolarisation and inhibit active transport in closely related species to reduce 
107 
 
bacterial competition (Llamas et al., 2007). Numerous ribosomal and metabolic proteins 
were also present in the list of affected proteins. With this, it appeared that the mutation 
in EF-G was affecting numerous biological networks which will be assessed in detail 
within this chapter. 
Alongside the T3SS proteins, two metalloproteinases, AprX and AprA, were 
amongst the most highly modulated proteins in FUS443. These proteases are secreted 
through a T1SS and, whilst not operonic, the encoding genes are clustered together on 
the chromosome alongside aprDEF which encode the corresponding ABC transporter. 
However, it appears that only AprA and AprX were significantly up-regulated in the 
mutant strain (Table 4.2).  AprI is a protease inhibitor which provides protection for self-
made proteins prior to protease secretion and was found at a significantly lower 
abundance in the mutant strain. AprI binds AprA to from a strong inhibitor complex with 
a stoichiometry of 1:1, blocking the AprA catalytic site (Bardoel et al., 2012). As AprA is a 
virulence factor typically involved in altering the bacterial cell surface to evade the host 
immune system (Bardoel et al., 2012), the increase in AprA abundance may have 
enhanced the proteolytic activity of the mutant strain, causing increased degradation of 
the central complement protein C3, IFN-gamma and flagellin. However, the lower 
abundance of AprI would increase the level of AprA activity prior to secretion and may 
have led to the degradation of proteins within the cell, disrupting various cellular 
processes and impacting cell fitness.  
 
Table 4.2. Abundance modulation of the proteins located within the apr gene cluster, 
organised by gene order. Shaded boxes represent proteins that have been significantly 
modulated. 
  FUS443 FUS443C 
Protein log2 FC P-value log2 FC P-value 
AprX 2.798 0.001 0.452 0.88 
AprD -0.099 0.646 0.284 0.743 
AprE -0.33 0.341 0.514 0.738 
AprF 0.27 0.126 0.065 0.962 
AprA 2.755 0.007 0.679 0.869 




In P. fluorescens, QS, temperature and iron availability have all been shown to 
influence the production of AprX (Burger et al., 2001).  Both aprX and aprA promoter 
sequences contain binding sites for iron response regulators, Fur and PvdS (Ithín 
Maunsell et al., 2017). My data shows that the abundance of Fur and PvdS was unchanged 
from that of the progenitor strain but as both are post translationally regulated their 
activity cannot be determined through this screen.  
 
4.3.3.2 Proteins of a decreased abundance 
As with analysing proteins of increased abundance, the significance of the down-
regulated proteins was defined as a log2 FC < -1 and an FDR (False Discovery Rate) 
adjusted P-value of ≤ 0.01. Table 4.3 lists the top 20 proteins in FUS443 that have the 
greatest reduction in protein abundance. The log2 FC of proteins from the complemented 

















Table 4.3. List of down-regulated proteins associated with the fusA1 mutation in FUS443.  
      
Protein function 
FUS443 FUS443C 
  Protein Locus tag log2 FC P-value log2 FC P-value 
1 ExaB PA1983  Ethanol oxidation  -3.154 0.000 -0.097 0.950 
2   PA5086  Predicted T6SS lipase 
immunity protein 
-3.088 0.000 -1.481 0.222 
3   PA2565  Hypothetical protein -2.962 0.002 -0.718 0.828 
4   PA3865  Probable amino acid binding 
protein 
-2.955 0.001 -0.248 0.938 
5   PA3785  Hypothetical protein -2.947 0.000 -0.288 0.899 
6   PA5481  Hypothetical protein -2.807 0.001 -0.194 0.950 
7   PA0270  Hypothetical protein -2.768 0.006 -0.601 0.888 
8   PA3576  Hypothetical protein -2.548 0.004 -0.428 0.903 
9   PA2134  Hypothetical protein -2.533 0.001 -0.474 0.858 
10   PA2807  Hypothetical protein -2.471 0.000 -0.667 0.470 
11   PA5505  Probable TonB-dependent 
receptor 
-2.467 0.002 -0.109 0.973 
12   PA4697  Hypothetical protein -2.409 0.001 -0.180 0.962 
13   PA5359  Hypothetical protein -2.366 0.000 -0.514 0.689 
14   PA4063  Hypothetical protein -2.300 0.067 -1.098 0.858 
15   PA3318  Hypothetical protein -2.291 0.001 -0.660 0.660 
16   PA2781  Hypothetical protein -2.278 0.000 -0.066 0.969 
17 ModA PA1863  Molybdate-binding protein -2.259 0.001 -0.194 0.944 
18 FliY PA0314  Flagellar rotor protein  -2.241 0.001 -0.160 0.956 
19   PA5330  Hypothetical protein -2.240 0.001 -0.201 0.944 
20   PA5088  Predicted T6SS lipase 
immunity protein 






Figure 4.9. Network of interacting proteins. STRING was used to identify groups of 
interacting proteins that had been significantly down-regulated in the FUS443 mutant 
strain. Thick lines between nodes represents a high confidence level for that interaction. 
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The majority of the top 20 down-regulated proteins in FUS443 were 
uncharacterised (Table 4.3). The protein with the greatest FC was ExaB, a cytochrome 
C550. Cytochrome C550 is an electron acceptor involved in the breakdown of ethanol to 
aldehyde (Schobert et al., 1999). From the STRING map in Figure 4.9, ExaB was amongst 
a small cluster of proteins including nitrite reductase, NirS, and azurin, Azu. Azurin 
transfers electrons from another c-type cytochrome, cytochrome C551, to cytochrome 
oxidase. Cytochrome C551 is the electron donor of nitrite reductase and plays a role in 
dissimilative denitrification (Cutruzzolà et al., 2002). PA3785, a predicted copper 
chaperone of the PCuAC family was also amongst the top 20 proteins. This protein 
chaperones copper to cytochrome oxidase, which contains a binuclear Cu-Cu centre 
(Serventi et al., 2012). These findings indicated that the mutated EF-G was influencing 
bacterial respiration.   
There were fewer predicted interactions between the down-regulated proteins, 
compared with the distinctive clustering of the up-regulated proteins. This is likely to be 
due to the high number of uncharacterised proteins and therefore uncharacterised 
interactions. Still, several distinct clusters were determined, such as the aforementioned 
cluster of cytochrome C and respiratory proteins, and a larger set of proteins localised to 
the periplasm with roles in disulphide bond formation, including DsbA, DsbD2 and TrxA. 
This group of proteins are all involved in protein folding and are closely linked to the 
electron transfer chain and cell respiration.  
Reduced abundance was identified for ModA, a binding protein for the metal, 
molybdenum, which is often used as a cofactor, for example, in the reduction of nitrate to 
nitrite. ModA functions alongside ModB and ModC to transport the metal into the cell. 
Several other highly down-regulated proteins were linked to the T6SS. PA5086 and 
PA5088 are predicted to encode T6SS lipase immunity proteins, which protect the cell 
from lipase inflicted self-harm, or protect against toxic effectors from the same species 
(Dong et al., 2013). PA5088 is operonic with a T6S phospholipase D effector and with 
VgrG5, which were not detected in this screen. VgrG proteins are secreted by the T6SS to 
form complexes that perforate host cell membranes, and its genomic position besides 
PA5088 makes it likely that its expression was also reduced.  The down-regulation of 
T6SS-assocated proteins observed here is consistent with its inverse regulation with 
T3SS proteins.  
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Another cluster of proteins was related to cell motility and chemotaxis, including 
CheR1, PA0177, PctC, PA1464, and the twitching motility protein, PilH. The flagellar 
motor protein, FliY, and an uncharacterised protein, PA2781, were also down-regulated 
in FUS443. PA2781 is operonic with PA2780 (bswR), a bacterial swarming regulator 
(undetected in the proteomic analysis), and PA2781 is predicted to interact with FlgB, a 
structural component of the bacterial flagellum. This strongly suggests that PA2781 is 
involved in flagellar mediated motility. 
 
4.4 Motility 
Bacteria respond to changes in environmental chemicals through cell surface 
chemoreceptors. The complex chemosensory system of P. aeruginosa comprises of over 
20 chemotaxis genes, arranged across five gene clusters. Flagellar motility is organised 
through che genes (clusters I, II and V), whereas T4P synthesis is controlled by the pil-chp 
gene cluster (IV) (Schmidt et al., 2011). Table 4.4 lists how the expression of these 
clusters were represented at a proteomic level. Cluster III encodes seven Wsp proteins 
which have been linked to pel and psl expression (Schmidt et al., 2011), but the Wsp 












Table 4.4. List of proteins encoded by the P. aeruginosa chemosensory system and their 
log2 fold change in the FUS443 and complemented mutant. Shaded boxes represent 
proteins that have been significantly modulated. 
Protein  
 FUS443 FUS443C 
Cluster log2 FC P-value log2 FC P-value 
CheY Two component response regulator I -0.708 0.001 -0.104 0.897 
CheZ Chemotaxis protein I -0.373 0.017 -0.058 0.950 
CheA Probable two-component sensor I -0.365 0.029 -0.281 0.630 
CheB Methylesterase I -0.560 0.002 -0.126 0.841 
MotD Flagellar motor protein I -0.569 0.002 -0.340 0.973 
Orf1 Probable plasmid portioning 
protein 
I -0.332 0.103 -0.034 0.980 
Orf2 Hypothetical protein I -0.159 0.143 -0.077 0.897 
CheW Purine-binding chemotaxis protein I -1.103 0.000 -0.359 0.450 
CttP Chemotactic transducer for 
trichloroethylene 
II 0.098 0.740 -0.199 0.899 
CheY2 Probable two component response 
regulator 
II -1.260 0.001 0.052 0.973 
CheA2 Probable two component sensor II 0.074 0.776 0.227 0.858 
CheW2 Probable purine-binding 
chemotaxis protein 
II -1.313 0.003 -0.034 0.987 
Aer2 Aerotaxis transducer II -0.294 0.118 0.105 0.915 
CheR2 Probable methyltransferase II 0.001 0.996 -0.138 0.933 
CheD Hypothetical protein II -0.054 0.887 -0.035 0.988 
CheB2 Probable methylesterase II -0.474 0.289 -0.057 0.985 
PilG CheY-like response regulator IV -0.972 0.000 -0.041 0.966 
PilH CheY-like response regulator IV -1.274 0.000 -0.150 0.743 
PilI Chemoreceptor adapter protein IV -0.251 0.360 -0.001 1.000 
PilJ Chemoreceptor IV 0.446 0.091 0.573 0.480 
PilK Methyltransferase IV 0.316 0.035 -0.135 0.855 
ChpA Histidine kinase IV 0.140 0.558 0.123 0.932 
ChpB Methylesterase IV -0.170 0.134 0.006 0.993 
CheV Probable chemotaxis protein V -0.242 0.232 -0.021 0.987 





The abundance of five of chemotaxis proteins (CheW, CheR, CheY2, CheW2 and 
PilH) was significantly lower in the FUS443 mutant and was complemented by the pfusA1 
plasmid. CheW conveys signals from cell surface chemoreceptors to the cytoplasmic 
histidine kinase, CheA. CheA relays this signal into the cell by activating CheY which 
controls the rotational switch on flagellar motors. CheR, a methyltransferase works 
antagonistically with the methylesterase, CheB, to reset the chemoreceptor after ligand 
binding by altering its methylation status (Ferrández et al., 2002). However, the 
homologs encoded in cluster II are predicted to form functionally distinct signalling 
complexes to that of cluster I, for example, there is no support to suggest that CheY2 
interacts with the flagellar motor (Ferrandez et al., 2002). The majority of flagellar-
associated proteins had been down-regulated in the mutant strain and, where PilG, PilH 
and PilI were all down-regulated, several of the other twitch-related proteins were 
marginally up-regulated. 
Phenotypic analysis of the mutant strain saw a decrease in swimming and 
twitching motility. Here, I have presented proteomic evidence that a large number of 
chemotaxis and motility proteins are reduced in abundance, many of which were 
complemented by the expression of pfusA1. The distribution of up-regulated proteins 
amongst different motility operons suggests that this change in abundance is occurring 
at a post-transcriptional level and so the mutated EF-G protein may be affecting mRNA 
stability or protein degradation systems. 
 
4.5 Type III secretion and ribosomal stress 
4.5.1 Type III secretion 
In P. aeruginosa, over 30 genes are involved in the regulation and biosynthesis of 
the T3SS (H. Yang et al., 2007). Due to the prevalence of T3SS-associated proteins 
amongst those most highly-modulated in FUS443, the proteomic abundance for the 





Table 4.5 List of proteins encoded by the P. aeruginosa T3SS and their log2 fold change 
in the FUS443 and complemented mutant. Shaded boxes represent proteins that have 
been significantly modulated.  
  FUS443 FUS443C 
Protein  log2 FC P-value log2 FC P-value 
Basal body 
PscD 0.382 0.291 0.199 0.926 
PscJ 0.758 0.002 0.027 0.980 
PscC 2.133 0.000 -0.076 0.962 
PscL 5.873 0.000 2.458 0.008 
Translocon 
PopB 3.151 0.000 -0.055 0.973 
PopD 3.895 0.000 -0.113 0.903 
PcrV 2.143 0.000 -0.305 0.738 
Needle 
PscF 2.507 0.000 -0.304 0.855 
PscP 4.178 0.000 -0.179 0.953 
Export apparatus 
PopN 4.187 0.001 0.172 0.973 
PscB 2.349 0.000 -0.017 0.987 
Regulatory network 
ExsC 2.358 0.000 -0.019 0.993 
ExsE 2.401 0.000 -0.162 0.945 
ExsA 0.894 0.000 0.068 0.925 
ExsD 0.846 0.000 -0.036 0.973 
Chaperones 
SpcS 3.263 0.000 -0.156 0.866 
PcrH 3.262 0.000 -0.352 0.777 
PcrG 3.211 0.000 -0.502 0.729 
PscE 1.982 0.000 -0.300 0.769 
PscG 2.205 0.000 -0.189 0.861 
Secreted toxins 
ExoS 3.261 0.000 0.157 0.861 
ExoT 2.836 0.000 0.138 0.861 





The majority of T3SS genes are clustered together in the P. aeruginosa genome, 
encoded across five operons. At least six other genes are distributed elsewhere in the 
chromosome, including the secreted exotoxins and their chaperones. All of the T3SS 
proteins identified in the proteomic screen were found to be up-regulated in the mutant 
strain, suggesting that the mutation to EF-G is disrupting the global regulation of all T3SS 
genes. 
The master regulator of the T3SS is ExsA, which binds to the promoter of T3SS 
operons and activates transcription. In FUS443, the abundance of ExsA was increased by 
a FC of 1.9 (86% more abundant than in the progenitor strain) and was completely 
complemented by the introduction of a functional fusA1 gene. ExsA regulates the T3SS 
through a ‘catch-and-release’ network with ExsCDE, all of which are positively regulated 
by ExsA (Brutinel et al., 2010). Whilst the change in ExsA abundance was not considered 
significant under the parameters of this study, this relatively small change may be enough 
to tip the balance and activate T3S expression. The abundance of another T3SS 
transcriptional regulator, PsrA, was unaffected in this study. 
 
4.5.2 Ribosomal stalling 
Over 60 ribosomal proteins were up-regulated in the mutant strain, of which the 











Table 4.6. List of ribosomal and ribosome-associated proteins encoded by P. aeruginosa 
and their log2 fold change in the FUS443 and complemented mutant strains. Shaded boxes 
represent proteins that have been significantly modulated in the mutant strain. 
    FUS443 FUS443C 
Protein  log2 FC P-value log2 FC P-value 
RplX 50S ribosomal protein L24 1.712 0.001 0.380 0.743 
RpmG 50S ribosomal protein L33 1.643 0.006 0.165 0.964 
RpmE 50S ribosomal protein L31 1.248 0.268 1.098 0.855 
RpsT 30S ribosomal protein S20 0.892 0.001 0.182 0.830 
YcfB Probable DNA methylase 0.891 0.001 0.155 0.847 
DeaD probable ATP-dependent RNA 
helicase 
0.878 0.002 0.250 0.794 
RplB 50S ribosomal protein L2 0.872 0.006 0.324 0.764 
RplA 50S ribosomal protein L1 0.863 0.008 0.382 0.729 
RplU 50S ribosomal protein L21 0.854 0.004 0.331 0.729 
RplT 50S ribosomal protein L20 0.845 0.008 0.276 0.828 
SmpB RNA binding protein 0.839 0.001 0.236 0.703 
RplC 50S ribosomal protein L3 0.825 0.007 0.311 0.775 
RplI 50S ribosomal protein L9 0.813 0.001 0.220 0.742 
RpsM 30S ribosomal protein S13 0.786 0.010 0.300 0.802 
FusA1 Elongation factor G (1A) 0.495 0.006 2.269 0.000 
FusA2 Elongation factor G (1B) 0.624 0.009 -0.025 0.985 
 
 
The abundance of ribosomal complexes is adjusted to meet the demand for 
protein synthesis in the cell (Aseev, Koledinskaya and Boni, 2016). If the EF-G protein 
reduces the efficiency of translation, as speculated, the cell may upregulate the synthesis 
and assembly of ribosomal proteins to compensate for this defect and to maintain a 
sufficient level of protein synthesis for cell survival.  
Amongst the ribosome-associated proteins was the RNA binding protein, SmpB. 
In E. coli, SmpB binds the RNA molecule, ssrA, which functions as both tRNA and mRNA. 
It binds to the A-site of stalled ribosomes where it acts as a surrogate mRNA transcript 
and directs the translation of a short peptide tag which targets the stalled peptide for 
proteolysis, preventing the accumulation of stalled ribosomes (Karzai et al., 1999). Whilst 
ssrA cannot be detected under proteomic analysis, SmpB is essential in stabilising the 
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association between ssrA and the ribosome, and so the increased abundance of SmpB may 
indicate an increase in ssrA.  This suggests that the mutated EF-G is causing the ribosome 
to stall. Unlike with previous modulations which have typically shown complete 
complementation by pfusA1, the abundance of ribosomal proteins was only partially 
recovered. The endogenous, mutated form of EF-G was still expressed in the 
complemented strain and so EF-G-P443L and the WT EF-G, expressed via pfusA1, would 
be competing for ribosomal binding, leading to incomplete complementation.  
 
4.5.3 Induction of exsA expression via ribosomal stress 
Amongst the up-regulated ribosomal proteins was the DEAD-box protein, DeaD. 
DeaD is an RNA helicase that is important in processing RNA prior to translation. 
Interestingly, DeaD has been found to stimulate ExsA translation and therefore promotes 
the expression of the T3SS (Intile et al., 2015). The abundance of DeaD in the mutant 
strain was increased by a FC of 1.8 (an 84% increase from that of the progenitor), similar 
to the increase in ExsA abundance. Therefore, it is possible that the global up-regulation 
of ribosomal proteins, induced by the mutant EF-G protein, may be causing an up-
regulation of T3SS genes via DeaD.  
Alternatively, amongst the highly down-regulated proteins was the copper-
binding protein, PA2807. This is encoded directly downstream of ptrA, also involved in 
copper tolerance, but unfortunately not detected in this screen. PtrA has been identified 
as a direct inhibitor of ExsA and its over-expression completely inhibits secretion via the 
T3SS (Ha et al., 2004). If ptrA was also down-regulated with PA2807 in response to 
copper levels, this may have added to the increased ExsA abundance.  
 
4.5.4 FusA homologs 
Two EF-G homologs exist in P. aeruginosa. The fusA1-encoded EF-G1A was found 
at a greater abundance than the fusA2-encoded EF-G1B, in the mutant and progenitor 
strains. The mutant strain expressed both homologs at a higher abundance than in the 
progenitor, but not to a significant level.  This up-regulation may have been induced 
through a common mechanism with the other ribosome-associated proteins. The fusA1 
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and fusA2 sequences are highly conserved among P. aeruginosa species, and previous 
transcriptomic studies have shown that fusA2 is expressed around 30-fold less than fusA1 
(Bielecki et al., 2012). The ratio between the two encoded proteins was not as skewed in 
this study but was consistent with fusA1 being the dominantly expressed homolog. 
 One study found that EF-G1B was more susceptible to the action of fusidic acid 
than EF-G1A (Palmer et al., 2013). The two homologs share 84% amino acid sequence 
identity. None of the amino acid variations are positioned within the fusidic acid binding 
pocket and so sensitivity to the antibiotic is likely to be due to global conformational 
differences that effect binding. The majority of amino acid variations are positioned in 
domain I, the site of GTP binding and hydrolysis, as well as numerous changes to domain 
IV. As these domains are key to the function of EF-G, this supports the idea that EF-G1A 
and EF-G1B play distinct roles in the cell.  
The proteomic data also quantified the abundance of EF-G in FUS443C at 4.8-fold 
greater than that observed level in the progenitor strain and the potential effects of this 
over-expression should be taken into consideration. The over-expression of fusA1 in the 
complemented strain did not lead to a change in abundance of the EF-G1B protein, 
showing that there was limited feedback between these two homologs. This suggests that 
the increase in EF-G1B in the mutant strain did not result from any interaction with the 
mutated EF-G1A and was induced through an independent mechanism, such as that of 
the other ribosomal proteins.  
 
4.6 Up-regulation of siderophore biosynthesis in FUS443 
4.6.1 Pyochelin-associated proteins 
Also amongst the proteins most affected by the P443L mutation was a variety of 
pyochelin-biosynthesis proteins that had been up-regulated (Table 4.7). Pyochelin is an 
iron-scavenging siderophore that is secreted into the environment to acquire iron for 
bacterial growth. Iron-bound pyochelin is detected by receptors on the cell surface 
membrane and is internalised where the iron can then be utilised by the cell.  
P. aeruginosa synthesises two siderophores; pyochelin and pyoverdine, the abundance of 
pyoverdine-associated proteins was unchanged in FUS443 whereas the expression of a 
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wide variety of pyochelin-associated proteins was increased. Interestingly, the 
abundance of regulatory proteins for pyochelin synthesis, such as PchR and Fur, was 
unchanged in the mutant strain, but the regulators may have been functioning at an 
altered level of activation.  Expression of the pfusA1 complementation plasmid only 
partially restored protein abundance levels to that of the progenitor strain, making it 
difficult to attribute this phenotype solely to the P443L mutation.  
Also amongst the down-regulated proteins was the hypothetical protein, PA2134, 
and FeoA. PA2134 shares homology with the iron storage protein, ferritin, and FeoA, 
encoded on the feoABC operon, is involved in ferrous iron acquisition. FeoA is a cytosolic 
protein thought to activate the iron permease FeoB, perhaps serving as GTPase activating 
protein, to promote iron transport into the cell (Seyedmohammad et al., 2016). The 
down-regulation of these proteins demonstrates how the P443L mutation is influencing 
multiple iron-uptake systems in different ways. 
 
Table 4.7. List of pyochelin-associated proteins encoded by P. aeruginosa and their log2 
fold change in the FUS443 and complemented mutant. Shaded boxes represent proteins 
that have been significantly modulated in the mutant strain. 
    FUS443 FUS443C 
Protein log2 FC P-value log2 FC P-value 
PchE Dihydroaeruginoic acid synthetase 2.441 0.003 1.321 0.470 
PchG Pyochelin biosynthetic protein  2.312 0.004 1.483 0.442 
PchD Pyochelin biosynthesis protein  1.888 0.001 0.657 0.532 
PchH Probable ATP-binding component of ABC 
transporter 
1.836 0.028 1.884 0.428 
PchF Pyochelin synthetase 1.810 0.006 1.050 0.536 
PchI Probable ATP-binding component of ABC 
transporter 
1.552 0.046 1.672 0.470 
PchA Salicylate biosynthesis isochorismate 
synthase 
1.398 0.016 0.562 0.808 
FptA Fe(III)-pyochelin outer membrane 
receptor precursor 
1.106 0.006 0.851 0.384 





4.6.2 Siderophore secretion 
With the up-regulation of pyochelin synthesis proteins, I expected FUS443 to 
secrete higher levels of siderophores than the progenitor strain. To test this, a Siderotech 
assay kit was used to detect the release of siderophores into the culture supernatant. If 
siderophores are detected within the cell-free supernatant the solution turns red in 
colour, as seen with the progenitor and the complemented strains. In a very unexpected 
result, the mutant strain did not secrete detectable levels of siderophores into the 
medium (Figure 4.10). This kit is not specific for pyochelin secretion which suggests that 
pyoverdine was also not being secreted from the mutant cells.  
 
 Figure 4.10. Siderotech assay was used for the detection of siderophores in the culture 
supernatants of the progenitor strain (PAPcdr), the FUS443 mutant and the 
complemented mutant strain (FUS443C). The supernatant from two biological replicates 
(1 and 2) were tested twice for each strain. Solution turns from blue to red upon the 
detection of siderophores in the culture supernatant. 
 
The lack of siderophore secretion suggests that either the siderophore-
biosynthesis pathways in the mutant strain were disrupted, or the secretory systems. 
Unlike for the secretion of pyoverdine, very little is known about the secretion of 
pyochelin from the cell. The protein, TonB, is vital for iron uptake and is required by all 
of the siderophore transport systems (Cuív et al., 2007). Amongst the top down-regulated 
proteins was PA5505, predicted to be a TonB-dependent receptor related to iron 
acquisition, possibly as a siderophore shuttle between the plasma membranes. A 
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reduction in the abundance of PA5505 highlights it as a potential bottleneck in 
siderophore secretion. 
An inability to acquire iron via siderophore secretion would mean that the cells 
would not grow well under iron limited conditions. To investigate this, the mutant strain, 
the progenitor and the complemented strain were grown on minimal media plates 
containing increasing concentrations (0.1 to 100 mM) of the iron chelator, 
ethylenedinitrilo tetra-acetic acid (EDTA) (Figure 4.11). Overall, little difference in 
growth was observed across the strains and all strains struggled to grow on media 
containing over 10 mM EDTA. This suggests that the mutant strain, despite disruption to 
siderophore secretion, is equally capable of surviving under iron limited conditions to the 
progenitor strain.  
 
Figure 4.11. Growth on minimal media supplemented with increasing concentrations of 
the metal chelator, EDTA. The formation of strains, labelled on the first plate, is consistent 
across all assay plates.  
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4.7 Antibiotic resistance  
In chapter three, antibiotic resistance assays suggested that the mutated EF-G 
protein plays a direct role in resistance to aminoglycosides by disrupting binding at the 
ribosomal A-site. Now, with the proteomic analysis, it was revealed that the mutant strain 
exhibited an increased abundance of efflux pumps, which were complemented with the 
pfusA1 plasmid (Table 4.8). This proposed that the mutated EF-G protein is promoting 
antibiotic resistance indirectly, via the up-regulation of efflux systems to expel antibiotics 
from the cell. 
 
Table 4.8. List of protein efflux systems encoded by P. aeruginosa which were found to 
be up-regulated in the FUS443. Log2 FC for the mutant and complemented mutant are 




log2 FC P-value log2 FC P-value 
ArmZ MexZ anti-repressor 2.106 0.000 0.022 0.985 
MexY Multidrug efflux transporter  1.929 0.001 0.170 0.942 
MexX Multidrug efflux membrane 
fusion protein 
1.830 0.000 0.110 0.915 
OpmH Probable outer membrane 
protein precursor 
1.282 0.001 -0.134 0.903 
MexZ  Transcriptional regulator 1.183 0.001 0.055 0.973 
OprM Efflux outer membrane protein -0.359 0.137 -0.150 0.907 
 
Of the main efflux systems encoded by P. aeruginosa (MexAB-OprM, MexCD-OprJ, 
MexEF-OprN and MexXY-OprM), only the MexXY system was seen to be significantly up-
regulated in the FUS443 mutant. This was reflected in the increased abundance of its 
regulators MexZ and ArmZ. However, the outer membrane protein for the MexXY system, 
OprM, was the only component not to be up-regulated and actually exhibited a slight 
decrease in protein abundance. The successful complementation with pfusA1 strongly 
suggested that the P443L mutation was causing changes in the abundance of this efflux 
system which may contribute to the increased aminoglycoside resistance observed in the 




4.8.1 Type III secretion 
The T3SS is a major virulence determinant and is one of the approaches used by 
bacteria to induce the cell death of eukaryotic host cells during infection. The needle 
complex of the T3SS penetrates the plasma membranes of adjac3333ent host cells and 
‘injects’ exotoxins into the host cell cytoplasm. These exotoxins disrupt cytoskeletal 
components to induce cell rounding and cell death. T3SS biogenesis and regulatory 
proteins are encoded across five clustered operons, consisting of 36 genes (Figure 1.4), 
with genes encoding the effector proteins and chaperones spread out throughout the 
genome (Hauser, 2009). Almost all of the T3SS proteins detected in the FUS443 
proteomic analysis were of a markedly higher abundance than in the progenitor and 
complemented strain. Typically, T3S is maintained at low basal levels until activated by 
environmental stimuli such as a low calcium concentration or host cell contact, which 
promote transcription of the system via the master regulator ExsA (H. Yang et al., 2007). 
Conditions across all replicates and strains in this study were kept constant, meaning that 
the T3SS should not have been activated by either of these stimuli.  Therefore, the P443L 
mutation must have been inducing T3S via a different mechanism.  
The proteomic analysis of the mutant strain confirmed an increase in ExsA 
abundance, whose activity is controlled by the ExsECD interaction cascade. Under non-
inducing conditions, two protein partnerships are formed; ExsD/A and ExsC/E. 
Activation of the T3SS results in secretion of ExsE through the injectosome, causing a 
series of partner-switching actions, where the newly relinquished ExsC binds to ExsD. 
ExsA is released and is free to activate the expression of T3SS genes, including its own 
promoter, creating a surge in the assembly of T3S complexes on the cell membrane (Intile 
et al., 2015). All of the proteins within this regulatory cascade were more abundant in the 
FUS443 strain but to varying degrees. ExsC underwent a far greater increase in 
abundance than ExsD, which would have increased the level of ExsD sequestration by 
ExsC. In doing so, more ExsA would be relinquished, and would be free to initiate the up-
regulation of T3SS genes.  
A known T3SS regulatory system, the Gac/Rsm pathway, was not affected on a 
proteomic level by the presence of the P443L mutation. Similarly, two other regulatory 
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systems, Vfr and cAMP signalling, were unchanged. One protein, DeaD, was found in 
higher abundance in FUS443 and has been found to directly regulate translation of the 
exsA transcript. DeaD is a DEAD-box RNA helicase, which assists in the translation of 
proteins by relaxing mRNA secondary structures and encouraging ribosome binding. 
Previous studies have identified DeaD as a positive post-transcriptional regulator of exsA 
through this mechanism (Intile et al., 2015). Control of the ExsECDA cascade is finely 
balanced and small changes can disrupt this equilibrium to create larger changes to T3S 
activity. With this, the small increase in the abundance of DeaD may raise ExsA levels 
enough to induce a positive feedback cascade on the expression of T3SS genes.  
In E. coli there are 5 DEAD-box RNA helicases, including DeaD, that facilitate the 
assembly of the 50S ribosomal subunit (Vakulskas et al., 2014). Synthesis of ribosomal 
proteins is adjusted so that the synthesis of cellular components can be maintained at an 
optimal level for growth. As protein biosynthesis is the largest consumer of energy in the 
cell, excess translation causes negative feedback on rRNA and tRNA genes (Nomura, 
1999). Suboptimal translation should therefore cause the inverse, seeing a rise in the 
number of ribosomal proteins to maintain growth. The reduced functional efficiency 
predicted for the mutated EF-G would put a strain on the ribosome to meet the protein 
synthesis requirements for optimal cell growth. This increased pressure may have led to 
the increase in ribosome-associated protein abundance in FUS443, including DeaD, and 
in doing so, promoted the expression of exsA and T3S. 
Alternatively, T3S induction might have occurred via PtrA, a transcriptional 
repressor that is known to negatively regulate ExsA. PtrA was absent from the proteomic 
profile of FUS443, however the neighbouring gene PA2807 was found at a reduced 
abundance. Both PA2807 and PtrA are involved in copper tolerance and so are likely to 
be co-expressed. It is postulated that PtrA negatively regulates ExsA, whilst up regulating 
copper resistance genes, to shut off energetically expensive systems such as the T3SS 
during unfavourable growth conditions (Ha et al., 2004). If the reduced levels of PA2807 
reflect a reduction in PtrA abundance, then this would elevate exsA repression and 
promote T3S. The role of EF-G in PA2807 and PtrA expression is unclear, but it is possible 
that the mutation affects the way in which the mutant cell senses copper, leading to 




4.8.2 Antibiotic resistance 
Phenotypic analysis of FUS443 identified that the strain was resistant to at least 
two aminoglycosides; kanamycin and gentamicin. As both EF-G and aminoglycosides 
target the A-site of the ribosome, it was logical to presume that a change in EF-G 
conformation had led to steric hindrance, preventing the action of the antibiotics on the 
ribosome. The proteomic data presented an alternative explanation by highlighting the 
up-regulation of an efflux system that is specific for aminoglycoside export.  
Expression of the MexXY efflux system is the predominant mechanism of 
aminoglycoside resistance in CF lung isolates and is induced upon exposure to antibiotics 
(Hay et al., 2013). But even in the absence of antibiotic selection, the MexXY efflux system 
was drastically up-regulated in the FUS443 mutant. ArmZ is the main activator of the 
MexXY efflux system which functions by inhibiting the mexXY repressor, MexZ. MexZ is 
the most commonly mutated gene in CF isolates and is predominantly mutated in 
aminoglycoside-resistant strains (Morita et al., 2012; Hay et al., 2013). During activation 
of the MexXY system, ArmZ is expressed in response to disrupted translation caused by 
the presence of antibiotics. During translocation the 30S ribosome rotates relative to the 
50S subunit, at which point the tRNA is moved into the next ribosomal position. 
Gentamicin has been shown to lengthen the non-rotated state and lock the tRNA into a 
conformation that stabilises its position within the A-site. This causes the ribosome to 
stall and peptide synthesis is aborted to allow the ribosome to be ‘reset’ (Tsai et al., 2013).  
Upstream of the armZ coding sequence lies a leader peptide that forms secondary 
structures to prevent transcription of the downstream armZ gene. If the ribosome does 
not translate the mRNA efficiently and stalls on the leader peptide, indicative of 
aminoglycoside action, the leader peptide cannot form the inhibitor secondary structure 
and promotes high-level constitutive expression of armZ. As a result, the mexXY operon 
is transcribed in response to the antibiotic action taking place on the ribosome (Morita et 
al., 2009).  
In chapter three, the intrinsic tryptophan fluorescent analysis indicated that there 
were likely to be changes in the structural conformation of domain I, which contained 
four tryptophan residues and is the site of GTP binding and hydrolysis. Being unable to 
hydrolyse GTP would lock EF-G in the ribosome and reduce the rate of its dissociation. If 
the mutation is indeed affecting EF-G in this way, translation would be halted, mimicking 
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the translational stalling caused by aminoglycosides. The presence of ribosomal stalling 
in the mutant strain was supported by the up-regulation of SmpB, which works with the 
RNA, ssrA, to prevent the accumulation of stalled ribosomes by targeting the problem 
peptide for degradation (Karzai et al., 1999). Therefore, even in the absence of antibiotics, 
ribosomal stalling would cause armZ to be fully transcribed and would induce the 
expression of the MexXY system. The mutant strain would then be prepared for the 
export of aminoglycosides resulting in increased resistance.   
 
4.8.3 Iron chelation and fusaric acid 
Iron is essential for almost all biological processes but due to the formation of 
insoluble ferric hydroxides its bioavailability is quite limited. To counter this, bacteria 
secrete siderophores which chelate the insoluble iron from the environment and deliver 
it back into the cell where it is made available for use (Brandel et al., 2012). P. aeruginosa 
synthesises two major siderophores to cover its need for Fe3+; pyoverdine and pyochelin. 
Pyoverdine is considered to be more essential for growth than pyochelin, which is 
produced at a lower abundance (Brandel et al., 2012). Despite this, many of the pyochelin 
biosynthesis and receptor proteins are up-regulated in the FUS443 mutant strain, 
whereas the abundance of pyoverdine biosynthesis proteins was unaffected. Pyochelin 
biosynthesis genes are encoded on two divergent operons, pchDCBA and pchEFGHI, with 
the regulatory gene, pchR, located between the two. Pyochelin binds iron with a 
stoichiometry of 2:1 (PCH:Fe3+), and is transported back into the cell through the outer 
membrane transporter, FtpA, and the inner membrane transporter, FptX. Once in the 
cytosol the iron-bound pyochelin binds to PchR to induce further expression of pyochelin 
biosynthesis genes (Figure 1.7). If iron accumulates in the cell, the iron binds to Fur, 
which inhibits the expression of iron-uptake genes, including pch genes, by binding the 
promoter sequences and blocking transcription (Cunrath et al., 2015). 
The fusA1 mutation heavily induced the expression of pyochelin biosynthesis 
proteins, including the uptake receptor, FtpA. But it was interesting to see that there was 
limited secretion of siderophores into the surrounding media. As all of the detected 
pyochelin biosynthesis proteins were up-regulated it appears that the issue with iron 
acquisition was occurring through an inability to successfully synthesise the siderophore 
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or unsuccessful transport out of the cell. Whilst studies have shown that pyoverdine is 
exported from the cell by the outer membrane efflux system, PvdRT-OpmQ, little is 
known about the export of pyochelin (Hannauer et al., 2010). Mutation to exporters can 
result in the accumulation of siderophores within the cell (Miethke et al., 2007) and so it 
is possible that the mutated EF-G protein is affecting the synthesis or activation of 
siderophore secretion systems, creating an internal iron-starved environment and 
perpetuating the synthesis of pyochelin biosynthesis proteins.  
Phenotypic characterisation revealed that FUS443 had developed sensitivity to 
fusaric acid.  In P. protegens, the presence of fusaric acid causes an up-regulation of genes 
involved in iron acquisition, including those for siderophore synthesis. Mutants in 
siderophore production were far less tolerant to fusaric acid, and as a consequence of 
these observations fusaric acid was identified as an iron chelator (Ruiz et al., 2015). As 
iron acquisition appeared to be disrupted in FUS443 the cell was likely to already be in 
an iron-limited state and so the presence of fusaric acid further reduced iron availability 
meaning that FUS443 was unable to obtain enough iron for cell survival. Therefore, 
fusaric acid may have exerted a toxic effect on the FUS443 mutant, indirectly, through 
iron sequestration and not by direct antimicrobial action.  However, the FUS443 mutant 
did not show impaired growth in the presence of another metal chelator, EDTA. This 
supports the notion that fusaric acid toxicity resulted from a direct interaction with the 
cell, however, a limited understanding as to the mechanism of action by which this 
antibiotic functions makes it unclear how this would have occurred. It is possible that the 
combination of siderophore disruption, iron-chelation by fusaric acid and a direct effect 
on the cell led to increased fusaric acid sensitivity.  
 
4.8.4 Motility 
In chapter three I found that the fusA1 mutation caused a reduction in swimming 
and twitching motility. The proteomic data in this chapter supported this finding, as 
numerous motility-associated proteins had been modulated. This confirmed that the 
effect on motility was a result of direct changes to motility systems and not due to the 
reduced growth rate.  
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Unlike the single set of che genes in E. coli, P. aeruginosa encodes four chemotaxis 
signal transduction systems; the Pil-Chp system for twitching motility, the Che and Che2 
systems for flagella motility and the Wsp system for Cup fimbria expression and Pel/Psl 
biosynthesis. The assembly and function of T4P, which mediates twitching motility, 
requires over 40 genes and its regulation involves numerous signal transduction systems, 
including the two-component system, PilR/S and AlgR/FimS, the global carbon 
metabolism regulator Crc, the virulence factor regulator Vfr and the chemosensory 
system PilGHIJK-ChpABC (Bertrand et al., 2010). Proteomic data revealed that the PilR, 
PilS, AlgR, Vfr and Crc regulators were relatively unaffected by the mutation, and FimS 
was not identified in the screen. Regardless, the Pil chemosensory system saw large 
decreases in the abundance of PilG and PilH. PilG is involved in pili extension whilst PilH 
is required for retraction, and previous studies have found that mutation to PilH causes 
aberrant twitching (Bertrand, West and Engel, 2010). With the reduced abundance of 
these two proteins the FUS443 mutant may be unable to coordinate directional twitching 
motility leading to a reduced bacterial spread across twitch agar. 
P. aeruginosa has a single polar flagellum which, like T4P, is coordinated by over 
40 genes, making these two systems extremely energetically expensive. Flagellar motility 
is regulated by a hierarchical regulatory network, of which the master regulator is FleQ 
(Dasgupta et al., 2003). FleQ was not affected in the FUS443 mutant, but may have had an 
altered activation status differentially impacting flagellar genes. Several of the Che 
proteins involved in flagellar motility were found at a reduced abundance in the mutant 
strain, in particular were CheW and CheR. CheW is a coupling protein that associates with 
the chemoreceptors on the cell surface and assists in signal transduction between the 
receptor and the sensor kinase, CheA. CheA activates CheY which interacts with the 
rotational switch of FliM and disrupts the flagellar motor. The reduced abundance of 
these proteins will therefore affect flagellar rotation and propulsion through a semi-solid 
media. 
The other significantly down-regulated protein, CheR, is a methyltransferase. 
Methyltransferases are important in ‘resetting’ the chemoreceptors after ligand binding 
to allow for continual sensing of the environment. The antagonistic action between CheR 
and the methylesterase, CheB, provides a kinetically fast feedback system for rapid 
adaption to the bacterial surroundings (Ferrández et al., 2002; Sampedro et al., 2014). 
Disruption to the abundance or activation of either of these proteins will reduce the 
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responsiveness of P. aeruginosa to the environment. Because of this, FUS443 may 
therefore be less efficient at moving up a nutrient gradient and would produce a smaller 
zone of swimming, as observed in the swimming assay. 
The cluster II protein, CheW2, was also significantly down-regulated in the mutant 
strain. Unlike cluster I genes, the cluster II genes are not essential for chemotaxis. In some 
cases, cluster II proteins can complement cluster I mutants, but previous studies have 
found that this is not the case for CheW2 and CheW (Ferrandez et al., 2002). This suggests 
that the cluster II proteins have distinct roles from that of cluster I and so demonstrates 
that the mutated EF-G protein is modulating the protein abundance of specific pathways 
involved in motility, covering both T4P movement and flagellar motility. 
In addition to the effect on chemotaxis proteins, the mutant also expressed MotD 
at a reduced abundance. P. aeruginosa encodes two homologous sets of Mot proteins, 
MotA/B and MotC/D which generate the torque that drives the rotation of the flagellum. 
The MotC/D complex is used for propulsion in liquid, whilst MotA/B are more efficient at 
movement through high-viscosity medium. The elimination of either MotC or MotD 
reduces swimming speed and radial expansion in semi-solid agar (Doyle et al., 2004), and 
so it is possible that the reduction in MotD may be contributing to the reduced motility 
on the swim assay plates. MotA/B are regulated as part of the flagellar biogenesis 
hierarchy, involving RpoN, FleQ and FleR, however, MotC/D appear to be regulated 
independently of this system (Doyle et al., 2004), and so it appears that the P443L 
mutation is impacting cell motility outside of the central regulatory networks.  
 
4.8.5 Disulfide bond formation 
Another prominent cluster of down-regulated proteins included numerous redox 
proteins, such as DsbA, DsbD2 and TrxA. Dsb proteins are from the thioredoxin 
superfamily and contain a disulphide bond in their catalytic site, making Dsb proteins 
strong oxidants. Various secreted proteins are transported in an unfolded state into the 
periplasm. In E. coli, the folding of these proteins operates in two stages; oxidation by 
DsbA and DsbB, and isomerisation/reduction by DsbC and DsbD (Figure 4.12) 
(Grabowska et al., 2011). After synthesis, DsbA introduces disulfide bonds on consecutive 
cysteines as they emerge through the cytoplasmic membrane and DsbC, a disulfide 
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isomerase, corrects the disulfide pairings for correct protein folding (Cho et al., 2013).  
The electron source for the reducing stage comes from the cytoplasmic protein 
thioredoxin (TrxA) which transfers electrons to DsbD, and are shuttled through to DsbC 
(Chung et al., 2000; Cho et al., 2013). During this pathway, electrons are shuttled to 
quinone molecules located within the cytoplasmic membrane, where they are transferred 
into the respiratory chain for the reduction of molecular oxygen (Arts et al., 2013). 
 
Figure 4.12. E. coli disulphide bond formation in the periplasm (figure taken from 
Berkmen, 2012). 
 
Whilst the reduction pathway remains similar in P. aeruginosa, the P. aeruginosa 
genome encodes multiple sets of Dsb proteins which are predicted to serve distinct roles. 
Many proteins are dependent on the Dsb reduction pathway, including cytochrome C 
(Cho and Collet, 2013), LasB, PilA, chitin binding protein (CbpD), immunomodulating 
metalloprotease and PrpL protease (Arts et al., 2013). With the down-regulation of Dsb 
proteins, it is likely that proteins dependent on disulphide bond formation will be less 
abundant as misfolding and protease degradation will be more prevalent, and may be the 
cause for the reduced abundance of cytochrome C550 and CbpD in FUS443. Alongside Dsb 
proteins was the down-regulation of two peptidyl-prolyl cis-trans isomerase proteins, 
132 
 
PpiA and PpiC2. Also located in the periplasm, these enzymes catalyse protein 
isomerisation, a process which is often responsible for regulating protein activity or 
function (Imperi et al., 2009). Together, these findings showed that aberrant protein 
folding is highly likely in the mutated strain and will have implications on protein activity 
and function. 
DsbA and DsbB are implicated in numerous cellular processes, including 
respiration and motility, with Dsb mutants being defective in both swimming and 
twitching motility. This then affects virulence and early biofilm formation through 
problems with pili and flagellum assembly (Arts et al., 2013). Therefore, the decrease in 
DsbA, DsbD2 and TrxA expression in the FUS443 mutant may be another additive to the 
reduction in cell motility.  
Induction of Dsb proteins has been linked to oxidative stress (as seen through its 
STRING map-association with glutathione peroxidase, PA1287) and to iron limitation, in 
a Fur-dependent manner. It is predicted that iron regulatory proteins are subjects of the 
Dsb reducing pathway and require the system for appropriate protein folding 
(Grabowska et al., 2011). It is clear that iron uptake has been dysregulated in FUS443, 
and so this may have impacted upon the Dsb pathway, or conversely, the disruption to 




This chapter has shown how a single residue mutation in EF-G causes dynamic 
cell-wide changes at a proteomic level. The mutation has affected distinct biological 
processes, such as motility by affecting the cell’s ability to respond appropriately to 
chemotactic agents in its surroundings, thus preventing directional flagellum and T4P 
movement. The mutated EF-G disrupted iron acquisition on a global scale, causing the 
increased biosynthesis of pyochelin whilst preventing its secretion from the cell. The 
dysregulation of iron uptake may have had downstream effects on antibiotic sensitivity 
and respiration which would then influence cell growth and viability. 
One of the main characteristics of the FUS443 strain was the substantial up-
regulation of the T3SS. It appears as though the up-regulation of T3S was induced by an 
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increase in the abundance of the master regulator, ExsA. The increase in T3S is likely to 
enhance host invasion and promote pathogenicity, making this strain an interesting 
model for monitoring bacterial virulence. Fortunately for sufferers of CF, this mutation 
appears to have deleterious effects on the cell which stunt fitness, most likely arising from 
disruption to respiration and the central metabolism.  
At this stage it is unclear how the mutation in EF-G is having a prominent effect on 
the distinct clusters of proteins discussed in this chapter. However, it is possible that the 
mutation is affecting the translation of transcription factors or post-translational 















5.Transcriptomic analysis of FUS443 
5.1 Introduction 
The proteome is the final product of gene expression whilst the initial point of 
expression is represented by the transcriptome. RNA makes up approximately 6% of a 
bacterial cell’s total weight, the majority of which is ribosomal RNA and only 1-4% of total 
RNA encompasses the coding mRNA (Brown, 2002). A complex series of mechanisms are 
in place to maintain the transcriptome, from transcriptional regulators and sigma factors 
influencing gene expression, to post-transcriptional regulation via RNA processing, 
stabilisation or degradation. Together these mechanisms alter the number of transcripts 
that are used as templates for protein synthesis. The proteome is then regulated via 
protein turnover, secretion and protein modification, and so in many cases the proteome 
is not an exact reflection of the transcriptome. 
Chapter four describes changes in the proteome of FUS443 resulting from the 
P443L mutation in EF-G. To gain an understanding of how the mutation affects the cell on 
a global scale, this chapter investigates the transcriptomic profile of FUS443. Any 
transcriptional data not specifically defined within the tables has been included within 
‘7. Appendix’. 
 
5.2 RNA extraction for transcriptomic analysis 
5.2.1 Sample preparation 
The role which EF-G plays during translation meant that the changes in protein 
abundance discussed in chapter four could have occurred directly by disrupting protein 
synthesis. To investigate whether the mutant variant was also having effects on gene 
expression, the transcriptomic profile of the mutant was analysed. The conditions within 
which the cultures were grown were kept consistent with those used in the proteomic 
study to allow for a comparison to be made between the two data sets.  
135 
 
Planktonic cultures of the progenitor (PAPcdr), mutant (FUS443) and 
complemented (FUS443C) strains were grown, in triplicate, in M9 minimal media and 
were harvested at late exponential phase into RNA Later (Ambion) to preserve the RNA 
transcripts. Total RNA was extracted using the RNeasy Mini Kit (Qiagen) and a Nanodrop 
spectrophotometer was used to determine the concentration and purity of the RNA. The 
extracted RNA samples had the ideal A260/280 purity of 1.8 – 2.0 and A260/230 purity of 2.0 
– 2.2.  
RNA is highly susceptible to degradation and so the total RNA was separated by 
gel electrophoresis to ensure that the RNA was intact. Two clear bands, representing the 
16S and 23S rRNA, were observed for each sample with no smearing below the 16S band 
(Figure 5.1), indicating that minimal damage had occurred during sample preparation. 
Unfortunately, due to the column-based process of extraction, the majority of small RNAs 
were not recovered. Atypically, a faint, higher molecular weight band of approximately  
4 - 4.5 k nucleotides was also identified above the 23S rRNA. A similar banding pattern 
was also recovered by Heera et al. (2015) using a phenol-free extraction kit where this 
band was predicted to represent the whole 70S ribosomal unit.  
 
 
Figure 5.1. Total RNA extracted from P. aeruginosa strains grown in planktonic culture 
and harvested during the late exponential phase of growth.  
 
DNA contamination can be detrimental to accurate RNA-sequencing and so  
on-the-column DNase I treatment was conducted during the extraction procedure. RNA 
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samples were used as template sequences for a standard PCR, none of which produced 
an amplification product, verifying that DNA was not present in these samples.  
 
5.2.2 cDNA synthesis and RT-PCR 
 cDNA was synthesised from the total RNA using reverse transcriptase. The cDNA 
samples were subject to RT-PCR, amplifying the exopolysaccharide biosynthetic gene, 
pslA, and two T3SS genes, exsA and pcrV.  
 Figure 5.2A shows that the expression of pslA was not obviously affected by the 
P443L mutation. Consistent with the proteomic data, the FUS443 mutant had a distinct 
up-regulation of T3SS genes, but changes in the expression of exsA were subtle and could 
only be visualised when the number of amplification cycles was reduced. The injectosome 
tip-encoding gene, pcrV, appeared to be expressed at a distinctly greater level compared 
with the progenitor and complemented strain. Western blot analysis against PcrV verified 
that the increase in pcrV mRNA was reflected in the increased abundance of the PcrV 
















Figure 5.2. (A) RT-PCR on cDNA, synthesised from the total RNA of the FUS443 mutant 
strain, progenitor and complemented strain. ExsA was amplified twice, with a reduced 
number of cycles in the lower frame. (B) Western blot analysis using α-PcrV antibodies 
on whole cell protein samples of the aforementioned strains. 
 
5.3 Transcriptomic analysis 
5.3.1 RNA-Sequencing 
 The total RNA from each triplicate sample of a strain was sent for single read  
RNA-Seq using Illumina sequencing, at GATC Biotech. The dataset obtained from these 
samples consisted of 5628 recognised gene transcripts, out of a total 5678 predicted 
ORFs in the P. aeruginosa genome. This provided a very good representation of genome 
wide transcription. It is possible that a number of the genes that were unidentified or 
underrepresented in this screen belong to the families of small RNAs that would have 
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been lost during the extraction process. RNA quantitation values were log2 transformed 
and, for this study, a log2 FC in gene expression was considered to be statistically 
significant when > 1 or < -1 and with a P-value of ≤ 0.01. On the whole more genes were 
found to be down-regulated in FUS443, however, of all the modulated genes only 374 
were considered to be significantly down-regulated whereas 657 were significantly up-
regulated (Figure 5.3). 
 
 
Figure 5.3. Modulation of gene expression in FUS443 compared with the gene expression 
in the progenitor strain, PAPcdr.  
 
5.3.2 Principal components analysis  
 As with the proteomic data, PCA was employed to assess any similarities in gene 
expression amongst the three strains. The PCA plot showed three main clusters of data 
points, each corresponding to the three strains analysed (Figure 5.4). The plot indicated 
that the transcriptomic profile of the FUS443 mutant was distinct from the 
transcriptomic profile of the progenitor and complemented strains. The progenitor and 
complemented strains also showed some variability indicating that differences also exist 




Figure 5.4. Principal components analysis of transcriptome data from P. aeruginosa 
strains, FUS443, PAPcdr, FUS443C. Each point on the graph represents one biological 
replicate.  
 
5.3.3 Volcano and FPKM scatter plots 
Volcano plots were produced to illustrate the fold change (log2 transformed) 
against the P-value (-log10 transformed) for all the quantified transcripts. This allowed for 
comparative analysis of the FUS443 mutant transcriptome or the complemented strain 
transcriptome against the PAPcdr progenitor. Data points that appear high on the Y axis 
have low P-values and are more highly significant.  
 The volcano plot, comparing the combined replicates of the progenitor strain and 
the combined replicates of the FUS443 mutant strain, shows that a large number of 
transcripts had been modulated in the mutant (Figure 5.5A). Far fewer transcripts were 
significantly modulated when comparing the progenitor strain with the complemented 
140 
 
strain (Figure 5.5B), indicating that the mutated EF-G induced a large number of 
significant changes in the cell at a transcriptomic level that were recovered by the 
expression of WT fusA1 from pfusA1. 
 
 
Figure 5.5. Volcano plot representing the log2 fold change (FC) of RNA transcript 
abundance against statistical significance for (A) the FUS443 mutant, and (B) the 
complemented FUS443C strain in relation to the PAPcdr progenitor strain. Significantly 
modified transcripts are highlighted in red. A FPKM (fragments per kilobase, per million) 
scatter plot comparing the log10 ratios of FPKM expression values for the progenitor 
strain with (C) the FUS443 mutant, and (D) the complemented FUS443C strain. 
 
 A FPKM (fragments per kilobase, per million) scatterplot is a common tool used in 
RNA-Seq analysis to quantify expression and visualise the level of variation between the 
transcriptomic profiles of two samples. Gene transcripts that have a similar level of 
abundance across the analysed conditions align closely to the midline. A FPKM scatter 
plot was constructed to assess the similarities between the transcriptomic profile of the 
progenitor strain with that of the mutant strain (Figure 5.5C) and the complemented 
strain (Figure 5.5D). The complemented strain aligned more closely to the midline than 
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the non-complemented mutant strain highlighting that a large number of gene transcripts 
were modulated in the mutant strain, which could be recovered with the expression of 
fusA1 from the pfusA1 vector.  
 
5.4. Genes with significantly increased expression 
 Due to the large number of genes affected by the fusA1 mutation, I focused on the 
transcripts that were complemented by the introduction of pfusA1, unless otherwise 
stated. Table 5.1 contains a list of the top 20 genes which exhibited the greatest positive 
change in expression. The log2 FC and P-values of the complemented mutant strain were 
included to indicate the degree to which the fold modulation could be attributed to the 

















Table 5.1. List of up-regulated gene transcripts associated with the fusA1 mutation. 
Shaded boxes feature genes associated with the T3SS and a P-value of 0.000 represents  
< 0.0005.  
      
Locus 
tag 
  FUS443 FUS443C 
  Gene Function log2 FC P-value log2 FC P-value 
1 ilvA2 PA1326 Threonine dehydratase 6.746 0.000 0.451 0.067 
2 
 
PA1325 Hypothetical protein 6.180 0.000 0.166 0.754 
3 popN PA1698 Type III secretion outer membrane 
protein 
5.536 0.000 0.253 0.470 
4 pscN PA1697 Type III secretion basal body 
protein 
5.101 0.000 0.078 0.903 
5 pcr1 PA1699 Type III secretion secreted protein 5.026 0.000 -0.072 0.898 
6 pcr3 PA1701 Type III secretion secreted protein 4.723 0.000 -0.139 0.811 
7 pscO PA1696 Type III secretion translocation 
protein 
4.718 0.000 0.061 0.964 
8 spcS PA3842 ExoS chaperone 4.461 0.000 0.370 0.106 
9 pcrV PA1706 Type III secretion needle tip 
protein 
4.411 0.000 -0.429 0.053 
10 
 
PA4192 ABC binding protein 4.213 0.000 0.822 0.283 
11 pcrH PA1707 PopB/PopD chaperone 4.173 0.000 -0.816 0.276 
12 pcr2 PA1700 Type III secretion secreted protein 4.057 0.000 -0.330 0.529 
13 exoY PA2191 Adenylate cyclase 4.057 0.000 -0.207 0.344 
14 popB PA1708 Type III translocator protein 4.051 0.000 -0.875 0.004 
15 pscP PA1695 Type III secretion translocation 
protein 
3.961 0.000 -0.292 0.575 
16 exoS PA3841 Exoenzyme S 3.879 0.000 -0.479 0.070 
17 exoT PA0044 Exoenzyme T 3.863 0.000 -0.440 0.073 
18 
 
PA2202 Probable permease 3.856 0.000 0.675 0.005 
19 popD PA1709 Type III translocator protein 3.827 0.000 -0.885 0.001 







Figure 5.6. Network of interacting proteins. STRING was used to identify groups of 
potentially interacting proteins encoded by the top 200 genes that had been significantly 
up-regulated in the FUS443 mutant strain. Thick lines between nodes represents a high 




As observed in the proteomic profile, the majority of up-regulated genes encoded 
components of the T3SS, showing an increase in gene expression as high 46-fold. This 
verifies that the T3SS is up-regulated at a transcriptional level as well as at a translational 
level in FUS443, and was complemented with the introduction of a functional fusA1 gene 
in trans. T3SS genes also make up the largest cluster on the STRING protein interaction 
map (Figure 5.6). Due to the large number of significantly affected genes, only the top 200 
modulated genes were used to predict interactions between the encoded proteins. There 
were several other distinct clusters predicted by STRING, including a group of ribosome-
associated proteins and a cluster of T6SS-associated proteins, which will be discussed in 
detail later within this chapter. 
 
5.4.1 Amino acid biosynthesis 
The genes with the greatest modulation in FUS443 were PA1325 and PA1326. 
PA1326 (ilvA2) encodes a threonine dehydratase, involved in glycine, serine and 
threonine metabolism, and is second in a two-gene operon with PA1325. PA1325 encodes 
a hypothetical protein but is likely to have a similar involvement in metabolism.  Amongst 
this region of the genome there were a number of genes that were linked to amino acid 
metabolism and were found to be up-regulated. For example, shortly downstream, ggt 
(PA1338) encodes a gamma-glutamyltranspeptidase, involved in glutathione catabolism, 
and a selection of genes encoding ABC transport systems for glutamate and aspartate 
transportation (aatJ, aatM, aatP and aatQ, (PA1339-PA1342)) (Kahlon, 2016). Up-
regulated elsewhere in the genome was metK, encoding a methionine 
adenosyltransferase for methionine biosynthesis, glyA3, encoding a serine 
hydroxymethyltransferase for glycine biosynthesis, and oprD, a porin for the transport of 
basic amino acids. Finally, two genes encoding glutamine ABC transporters, PA4192 and 
PA4193, were also up-regulated. 
 Another up-regulated gene was PA3965, which encodes an AsnC-type 
transcriptional regulator and, whilst largely uncharacterised, it is one of two Lrp 
homologs encoded in the genome. In P. aeruginosa, Lrp regulates genes for amino acid 
biosynthesis and catabolism (Diraviam Sriramulu, 2009).  It is possible that the PA3965 
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encoded regulator plays a similar role in amino acid metabolism and may be influencing 
the expression of amino acid transport systems.  
 
5.4.2 Heat shock proteins 
Amongst the STRING network were five heat shock protein (HSP) encoded genes; 
htpG, hslV, hslU, ibpA and grpE (Table 5.2). Several other HSP genes were significantly up-
regulated in the transcriptomic data, including groEL which underwent a FC of 2.4. HSPs 
are typically expressed in response to high temperatures, but can be induced by 
alternative stress conditions including chemical and oxidative stressors. RpoH encodes 
the major sigma factor involved in the heat shock response and was up-regulated by a FC 
of 2.0 in FUS443, suggesting its involvement in the altered expression of HSPs in the 
mutant strain. Interestingly, genes encoding the DnaK-DnaJ-GrpE chaperone group, 
which control the turnover of RpoH, were also significantly up-regulated.  
 
Table 5.2. Modulation in the expression of genes involved in the heat shock response.   
 
 FUS443 FUS443C 
Gene Function log2 FC P-value log2 FC P-value 
htpG Hsp90 2.827 0.000 -0.487 0.098 
hslV ATP-dependent protease 2.442 0.000 -0.803 0.000 
hslU ATP-dependent protease 2.231 0.000 -0.732 0.005 
grpE Nucleotide exchange factor 2.019 0.000 -0.942 0.000 
ibpA Hsp20 1.987 0.000 -1.318 0.000 
dnaK Hsp70 1.618 0.000 -1.020 0.005 
rpoA RNA polymerase 1.576 0.000 0.449 0.191 
groES Chaperonin  1.554 0.000 -0.359 0.104 
dnaJ Chaperonin 1.491 0.000 -0.784 0.004 
clpB Chaperonin 1.460 0.000 -0.942 0.003 
PA1068 Hsp90 1.443 0.000 0.169 0.481 
rpoD Sigma factor 1.125 0.001 0.173 0.578 
rpoH Sigma factor 1.031 0.002 0.040 0.890 
 
 
Due to the potential post-transcriptional regulation of RpoH by DnaKJ-GrpE, I 
referred to the proteomic profile of the FUS443 mutant. RpoH and HSPs were not 
significantly modulated during proteomic analysis, indicating that this response occurred 
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specifically in the culture prepared for transcriptomic analysis. From this I determined 
that HSPs were not constitutively expressed as a result of the fusA1 mutation, but were 
modulated in response to biological stressors occurring within the mutant strain at the 
time of harvest for RNA extraction. 
In P. aeruginosa activation of the heat shock response induces the expression of 
the sigma factor, RpoD, and the RNA polymerase subunit, RpoA. Both of the encoding 
genes for these proteins were significantly up-regulated in FUS443, suggesting that the 
heat shock response was activated. RpoD is the primary sigma factor in the 
transcriptional regulation of housekeeping genes (Miura et al., 2015), and so RpoD up-

















5.5 Genes with significantly decreased expression 
 A large number of genes were down-regulated in FUS443 and I have focused on 
the genes whose expression was complemented when introducing pfusA1. Table 5.3 
contains a list of the top 20 most down-regulated genes in FUS443. The log2 FC and  
P-values of the complemented strain were included to indicate the degree to which 
changes in gene expression could be attributed to the fusA1 mutation. 
 
Table 5.3. List of down-regulated genes associated with the EF-G P443L mutation.  
     
Locus tag 
  FUS443 FUS443C 
  Gene Function log2 FC P-value log2 FC P-value 
1 
 
PA5475 Hypothetical -2.875 0.000 -0.439 0.107 
2 arcD PA5170 Arginine/orthithine antiporter -2.625 0.000 -0.393 0.223 
3 
 
PA1414 Hypothetical protein -2.427 0.000 -0.377 0.167 
4 tRNAMet PA4746.1 tRNA-Met -2.417 0.000 -0.399 0.269 
5 
 
PA2274 Hypothetical protein -2.345 0.000 0.224 0.339 
6 
 
PA5027 Hypothetical protein -2.300 0.000 -0.741 0.005 
7 
 
PA4523 Hypothetical protein -2.235 0.000 -0.385 0.275 
8 
 
PA4352 Hypothetical protein -2.188 0.000 0.127 0.560 
9 olsA PA4351 Membrane lipid biosynthesis 
protein 
-2.166 0.000 -0.388 0.276 
10 
 
PA0200 Hypothetical protein -2.134 0.000 -0.491 0.031 
11 
 
PA1673 Metal binding -2.120 0.000 0.178 0.466 
12 
 
PA3431 Hypothetical protein -2.071 0.000 0.362 0.401 
13 
 
PA3430 Probable adolase -2.045 0.000 1.092 0.000 
14 feoB PA4358 Iron transport protein -1.972 0.000 -0.440 0.052 
15 mexH PA4206 Resistance nodulation cell division 
multidrug efflux transporter 
-1.946 0.000 -0.282 0.304 
16 rsmY PA0527.1 Non-coding RNA -1.925 0.000 0.148 0.501 
17 mexG PA4205 Hypothetical protein -1.922 0.000 0.150 0.585 
18 glpF PA3581 Glycerol uptake facilitator protein -1.901 0.000 0.488 0.030 
19 
 
PA0718 Hypothetical protein of 
bacteriophage Pf1 
-1.882 0.000 -0.980 0.000 
20 
 








Figure 5.7. Network of interacting proteins. STRING was used to identify groups of 
potentially interacting proteins encoded by the top 200 genes that had been significantly 
down-regulated in the FUS443 mutant strain. Thick lines between nodes represents a 
high confidence level for that interaction. 
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 A large number of the down-regulated genes were uncharacterised. The second 
most down-regulated gene was arcD which encodes an arginine/ortnithine antiporter 
and is a part of the arcDABC operon which is responsible for arginine fermentation. The 
sensor kinase, NarX, and its response regulator, NarL, repress the expression of arcDABC 
during anaerobic growth (Benkert et al., 2008). The transcriptomic data of FUS443 
showed a significant down-regulation of both narL and narX, highlighting that NarX-
NarL-controlled denitrification pathways were inactive and arc repression was occurring 
via an alternative mechanism.  
 Other amino acid-associated genes that were down-regulated included PA0220, an 
amino acid APC family transporter gene, PA3035, encoding glutathione S-transferase, the 
opdO pyroglutamate porin gene and aroP1 encoding an aromatic amino acid transporter. 
It is possible that a surplus of their respective amino acids negatively fed back on these 
systems to reduce amino acid uptake and metabolism to prevent energy loss from these 
systems. 
 Other top down-regulated genes included efflux systems and iron transport 
systems, which will be discussed in more detail within this chapter. The small noncoding 
RNA, rsmY, of the Gac/Rsm pathway was also down-regulated. Almost all of the other 
Gac/Rsm pathway components (ladS, retS, gacA, gacS, rsmZ) had not been modulated in 
the mutant strain, apart from the transcriptional regulator rsmA, which was decreased by 
a FC of 3.7. However, the complemented strain exhibited a 10.2-fold decrease in rsmA 
expression and so this modulation may be linked to the over-expression of fusA1 and not 
specifically due to the mutated EF-G protein. This highlights the involvement of EF-G in 
the regulation of the Gac/Rsm pathway, and its effect on this pathway may be the cause 
of changes to expression of the T3SS. However, this does not explain why the up-
regulation of the T3SS was complemented in FUS443C by expression a WT fusA1 gene in 
trans. 
 
5.5.1 Antibiotic resistance mechanisms 
 In chapter four, the proteomic analysis revealed an increased abundance of the 
MexXY efflux transporter proteins in FUS443.  Consistent with this, mexXY gene 
expression was also up-regulated at a transcriptional level (Table 5.4), but with no effect 
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on expression of the mexXY transcriptional repressor, mexZ. This indicated that the 
mexXY system is constitutively up-regulated in response to the fusA1 mutation and is the 
most promising explanation for the observed aminoglycoside resistance.  
 The transcriptomic data also identified the down-regulation of another resistance 
nodulation division efflux pump in FUS443, mexGHI-opmD (Table 5.4). This efflux system 
provides resistance to ethidium bromide, vanadium, norfloxacin and acriflavine, but has 
no known association with gentamicin resistance (Sekiya et al., 2003; Sakhtah et al., 
2016).  However, MexI, MexG and OpmD were not detected in the proteomic analysis and 
MexH abundance was not modulated in the mutant compared with the progenitor.  
   
Table 5.4. Gene expression of the Mex efflux systems in P. aeruginosa.  
   FUS443 FUS443C 
Gene Function log2 FC P-value log2 FC P-value 
mexI Multidrug resistance efflux transporter -1.215 0.000 -0.387 0.244 
mexG Multidrug resistance efflux transporter -1.922 0.000 0.150 0.585 
mexH Multidrug resistance efflux transporter -1.946 0.000 -0.282 0.304 
opmD Outer membrane porin -0.429 0.296 -0.418 0.398 
mexX Multidrug resistance efflux transporter 1.365 0.000 -0.161 0.468 
mexY Multidrug resistance efflux transporter 0.981 0.000 -0.345 0.156 
 
 
 The mutant also exhibited a down-regulation of pprA expression by 2.4-fold. PprA 
and PprB are predicted to be part of a two component regulatory system for membrane 
permeability. PprAB expression leads to higher membrane permeability and increased 
sensitivity to antibiotics, including aminoglycosides (Wang et al., 2003). The fusA1 
mutation did not alter pprB expression, but decreased the expression of pprA. This may 
have been enough to prevent activation of the two component system and reduce cell 
permeability, adding to the increased antibiotic resistance observed in the FUS443 strain.  
 PprAB reduce cell permeability by altering membrane transportation systems. 
PprAB may have affected the outer membrane porin, OprP, which is associated with 
carbapenem influx and was down-regulated by 2.3-fold at a transcriptional level. The 
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sigma factor SigX is thought to reduce mexXY-oprM expression via PprAB (Gicquel et al., 
2013) and exhibited a 2.4-fold reduction in gene expression in FUS443. The reduced 
expression of both sigX and pprA may explain the increased mexXY expression, observed 
in the proteomic and transcriptomic data.  
 
5.6 Secretion systems 
5.6.1 The type III secretion system 
 Building on the proteomic data, the transcriptomic profile of FUS443 also 
demonstrated an increase in T3SS expression at a transcriptional level (Table 5.5). More 
T3SS genes were identified than in the proteomic screen, all of which were up-regulated 
and the majority were completely complemented by the introduction of pfusA1.  
 After proteomic analysis, western blot analysis and RT-PCR, it was not surprising 
to see an up-regulation of exsA gene expression in FUS443. ExsA is most likely to be the 
main cause for the global up-regulation of the T3SS, however, the transcriptional 
regulator PsrA is thought to be required for full activation of the exsCEBA operon (Shen 
et al., 2006). Quite unexpectedly, the psrA gene exhibited a 2.1-fold reduction in 
expression. These findings suggest that PsrA is, in fact, not a major requirement for T3S 
and low levels of psrA transcription do not prevent the expression of the exsCEBA operon.  
 The transcriptomic data also recorded the up-regulation of four small hypothetical 
T3SS proteins namely, pcr1, pcr2, pcr3 and pcr4. These genes reside in second to fifth 
position within the popN T3SS operon, although the function of the pcr1234 gene 








Table 5.5. List of genes encoding the T3SS and their log2 fold change in expression in the 
FUS443 mutant and complemented strain.  
 
 
  FUS443 FUS443C 
Gene log2 FC P-value log2 FC P-value 
Basal body 
pscC 2.196 0.000 0.019 0.944 
pscD 1.928 0.000 0.525 0.065 
pscH 2.358 0.000 0.361 0.545 
pscI 2.579 0.000 0.693 0.275 
pscJ 2.383 0.000 0.730 0.738 
pscK 2.119 0.000 0.454 0.231 
pscL 1.157 0.000 0.364 0.208 
pscO 4.718 0.000 0.062 0.964 
pscQ 2.772 0.000 -0.230 0.557 
pscN 5.101 0.000 0.078 0.903 
pcrD 2.078 0.000 -0.004 0.988 
Translocon 
popB 4.051 0.000 -0.875 0.004 
popD 3.827 0.000 -0.885 0.001 
pcrV 4.411 0.000 -0.429 0.053 
Needle 
pscF 3.466 0.000 1.275 0.000 
pscP 3.961 0.500 -0.292 0.575 
Export apparatus 
popN 5.536 0.000 0.253 0.470 
pscB 2.642 0.000 0.326 0.524 
Regulatory network 
exsC 1.689 0.000 -0.714 0.005 
exsE 1.976 0.000 -0.275 0.272 
exsA 1.697 0.000 0.388 0.201 
exsD 2.236 0.000 -0.062 0.814 
Chaperones 
spcS 4.608 0.000 0.370 0.106 
pcrH 4.173 0.000 -0.816 0.276 
pcrG 3.730 0.000 -0.643 0.016 
pscE 2.395 0.000 0.183 0.789 
pscG 2.987 0.000 0.848 0.128 
Secreted toxins 
exoS 3.879 0.000 -0.479 0.070 
exoT 3.863 0.000 -0.440 0.073 
exoY 4.057 0.000 -0.207 0.344 
Hypothetical T3SS proteins 
pcr1 5.026 0.000 -0.073 0.898 
pcr2 4.057 0.004 -0.330 0.529 
pcr3 4.723 0.000 -0.139 0.811 
pcr4 3.068 0.180 -0.330 0.679 
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5.6.2 The type II secretion system 
 Unlike the T3SS genes, several T2SS genes were significantly down-regulated. This 
included three pseudopilin encoding genes, hxcT, hxcW and hxcX, as well as the secretin, 
hxcQ (Table 5.6). Pseudopilin form the pseudopilus through which the T2SS secretory 
proteins are expelled from the cell. This phenotype was complemented completely with 
the introduction of pfusA1, confirming the influence of the fusA1 mutation on this system.  
 The hxc cluster is named after homology to xcp genes, which are the main T2SS 
cluster. The xcp encoded cluster secrete elastases, lipases, phospholipases and exotoxin 
A, whereas the hxp cluster is specific for alkaline phosphatases, such as LapA, and 
secretins such as the lipoprotein, HxcQ (Ball et al., 2002). The main T2SS cluster (xcp) was 
unaffected by the P443L mutation, with the exception of xcpP (2.3-fold decrease). 
Another gene, xqhB, is predicted to encode a probable T2SS protein and was significantly 
down-regulated in FUS443. This gene is located independently from the other two 
clusters showing how the mutant EF-G was causing the specific down-regulation of select 
T2SS genes.  
 
Table 5.6. List of genes encoding the T2SS and their log2 fold change in expression in the 
FUS443 and complemented mutant. Shaded boxes represent modulations that are 
statistically significant. 
    FUS443 FUS443C 
Gene Function log2 FC P-value log2 FC P-value 
hxcW Pseudopilin -1.129 0.000 0.021 0.934 
hxcU Pseudopilin -0.895 0.095 -0.425 0.446 
hxcP Inner membrane protein -0.742 0.004 -0.327 0.194 
hxcV Pseudopilin -0.883 0.008 0.112 0.692 
hxcT Pseudopilin -1.046 0.001 0.007 0.983 
hxcX Pseudopilin -1.264 0.000 0.036 0.893 
hxcZ Inner membrane protein -1.320 0.158 -0.169 0.838 
hxcQ Secretin -1.285 0.000 -0.175 0.611 
hxcR ATPase  -1.231 0.030 -0.261 0.645 
lapA Alkaline phosphatase A -0.961 0.000 -0.220 0.303 
lapB Alkaline phosphatase B -1.142 0.000 -0.034 0.885 
xcpP Secretion protein -1.214 0.000 -0.037 0.895 




 I was unable to confirm that the down-regulation of hxc genes corresponded to a 
reduction in protein abundance, as none of the Hxc proteins were detected in the 
intracellular proteomic data. Again, XcpP was the only protein of the detected Xcp 
proteins that was reduced in protein abundance, indicating the presence of specific 
regulatory efforts against xcpP expression.  
 
5.6.3 The type VI secretion system 
 As with the T3SS, the T6SS was up-regulated in FUS443. The T6SS is reminiscent 
of major bacteriophage tail proteins, and is composed of Hcp and VgrG proteins which 
assemble to form a puncturing device (Chen et al., 2015). TssB and TssC form a contractile 
sheath structure which extends to puncture the target cell and drive the delivery of 
effector proteins. This retraction and extension is powered by the ATPase, ClpV, and the 
secretion complex is anchored to the membrane by an envelope-spanning complex, 
composed of TssL, TssM and TssJ (Figure 5.8). The T6SS transports numerous different 
effector proteins including amidases, lipases, nucleases and chaperone proteins (Alteri et 
al., 2016). The transcriptomic data revealed that the majority of T6SS were up-regulated, 
some as high as 11-fold, including the aforementioned vgrG1, hcp1, clpV1, tssB1, tssC1, 
tssL1, tssJ1 and tssM1 (Table 5.7).  
 The T6SS exports at least three toxins, including Tse1, Tse2 and Tse3. Tse1 and 
Tse3 target and degrade peptidoglycan whilst Tse2 acts within the cytoplasm.  
P. aeruginosa also encodes three immunity proteins, Tsi1, Tsi2 and Tsi3, which inhibit the 
activity of the Tse proteins to prevent self-intoxication (Chen et al., 2015).  The majority 
of exotoxin-encoding genes were up-regulated in FUS443, further confirming that all of 









Figure 5.8. The type VI secretion system of P. aeruginosa. 
 
 P. aeruginosa encodes three T6SS clusters, termed HSI for Hcp secretion island. 
The genes discussed here represent the main T6SS cluster, HSI-I. A number of the HSI-II 
genes were also significantly up-regulated in FUS443, such as hsiB2, hsiC2, orfX and fha2, 
along with a general up-regulation of the remaining HSI-II genes. HSI-III was mostly 
unaffected by the fusA1 mutation and so shows that the mutated EF-G is affecting 









Table 5.7. A list of T6SS encoding genes that have been modulated in FUS443. Shaded 
boxes represent genes whose expression was significantly modulated. 
    FUS443 FUS443C 
Gene Function log2 FC P-value log2 FC P-value 
hcp1 Secretion tip 3.717 0.000 1.554 0.000 
tagQ1 Regulatory protein 3.473 0.000 0.514 0.040 
tssA1 T6SS basal body 3.195 0.000 -0.246 0.441 
tssB1 T6SS basal body 3.195 0.000 0.964 0.002 
tssC1 T6SS basal body 3.005 0.000 0.959 0.008 
tssE1 T6SS basal body 2.748 0.009 0.879 0.010 
tssF1 T6SS basal body 2.667 0.000 0.703 0.002 
pppA Phosphatase 2.597 0.000 0.668 0.007 
tagF1 Regulatory protein 2.468 0.028 0.295 0.770 
tssL1 T6SS basal body 2.434 0.000 -0.083 0.709 
tagJ1 T6SS basal body 2.430 0.000 0.073 0.770 
vgrG1 Secretion tip 2.229 0.000 0.882 0.003 
tssM1/icmF1 T6SS basal body  2.213 0.000 0.102 0.739 
clpV1 ATPase 2.137 0.000 0.702 0.104 
tssK1 T6SS basal body 2.056 0.000 0.341 0.274 
ppkA Ser/thr protein kinase 2.041 0.001 0.184 0.795 
tssJ1 T6SS basal body 2.032 0.000 0.799 0.014 
tagT1 Regulatory protein 1.274 0.648 0.215 0.902 
tagS1 Regulatory protein 1.121 0.679 0.158 0.864 
Tse3 Effector protein 1.091 0.000 0.324 0.276 
Tse2 Effector protein 1.046 0.000 0.340 0.117 
fha1 Fork head associated protein 0.437 0.083 -0.095 0.691 
 
 
 A threonine phosphorylation pathway has been found to activate T6S via the 
forkhead-associated protein, Fha, which assists the recruitment of ClpV1. The kinase, 
PpkA, activates Fha through phosphorylation, a process that is facilitated by TagQ, TagR, 
TagS and TagT (Hood et al., 2010; Alteri et al., 2016). The transcriptomic data revealed 
only modest up-regulation of fha1, whereas ppkA, tagQ1, tagS1 and tagT1 are up-
regulated significantly. Even without the significant modulation of fha expression, its 
post-translational activation may be the main mechanism behind the up-regulated T6SS 
in FUS443. Typically, high levels of T6S occur due to a reduction in PppA, a phosphatase 
that deactivates Fha. However, my results showed that pppA was significantly up-
regulated in FUS443 which is in discordance with the up-regulated T6SS. PppA resides 
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within the tagQRSTF-ppkA-pppA operon and so is up-regulated with the rest of the T6SS 
genes, highlighting the importance of post-translational regulation in this system.  
With the increase in T6S it was possible that the mutant strain would be better 
equipped for inter-species competition. When co-cultured with E. coli for 5 hours, and 
plated onto E. coli-selective agar, there was no significant difference between the E. coli 
cell count for the mutant and progenitor co-culture conditions (unpaired t-test, 
t(4)=0.998, p=0.375) (Figure 5.9).  This suggested that the mutant EF-G protein did not 
improve the ability of P. aeruginosa to out-compete other bacterial species.   
 
Figure 5.9. E. coli total colony counts after a 5 hour co-culture with P. aeruginosa strains, 
FUS443 or PAPcdr, in glucose M9 minimal media. Values represent three biological 
replicates for each condition and a culture of E. coli grown in the absence of P. aeruginosa 
was used as a control. 
 
5.7 Iron homeostasis 
5.7.1 Siderophore biosynthesis 
 Proteomic data had highlighted the up-regulation of iron-uptake and -regulatory 
proteins in FUS443, although the strain appeared to be defective in the secretion of 
siderophores from the cell. A large number of iron response genes were also over 
expressed at a transcriptional level in the mutant strain, suggesting that a global 
transcriptional regulator of iron uptake had been affected by the mutated EF-G protein.  
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 The proteomic analysis revealed an increase in the abundance of pyochelin-
biosynthesis proteins, whereas pyoverdine-biosynthesis proteins remained relatively 
unaffected by the fusA1 mutation. However, in the transcriptomic data, pyoverdine 
biosynthesis genes, including pvdA, pvdF, pvdN and pvdP, were up-regulated (Table 5.8). 
Of the pyochelin biosynthesis genes that were detected in the transcriptome analysis, 
pchA, pchB, pchC and pchD were up-regulated, however none of these changes were 
considered statistically significant due to a high P-value. Therefore, the effect on iron 
uptake systems was variable across the two profiled conditions.   
 
Table 5.8. List of genes associated with iron acquisition that have been modulated in 
FUS443. Shaded boxes represent genes whose expression has been significantly 
modulated.  
    FUS443 FUS443C 
Gene Function log2 FC P-value log2 FC P-value 
exbB1 Ton-B dependent transport 2.808 0.000 0.357 0.112 
tonB2 TonB2 protein 2.465 0.000 0.475 0.051 
pvdN Pyoverdine biosynthesis protein 2.033 0.000 0.799 0.014 
PA5505 TonB-dependent receptor 1.945 0.000 0.618 0.026 
pvdF Pyoverdine biosynthesis protein 1.726 0.000 0.498 0.177 
chtA TonB-dependent receptor 1.693 0.000 0.421 0.077 
pvdP Pyoverdine biosynthesis protein 1.416 0.000 0.452 0.175 
exbD1 Ton-B dependent transport 1.389 0.000 0.454 0.046 
PA3268 TonB-dependent receptor 1.349 0.000 0.445 0.051 
pvdA Pyoverdine biosynthesis protein 1.310 0.010 0.112 0.827 
PA1271 TonB-dependent receptor 1.297 0.000 0.234 0.295 
PA1365 Siderophore receptor 1.243 0.000 0.424 0.089 
pchD Pyochelin biosynthesis protein 1.199 0.247 0.039 0.966 
pchC Pyochelin biosynthesis protein 1.050 0.655 -0.019 0.970 
pchB Pyochelin biosynthesis protein 0.882 0.641 -0.046 0.979 
pchA Pyochelin biosynthesis protein 0.599 0.505 -0.309 0.731 
feoA Ferrous iron transporter A -1.498 0.000 0.364 0.107 
feoB Ferrous iron transporter B -1.972 0.000 -0.533 0.063 
 
 
5.7.2 Iron transporter systems 
 In addition to siderophore biosynthesis genes, numerous iron transport systems 
were expressed at higher levels in the FUS443 mutant, including PA1365, which encodes 
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a probable siderophore receptor, and numerous TonB-dependent transporters (PA5505, 
PA4675, PA3268 and PA1271). Whilst the general trend appeared to promote iron 
acquisition, two genes, feoA and feoB, which encode ferrous-iron transport proteins A and 
B, were significantly down-regulated. The changes in expression of all these genes was 
largely complemented by pfusA1. The down-regulation of feoA was consistent with the 
reduced abundance of FeoA protein (1.6-fold decrease) in the FUS443 proteomic profile, 
whereas FeoB protein abundance was not detected.  
The protein, TonB, is essential for siderophore-mediated iron acquisition (Takase 
et al., 2000). The TonB protein is anchored to the cytoplasmic membrane via ExbB and 
ExbD, which were transcriptionally up-regulated in FUS443. The uptake of iron-bound 
siderophores through the outer membrane proteins, FpvA (for pyoverdine uptake) and 
FptA (for pyochelin uptake), both require the presence of TonB (Figure 1.7) (Takase et 
al., 2000). P. aeruginosa encodes two TonB proteins; tonB1 is monocistronic and tonB2 is 
located within an operon with exbBC genes. TonB1 has a dominant and well defined role 
in iron uptake, whereas the role of TonB2 in iron acquisition has not been defined. It does, 
however, contain a Fur box within its promoter, identifying this gene as an iron response 
gene (Cornelis et al., 2009).  TonB2 was up-regulated in the FUS443 mutant by 5.5-fold, 
along with exbB1 and exbD1, highlighting an effect on the whole operon. In Vibrio strains, 
the TonB-ExbB-ExbD complex creates a proton motive force that drives the transport of 
iron compounds into the periplasm (Zhao et al., 2000; Chakraborty, 2013). Changes in the 
expression of this system would therefore affect all TonB-dependent receptors and affect 
the ability to translocate iron into the cell. With this, the up-regulation of these three 
genes, and their successful complementation by pfusA1, shows how the mutated EF-G 
protein is affecting not only iron scavenging mechanisms, but also iron transportation 
across the membrane.  
 
5.7.3 Regulatory systems of iron uptake  
 Very few sigma factors that respond to iron starvation are highly characterised in 
P. aeruginosa. FpvI, FiuI and FoxI are sigma factors which regulate the uptake of iron via 
pyoverdine, ferrichrome and ferrioxamine B, respectively. Their transcriptional 
expression was decreased in the FUS443 mutant but not by a statistically significant level. 
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The most highly affected system was the Fiu ferrichrome uptake system where FUS443 
exhibited a significant down-regulation in fiuA and fiuR expression. The ferrichrome 
receptor FiuA transduces its signal through FiuR to activate the sigma factor FiuI (Llamas 
et al., 2006). All of the fiu transcripts were down-regulated indicating that there is an 
abundance of intracellular ferrous iron in FUS443, repressing this system. Expression of 
the Fox system was also slightly reduced and functions in a similar manner to the Fiu 
transduction pathway, with the receptor, FoxA, transducing a signal through FoxR to 
activate the sigma factor FoxI. The fox operon also encodes an uncharacterised gene 
PA2469 which is a probable transcriptional regulator. PA2469 was under-expressed in 
FUS443 at 2.2-fold lower than the progenitor strain. It is uncertain how PA2469 interacts 
with the Fox proteins but it’s expression is consistent with the reduced transcription of 
the Fox iron-response system (Bastiaansen et al., 2015). 
 Another sigma factor, PvdS, controls pyoverdine biosynthesis, exotoxin A and 
PrpL endoprotease production (Llamas et al., 2007). PvdS was not considered to be 
significantly modulated in FUS443 although it’s expression was increased 1.9-fold, and 
was partially complemented with the expression of a WT fusA1 gene via pfusA1. However, 
the downstream effects of this modulation were not evident in toxA expression, encoding 
exotoxin A, or prpL expression.  
 Fur was not significantly affected at a transcriptional or proteomic level however 
this is not to say that the post-translational activity of Fur was not affected in FUS443. Fur 
is a transcriptional repressor when iron-bound and releases promoter sequences to 
allow for transcription under iron-limited conditions. Several factors indicate that Fur is 
functioning in its iron-unbound state in FUS443, such as the global up-regulation of a 
wide variety of iron-uptake genes. Another indicator of de-repression by Fur was via the 
PhuR regulatory system for heme uptake. PhuR may be considered quite primitive as it 
is regulated by Fur alone, and is not dependent on any sigma factors as far as our current 
understanding goes (Cornelis et al., 2009).  The transcriptional data revealed that phuR, 
was up-regulated 3.9-fold, providing a strong indication that the intracellular 
environment of FUS443 is iron-limited. However, several Fur-induced genes do not 
follow this pattern of expression. For example, Fur controls the transcription of two small 
RNAs, prrF1 and prrF2 involved in the regulation of iron-associated proteins (Cornelis et 
al., 2009). PrrF1 expression was not affected in the mutant strain and prrF2 was not 
detected in the analysis.  
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 It is difficult to determine the activity of the key iron response regulators due to 
the amalgamation of numerous regulatory pathways on target genes, and the opposing 
expression profiles of different iron uptake systems makes it difficult to uncover how  
EF-G impinges upon the iron response system. However, there does appear to be a 
particular emphasis on the up-regulation of siderophore based ferric-iron-acquisition.  
 
5.7.4 Iron and type III secretion 
 Several studies have linked iron availability to the activation of the T3SS. To 
investigate if the dysregulation of the iron-response system was causing the up-
regulation of the T3SS, strains were grown in media supplemented with Fe3+ and were 
analysed by western blot to identify changes in the expression of the T3SS protein, PcrV.  
 The addition of 100 μM of Fe(III) chloride to minimal media improved the growth 
rate of both the progenitor strain and the mutant strain. No change in growth rate was 
observed for the complemented FUS443C strain (Figure 5.10A). Proteins were extracted 
from each culture and were separated by SDS-PAGE, then transferred to PVDF membrane 
for blotting against PcrV. As previously demonstrated, PcrV was up-regulated in the 
mutant strain in the absence of iron supplementation, as observed through a visual 
increase in the protein band intensity for PcrV (Figure 5.10B). The addition of iron in the 
growth media did not affect the expression of PcrV in the progenitor strain or in the 
complemented strain, however the intensity of the PcrV band was stronger in the mutant 
strain indicating that iron had further promoted the expression of PcrV. 
 This showed that the up-regulation of the T3SS was not due to iron limitation, but 
could perhaps be due to the converse, whereby the mutant is importing more iron into 







Figure 5.10. The effect of iron supplementation on (A) growth in M9 minimal media with 
glucose and (B) on the expression of the type III secretion system protein, PcrV.  
 
5.8 EF-G and translation 
5.8.1 Ribosomal proteins 
As highlighted from the STRING protein-interaction map, a large cluster of the up-
regulated genes in FUS443 consisted of ribosome-associated genes, which was consistent 
with the proteomic profile of FUS443. In total, 62 genes encoding ribosomal or ribosomal-
associated proteins were upregulated, 20 of which encoded 30S ribosomal proteins, 26 
for 50S ribosomal proteins, three peptide chain release factors, elongation factor Tu and 





Table 5.9. List of ribosomal and ribosomal-associated proteins encoded by P. aeruginosa 
and their log2 fold change in the FUS443 and complemented mutant strains. 
    FUS443 FUS443C 
Gene Function log2 FC P-value log2 FC P-value 
PA5470 Peptide chain release factor 3.346 0.000 0.329 0.541 
rpsR 30S ribosomal protein S18 2.022 0.000 0.850 0.003 
efp Elongation factor P 2.011 0.000 0.757 0.004 
rplW 50S ribosomal protein L23 2.006 0.011 0.840 0.222 
rpsI 30S ribosomal protein S9 1.940 0.000 0.606 0.022 
rplD 50S ribosomal protein L4 1.923 0.000 0.563 0.140 
rpmG 50S ribosomal protein L33 1.801 0.000 0.789 0.010 
rpsG 30S ribosomal protein S7 1.767 0.000 0.307 0.284 
rpsF 30S ribosomal protein S6 1.749 0.000 0.649 0.022 
rplC 50S ribosomal protein L3 1.720 0.000 0.554 0.067 
rplK 50S ribosomal protein L11 1.713 0.003 0.357 0.515 
rpsK 30S ribosomal protein S11 1.703 0.000 0.753 0.013 
rplR 50S ribosomal protein L18 1.681 0.000 0.692 0.014 
rplY 50S ribosomal protein L25 1.663 0.000 0.297 0.270 
fusA1 Elongation factor G 1.657 0.000 - - 
fusA2 Elongation factor G 0.298 0.321 -0.316 0.273 
 
 
 In addition to ribosomal genes, the transcriptomic data highlighted several genes 
involved in RNA processing. Two such genes were, rtcA and rtcB, which were up-
regulated in FUS443. RtcA encodes an RNA 3’-terminal phosphate cyclase whose 
expression was increased by 5.2-fold in FUS443. RtcB encodes a probable RNA ligase and 
was up-regulated 9.3-fold. RNA ligases join RNA molecules that have been cleaved by 
RNases and are important in the processing of tRNA and defence against phage attack. 
RNA ligases have also been shown to cap 3’ DNA which would protect DNA from 
exonuclease attack (Maughan et al., 2015). Because of this, the rtcBA operon is often 
induced by cellular stress to prevent damage caused by the RNA toxins that are released 
by the cell to regulate growth rate and facilitate the cells stress response (Zhabokritsky 
et al., 2011; Maughan et al., 2015). The rtcBA operon is regulated by RtcR, however the 
rtcR gene does not appear to be drastically altered by the fusA1 mutation and so its action 
may be regulated post-transcriptionally. 
 Six tRNA synthetase genes were also up-regulated for the charging of tyrosyl-tRNA 
(PA4138), tryptophanyl-tRNA (PA4440), glutamyl-tRNA (PA3134), alanyl-tRNA 
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(PA0903), phenylalanyl-tRNA (PA2740) and prolyl-tRNA (PA0956). This may be due to an 
increased demand for protein synthesis in FUS443. Conversely to this, many of the 
detected tRNA encoding genes had been down-regulated. Those most affected included 
two tRNAThr genes and a tRNAMet gene that were down-regulated by between 3- and  
8-fold. Whilst tRNA levels could not be detected in the proteomic screen, the up-
regulation of tRNA-synthetase genes was also evident at a protein level in FUS443. 
Unlike in the proteomic data which did not reveal any significant increase in the 
expression of fusA1 or fusA2 in the mutant strain, fusA1 transcriptional expression was 
increased whilst fusA2 remained relatively unaffected. This further verifies the notion 
that these two genes and gene products are regulated distinctly from one another.  
 
5.8.2 DeaD 
 The consistent up-regulation of ribosomal proteins and T3SS proteins across the 
proteomic and transcriptomic profile of FUS443 strongly suggests that these systems are 
constitutively activated in response to the mutated EF-G protein. In chapter four the RNA 
helicase DeaD was suggested as a potential regulatory link between these two systems. 
The transcriptomic data revealed that deaD transcription was unaffected by the mutation 
in fusA1. It is possible that post-translational regulation of DeaD led to an increased 
abundance at a proteomic level which would, in turn, promote ExsA expression. But as 
deaD expression does not reflect the transcriptomic profile of other ribosomal proteins it 
appears unlikely that the expression of the T3SS is linked to the up-regulation of 




 Phenotypic analysis and proteomic profiling revealed a decrease in the motility of 
FUS443 and in the abundance of motility apparatus. In part, this was reflected in the 
transcriptomic profile of FUS443 through the down-regulation of several flagellar-related 
genes. This included the flagellar biosynthesis gene, flhB, and flagellar biosynthesis 
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chaperone, fliJ (Table 5.10).  Yet, a larger number of motility genes were up-regulated as 
a result of the fusA1 mutation, including five genes encoding chemotaxis transducers, 
multiple flagellar encoding genes and several genes encoding T4P. 
 
Table 5.10. List of genes associated with cell motility that were modulated in FUS443. 
    FUS443 FUS443C 
Gene Function log2 FC P-value log2 FC P-value 
PA2652 Chemotaxis transducer 1.683 0.000 0.058 0.819 
pctB Chemotaxis transducer 1.475 0.000 -0.210 0.618 
pilA Type 4 fimbrial protein 1.375 0.000 0.291 0.401 
chpE Chemotaxis transducer 1.370 0.000 0.172 0.471 
flgC Flagellar basal body rod protein 1.342 0.000 0.190 0.384 
cupE4 Pili assembly chaperone 1.266 0.000 -0.129 0.575 
PA5072 Chemotaxis transducer 1.263 0.000 0.550 0.022 
flgB Flagellar basal body rod protein 1.133 0.000 0.067 0.765 
flgD Flagellar basal body rod modification 
protein 
1.116 0.000 0.147 0.539 
flgG Flagellar basal body rod protein 1.045 0.000 -0.064 0.803 
PA2654 Chemotaxis transducer 1.012 0.000 0.328 0.223 
PA1608 Chemotaxis transducer 1.011 0.000 0.509 0.043 
ctpL Chemotaxis transducer -1.036 0.000 0.089 0.685 
flhB Flagellar biosynthesis protein -1.137 0.000 -0.204 0.351 
morA Motility regulator -1.163 0.000 -0.260 0.335 
cheY2 Probable two component response 
regulator 
-1.277 0.000 0.231 0.460 
cheA2 Probable two component sensor -1.427 0.000 -0.073 -0.133 
fliJ Flagellar biosynthesis chaperone -1.533 0.000 -0.062 0.794 
 
 
  The inconsistencies observed between the expression of motility genes and their 
corresponding protein abundance indicates the presence of strong post-transcriptional 
regulation controlling the turnover of mRNA or proteins, or that the motility genes are 
not constitutively effected by the fusA1 mutation. In the latter case, the differences in the 
proteomic and transcriptomic profiles may have arisen as a consequence of 
environmental influences or biological stressors acting at the point of cell harvest. It is 
expected that these profiles would differ from the plate assays in chapter three, as 
motility gene expression will vary on solid/semi-solid media versus the liquid culture 
used in the proteomic and transcriptomic analysis. 
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 Amongst the down-regulated genes were the two-component chemotaxis 
response genes, cheY2, and cheA2, which were addressed in the proteomic profile. The 
Che system is essential for flagellar motility and the Che2 system is also implicated in 
flagellar-based chemotaxis but not with the same prominence (Güvener et al., 2006).  If 
chemotaxis is dysregulated the cells will be incapable of directional movement, 
regardless of the up-regulation of flagellar genes, therefore would not move far from the 
point of inoculation. 
 Several transcriptional regulators were modulated in the FUS443 mutant which 
may play a role in the opposing changes associated with motility. One such regulatory 
gene was PA3341 which was expressed 2.4-fold lower than in the progenitor strain. 
PA3341 encodes a probable transcriptional regulator that could potentially play a 
regulatory role in motility due to its genomic position upstream of a flagellar biosynthesis 
cluster and hsb genes (PA3343-PA3353). The hsb gene cluster is known to regulate biofilm 
formation, twitching, swimming, swarming and chemotaxis by intersecting the Gac/Rsm 
pathway (Valentini et al., 2016). This cluster of genes was down-regulated in FUS443, 
including the response regulator hsbR. HsbR promotes flagellar motility by activating 
HsbA, which subsequently binds to the anti-sigma factor FlgM. Sequestration of FlgM 
relinquishes the corresponding sigma factor, FliA, which then induces the expression of 
flagellar biosynthesis and assembly genes (Figure 5.11) (Bhuwan et al., 2012; Valentini 
et al., 2016). Because of this, the down-regulation of hsbR would have a negative effect on 
cell motility. Interestingly, HsbA also activates the diguanylate cyclase HsbD which has 
been found to increase rsmY levels though an unknown mechanism (Francis et al., 2017). 
This may therefore link into the down-regulation of rsmY transcripts that was observed 





Figure 5.11. Regulation of motility in P. aeruginosa via the histidine phosphotransfer 
protein (HptB) and Hsb proteins in response to activation by sensor kinases, PA1611, 
SagS and ErcS’. 
 
The transcriptional expression of FliA, along with another well characterised sigma factor 
that regulates chemotaxis and motility, RpoN, were unaffected in this screen. Due to the 
high level of post-translational regulation involved in bacterial motility and the 
inconsistency of expression across motility genes in this study, the precise mechanism 
behind the involvement of EF-G on motility remains unclear. However, the mutated EF-G 
variant did appear to have impacted upon numerous subgroups of motility genes but 
these were not affected constitutively. 
 
5.9.2 Cell division 
 Analysis of cell morphology by light microscopy revealed that the FUS443 strain 
had an elongated cell morphology which appeared to be associated with the replication 
of the pUCP20 plasmid. The transcriptomic analysis revealed how this phenotype was 
reflected in changes to the expression of genes involved in the maintenance of cell shape. 
Disturbance to cell morphology appeared to have resulted from the up-regulation of 
numerous genes that inhibit the cell division process; minD encodes a cell division 
inhibitor and was up-regulated 2.5-fold, whilst zapE was increased by 2.8-fold and 
encodes a protein that reduces the stability of the cell division protein, FtsZ. Other up-
regulated genes included spoOJ (2.0-fold), encoding a chromosome partitioning protein, 
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and mreB (2.9-fold), encoding a rod-shape determining protein. Conversely, rodA was 
down-regulated (2.3-fold), which encodes another rod shape-determining protein. All of 
these genes were complemented, at least in part, by the pfusA1 plasmid showing that the 
fusA1 mutation indirectly affected cell shape. The reduced fitness of the FUS443 mutant 
is likely to be exacerbated by the added pressure of replicating the pUCP20 plasmid, 
leading to the disruption of basic cellular processes such as cell division. 
 
5.10 Redox pathways 
 A variety of redox-active proteins, typically located within the periplasm, were 
transcriptionally modulated in response to the fusA1 mutation. This included the down-
regulation of numerous cytochrome C encoding genes; PA2482, PA1856, cooN2 and 
cooO2, whilst the cytochrome B encoding gene, PA4430, and cytochrome P450 encoding 
PA3331 gene, exhibited increased expression (Table 5.11). Several other genes encoding 
redox-active proteins such as thioredoxin, glutaredoxin and numerous oxidoreductases 
were up-regulated in the mutant strain. The cluster I phenazine biosynthesis genes were 
also up-regulated, with phzA1 and phzC1 expression increased by 3.5- and 7.1-fold 
respectively. Phenazines are virulence factors produced by P. aeruginosa to damage 











Table 5.11. List of genes involved in oxidation/reduction pathways within the periplasm 
of P. aeruginosa and their log2 fold change in expression in FUS443 and the complemented 
strain. 
    FUS443 FUS443C 
Gene Function log2 FC P-value log2 FC P-value 
PA3331 Cytochrome P450 2.763 0.000 0.745 0.168 
PA4061 Thioredoxin 1.616 0.000 -0.268 0.283 
PA4430 Cytochrome B 1.567 0.001 0.243 0.614 
grx Glutaredoxin 1.382 0.000 0.402 0.080 
ahpF Alkyl hydroperoxide reductase 1.375 0.000 0.087 0.713 
PA3795 Oxidoreductase 1.160 0.000 0.162 0.536 
PA0840 Oxidoreductase 1.096 0.000 0.314 0.150 
PA1856 Cbb3-type cytochrome C -1.076 0.000 -0.164 0.478 
PA2477 Thiol:disulfide interchange protein -1.179 0.011 -0.328 0.451 
coxB Cytochrome C oxidase subunit II -1.249 0.000 -0.208 0.520 
fprB Oxidoreductase -1.299 0.000 -0.317 0.251 
PA4621 Oxidoreductase -1.343 0.000 0.057 0.843 
PA2482 Cytochrome C -1.402 0.000 -0.148 0.694 
ccoN2 Cbb3-type cytochrome C subunit I -1.590 0.000 0.109 0.685 
ccoO2 Cbb3-type cytochrome C subunit II -1.590 0.000 0.267 0.242 
 
 
 PA3398 encodes the transcriptional regulator FinR, and was up-regulated 2.2-fold 
in FUS443. FinR senses oxidative stress and has been found to induce the expression of 
its neighbouring gene, fprA, upon exposure to superoxides. FprA encodes a ferredoxin 
NADP-reductase which participates in iron acquisition, iron-sulfur cluster biogenesis and 
oxidative defence (Boonma et al., 2017). In FUS443, fprA expression was increased by 
2.5-fold. If FinR was responsible for the up-regulation of fprA, this defines a link between 
the oxidative stress response and iron uptake in FUS443. In addition to this, SoxR is a 
transcriptional regulator involved in mediating the oxidative stress response with its 
activity regulated post-translationally via the oxidation state of its iron-sulfur cluster 
(Sheplock et al., 2013). Transcriptomic data saw the expression of soxR reduced by  
2.1-fold. SoxR negatively regulates FinR and so the reduction in its transcriptional 





5.11 Sulfur metabolism 
 A large number of genes that were affected by the fusA1 mutation were involved 
in sulfur metabolism and uptake. Sulfate esters are the most abundant sulfur source in 
aerobic soils and bacteria produce enzymes to hydrolyse these compounds to release 
usable sulfur. Many bacteria can grow on alkylsulfates, such as sodium dodecyl sulfate 
(SDS), which requires arylsulfatase. Arylsulfatase genes (astABC) and the regulator of this 
operon, astR, were up-regulated in fusA1P433L (Table 5.12), which suggests that the 
mutant is not obtaining enough sulfur from its environment or that sulfur stores are 
diminishing faster in FUS443 than in the progenitor and complemented strain.  
 The ssu gene cluster was highly up-regulated in FUS443, with some genes being 
expressed as high as 108-fold higher than in the progenitor strain. This cluster is required 
for growth on aliphatic sulfonates, excluding the compound, taurine. The uptake and 
release of sulfite from taurine is dependent on the tauABCD operon, which was also highly 
up-regulated as a result of the fusA1 mutation. These genes were only partially 
complemented by the expression of the WT fusA1 gene. The high level of modulation that 
also occurred in FUS443C made it difficult to decipher the degree to which expression 
was complemented. By converting the log2 FC to FC helps to emphasise the recovery of 
the WT expression profile, for example, the 108-fold increase of ssuD expression in 
FUS443 is reduced to 11.6-fold in FUS443C. This makes it clearer that the fusA1 mutation 
is most likely to be the leading cause of these modulations and incomplete 
complementation was likely to be due to the presence of the remaining mutated fusA1 
variant in the genome of FUS443C.   
 Another protein that is central to the regulation of sulfur metabolism is CysB, 
which is the primary transcriptional regulator of the cys genes for cysteine biosynthesis. 
The cys genes are not clustered together but are distributed throughout the genome. In 
FUS443, cysB is up-regulated along with all of the cys genes, indicating that the CysB 
protein is highly active in the mutant strain. CysB is not only involved in the regulation of 
cysteine biosynthesis but also positively regulates taurine metabolism (through the tau 
genes), sulfate metabolism (through ssu regulation), and sulfate-ester transport (via 
astRBC). This shows how the fusA1 mutation caused the global up-regulation of sulfur 
metabolism genes via cysB, and was also supported by the proteomic data which saw both 
taurine and sulfate metabolising proteins at an increased abundance. 
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Table 5.12. List of genes involved in sulfur metabolism and their log2 fold change in 
expression in FUS443 and the complemented strain. 
    FUS443 FUS443C 
Gene Function log2 FC P-value log2 FC P-value 
ssuB ATP-binding component of ABC transporter 4.518 0.000 1.495 0.004 
ssuC Permease of ABC transporter 6.198 0.000 2.463 0.000 
ssuD Hypothetical protein 6.766 0.000 3.540 0.000 
ssuE Hypothetical protein 5.544 0.000 3.060 0.000 
ssuF Molybdopterin-binding protein 3.419 0.000 2.654 0.000 
tauA Taurine binding protein 5.042 0.000 3.342 0.000 
tauB ATP-binding component of ABC transporter 5.322 0.000 3.023 0.000 
tauC Permease of ABC transporter 4.118 0.000 1.675 0.001 
tauD Taurine dioxygenase 3.989 0.000 1.293 0.000 
astR Binding protein component of ABC transporter 1.096 0.000 0.487 0.025 
astA Arylsulfatase 0.706 0.001 -0.076 0.724 
astB ATP-binding component of ABC transporter 0.756 0.025 -0.109 0.720 
astC Permease of ABC transporter 0.900 0.008 -0.021 0.951 
cysB Transcriptional regulator 0.962 0.001 0.434 0.113 
cysA Sulfate transport protein 5.141 0.000 1.590 0.000 
cysD ATP sulfurylase  3.754 0.000 2.141 0.000 
cysH 3'-phoshoadenosine-5'-phoshoulfate reductase 1.471 0.000 0.888 0.000 
cysI Sulfite reductase 3.741 0.000 1.515 0.000 
cysK Cysteine synthase 1.311 0.000 0.116 0.642 
cysN ATP sulfurylase  3.913 0.000 1.802 0.000 
cysP Sulfate-binding protein of ABC transporter 3.561 0.000 1.814 0.000 
cysT Sulfate transport protein 5.620 0.000 2.290 0.000 





 The expression of a large number of genes was modulated in the FUS443 mutant, 
affecting distinct clusters of cellular processes that played diverse roles across the cell. 
 Motility and chemotaxis are systems that have been consistently disrupted 
throughout FUS443 phenotypic analysis, proteomic analysis and transcriptomic analysis, 
although not always to the same extent. Several of the proteins that were up-regulated in 
the proteomic screen were down-regulated at a transcriptional level, but the cluster II 
flagellar-chemotaxis genes remained consistently down-regulated across both profiles. 
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Well-known regulators and sigma factors of chemotaxis, such as FlgM, RpoN and FliA, 
were unaffected at a transcriptional level in the mutant strain, but this is not to say that 
their post-translational activity had not been altered. There was however, a reduction in 
hsbR, which encodes a response regulator related to flagellar motility. HsbR is involved 
in the post-translational activation of the HptB pathway, implicated in biofilm formation, 
twitching, swimming, swarming and chemotaxis.  This pathway culminates in the 
sequestration of the anti-sigma factor FlgM and induces flagellar gene expression through 
the release of the sigma factor, FliA (Valentini et al., 2016). The down-regulation of hsbR 
might therefore have caused the changes in gene expression of some of the motility genes 
and proteins.  
 The differences in protein and transcript abundance suggest that the motility-
regulatory network is heavily dependent upon post-transcriptional activation or 
inhibition. This makes it difficult to determine the molecular mechanisms that were 
responsible for the changes in motility by just using the transcriptomic and proteomic 
methods undertaken in this study. It is also likely that any modulations induced as a result 
of the mutated EF-G protein were minor and expression was vulnerable to other 
regulatory inputs from the cell and its surroundings. One exception to this was the  
cluster II chemotaxis genes and proteins which were consistently down-regulated. In this 
case, the mutated EF-G is likely to affect the activity of a regulator that specifically targets 
the che2 genes with minimal input from alternative pathways. 
 
 5.12.2 Amino acid biosynthesis 
 Central metabolism and amino acid biosynthesis were among the major processes 
affected by the fusA1 mutation. The most over-expressed genes in FUS443 were ilvA2 and 
its operonic gene partner, PA1325. These genes are important in central metabolism by 
controlling the complex synthesis of aspartate-derived amino acids (Rosenberg et al., 
2016). The Ilv pathways can be induced by a shortage of aminoacylated-tRNAs, an 
abundance of substrates or through catabolite repression (Tarleton et al., 1991). A 
number of tRNA synthetase genes were also up-regulated in FUS443, and so together, this 
suggests that there was an increased demand for aminoacyl-tRNAs and protein synthesis 
in the mutant strain. With these findings echoed at proteomic level, this indicates that the 





Figure 5.12. The (p)ppGpp-mediated stringent response in P. aeruginosa. 
 
 Having uncharged tRNA molecules positioned within the ribosome is a sign of 
amino acid depletion and is the major cause of ribosomal stalling. In chapter four I 
highlighted the increased abundance of SmpB in FUS443, which is a protein involved in 
the recovery of stalled ribosomes. This finding supported the notion that ribosomal 
stalling was occurring in the mutant strain, and now the transcriptomic data has provided 
evidence that this was potentially caused by the accumulation of uncharged tRNAs. RelA 
is a ribosome-associated protein which senses the presence of uncharged tRNA 
molecules on the ribosome and triggers the stringent response. To do this, RelA 
synthesises the alarmone, (p)ppGpp, which binds to RNA polymerase and coordinates the 
up-regulation of amino acid biosynthesis genes. During the stringent response rRNA and 
tRNA synthesis is inhibited and metabolism is down-regulated to reduce energy wastage 
(Figure 5.12) (Raina et al., 2014). The transcriptomic data identified the up-regulation of 
dskA, which encodes a transcriptional regulator. DskA functions as a general accessory 
factor of (p)ppGpp and assists in the repression of rRNA genes and promotes amino acid 
biosynthesis and transport (Paul et al., 2004; Blaby-Haas et al., 2011). The up-regulation 
of tRNA synthetase genes, several amino acid biosynthesis operons and dskA support the 
idea that the stringent response was activated in the mutant strain. Initiation of the 
stringent response may benefit the cell by limiting the activity of EF-G on the ribosome. 
EF-G, along with EF-Tu and IF-2, are targets of the stringent response and are inhibited 
by (p)ppGpp (Kanjee et al., 2012; Corrigan et al., 2016; Beljantseva et al., 2017) and so by 
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initiating the stringent response the cell could reduce the deleterious effects that the 
mutated protein is having on the cell.  
 Nevertheless, this was not consistent with the up-regulation of a large number of 
ribosomal-associated proteins that were significantly modulated in FUS443, as these 
should be repressed by (p)ppGpp and DskA (Vogt et al., 2011). As the down-regulation of 
ribosomal proteins is one of the major objectives of the stringent response its activation 
appears improbable in FUS443. In addition to this, fusA mutations in S. enterica have been 
linked to a decrease in ppGpp levels as it was proposed that EF-G interferes with RelA-
mediated synthesis of ppGpp on the ribosome (Macvanin et al., 2000, 2004). Therefore, I 
postulate that the up-regulation of tRNA synthetases, amino acid metabolism genes and 
ribosomal proteins is due to a common regulatory mechanism that coordinates the rate 
and demand of protein synthesis.   
 
5.12.3 Ribosomal protein expression 
 The up-regulation of ribosomal proteins in FUS443 was another observation that 
was consistent across both the proteomic and transcriptomic profile, showing that these 
changes are direct effects of the fusA1 mutation. In chapter four I discussed the possibility 
that the up-regulation of ribosomal proteins was a direct result of inadequate EF-G 
functioning and was induced to counteract poor translational efficiency. Whilst this may 
still be true, the transcriptomic profile of the mutant provided further insight and an 
alternative explanation for these findings.  
 The main regulatory system for ribosomal gene expression occurs via direct 
negative feedback from excess ribosomal proteins which bind to and prevent translation 
of their own mRNA (Nomura et al., 1984; Aseev et al., 2016).   With the up-regulation of 
ribosomal proteins in FUS443, this suggests that ribosomal proteins are not in excess, 
and are successfully being incorporated into ribosomal complexes and used for protein 
synthesis. It is possible that FUS443 has an increased demand for protein synthesis, 
reducing negative feedback by ribosomal proteins, and draining the intracellular pools of 
amino acids, triggering the up-regulation of amino acid metabolic genes.  
 An increase in the demand for protein synthesis in FUS443 may be down to cell 
morphology. Protein synthesis has a well-defined correlation with cell size, and over-
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expression can lead to the production of large, slow growing cells (Basan et al., 2015). 
FUS443 had an elongated cell morphology likely due to the dysregulation of various cell 
division-associated genes.  This added mass would demand a greater level of protein 
synthesis to maintain cellular functions and growth, explaining why there was an 
increase in ribosomal protein synthesis. This elongated cell morphology was also found 
in fusA mutants of S. enterica which exhibited a decreased growth rate. In these mutants 
the defective EF-G was believed to disrupt the size threshold at which the cell begins 
dividing (Macvanin et al., 2000). It should be noted, however, that the elongated 
phenotype in FUS443 was only apparent through a combination of the fusA1 mutation 
and replication of the pUCP20 vector, and was not observed in the original vector-free 
mutant. With this, it is also possible that the up-regulation of ribosomal proteins did not 
occur in the absence of the pUCP20 vector.  
 
5.12.4 Antibiotic resistance 
 The MexXY system was consistently up-regulated at a transcriptional level as well 
as at a proteomic level indicating its permanent up-regulation in response to the mutation 
in fusA1. Unlike in the proteomic profiling, the transcriptional expression of mexZ was not 
affected in FUS443 despite being divergently transcribed from the mexXY operon. MexZ 
is a transcriptional repressor of the MexXY system and several MexXY over-producing 
strains have been described which contain mutations in the mexZ gene (Suresh et al., 
2018). Whole genome sequencing of FUS443 verified the absence of any mutations in 
mexZ and so if MexZ was the cause of mexXY up-regulation this would be due to post-
transcriptional regulation of the protein affecting it’s activity. 
 Alongside mexXY modulation, the transcriptomic data also uncovered the down-
regulation of mexGHI-opmD. Whilst the MexGHI-OpmD efflux system does not affect 
gentamicin susceptibility, mutants in this system have been found to be defective in the 
production of elastases, rhamnolipids and pyocyanin. These are all AHL-regulated 
exoproducts and so it has been postulated that the MexGHI system plays into QS systems 
by removing precursors of PQS (Aendekerk et al., 2005; Sakhtah et al., 2016).  This efflux 
system has also been linked to the exportation of OdDHL, produced by the las QS system, 
affecting cell-cell communication (Southey-Pillig et al., 2005).  QS is a key regulator of 
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virulence and so its disruption via MexGHI may also contribute to the observed changes 
in QS signalling, motility, secretion and virulence in the FUS443 mutant. 
 Membrane permeability was potentially affected by the fusA1 mutation through 
down-regulation of the ppr genes, which represent the Pseudomonas permeability 
regulators (Giraud et al., 2011).  Membrane impermeability can occur from changes to 
porins and lipopolysaccharide structures, and in combination with secondary resistance 
mechanisms, such as efflux systems and modifying enzymes, these adjustments can 
dramatically enhance the cells resistance to a variety of antibiotics (Wang et al., 2003). 
PprAB is under the control of SigX, which was also down-regulated at a transcriptional 
level. The sigma factor SigX is a putative pleiotropic regulator and its mutation has been 
linked to transcriptional changes in chaperones and HSPs, antibiotic resistance genes, 
and genes involved in metabolism and motility, all of which have been affected in the 
mutant strain. PprB has also been found to downregulate the mexXY operon (Gicquel et 
al., 2013), therefore, both decreased membrane permeability and increased mexXY 
expression may have resulted from sigX down-regulation or inactivity.  
 It is still formally possible that the structural changes to EF-G are having a direct 
impact on the binding of aminoglycosides to the ribosome. However, there is now 
accumulating evidence to suggest that the activation of efflux systems and membrane 
impermeability are the main cause of aminoglycoside resistance in FUS443.  
 
5.12.5 Iron homeostasis 
5.12.5.1 Siderophores and iron uptake 
 In addition to the up-regulation of pyochelin biosynthesis proteins in the 
proteomic profile, pyoverdine biosynthesis and uptake genes were up-regulated at a 
transcriptomic level. The ferric uptake regulator, Fur, is the master regulator of the iron 
starvation response and was unaffected in both the proteomic and transcriptomic data. 
However, its effect on some downstream targets, such as PhuR, suggests that Fur is in a 
de-repressing, iron-free state.  Therefore, Fur may have caused the up-regulation of 
pyoverdine and pyochelin biosynthesis genes and proteins.  
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 PvdS is another sigma factor that has been identified as a positive regulator of 
iron-response genes, including the pvd operon. The expression of pvdS was up-regulated 
in FUS443 and, whilst under the control of Fur at a transcriptional level, PvdS is also 
controlled at a post-translational level by the anti-sigma factor FpvR (associated with the 
cell surface FpvA pyoverdine receptor) in the absence of ferric-bound pyoverdine (Figure 
5.13) (Imperi et al., 2010; Edgar et al., 2014). PvdS acts exclusively as a positive regulator, 
binding to IS (iron starvation) boxes within the promoters of iron-uptake and metabolism 
genes (Ochsner et al., 2002). Therefore, the combination of Fur de-repression and PvdS 




Figure 5.13. Iron uptake systems in P. aeruginosa that were affected by a mutation in the 
fusA1 gene.  
  
 Siderophores are required for the chelation of insoluble Fe3+ from the 
environment and are taken into the cell via TonB-dependent transportation systems. 
Ferrous iron (Fe2+), however, is soluble and is imported directly through Fe2+ Feo 
transporters (Figure 5.13). FeoAB is under the control of Fur, but FeoA can also modulate 
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the activity of FeoB in response to intracellular Fe2+ levels to prevent Fe2+ accumulation 
toxicity (Kim et al., 2012; Cornelis et al., 2013). Feo genes are typically expressed at a 
constitutive level (Lau et al., 2016), but the expression of feoAB was down-regulated in 
FUS443. With the previous findings predicting the de-repressive activity of Fur, this data 
suggests that the mutant EF-G protein was causing feoAB suppression independently of 
Fur, through an unknown mechanism. 
 The fiu system for ferrichrome uptake and the fox system for ferrioxamine uptake 
were also down-regulated in FUS443. Therefore, the EF-G mutation appears to only 
promote the expression of a subgroup of iron-uptake systems that involve pyoverdine 
and pyochelin-based iron acquisition and suppresses the uptake of ferrous iron, 
ferrichrome and ferrioxamine. The opposing regulation of different iron uptake systems 
highlights the dense network of regulatory pathways in place to maintain iron 
homeostasis and contradicts a strong involvement by Fur which would see a global up-
regulation of all systems. 
 
5.12.5.2 Iron and sulfur co-regulation 
Sulfur metabolism and iron homeostasis are coordinated systems. One possibility 
for this association is the need to maintain iron-sulfur ([Fe-S]) cluster biogenesis. [Fe-S] 
clusters are co-factors for a wide variety of proteins and can act as catalysts or redox 
sensors for electron transfer, gene regulation, environmental sensing and substrate 
activation (Imperi et al., 2010; Roche et al., 2013). There are three systems for [Fe-S] 
biosynthesis in bacteria, only one of which, the Isc (iron-sulfur cluster) system, is found 
in P. aeruginosa. IscR is a global regulator for [Fe-S] biogenesis by binding to, and 
detecting the levels of intracellular [Fe-S] (Romsang et al., 2016). Expression of iscR, was 
not significantly modulated in FUS443, but as with many transcriptional regulators, its 
activity is managed post-translationally, and so cannot be reliably assessed by the work 
presented here.   
 Sulfate or cysteine limitation induces the expression of a variety of sulfate 
metabolising proteins. The ssuBCDEF gene cluster is required for growth on aliphatic 
sulfonates, except for taurine which requires the tau operon. The tauABCD operon 
encodes a transporter system and α-ketoglutarate dependent dioxygenase, involved in 
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the release of sulfite from taurine (van der Ploeg et al., 1997; van Der Ploeg et al., 1999).  
The tauABCD and ssuBCDEF operons were both amongst the most highly up-regulated 
genes in FUS443, indicating that the cells were in a sulfur-starved state.  
 CysB is central in the regulation of sulfur metabolism and is closely associated with 
promoting cysteine biosynthesis via the cys regulon. CysB also positively regulates the 
tau and ssu operons (Hummerjohann et al., 2000; Imperi et al., 2010) and controls the 
sulfate-ester transportation system, encoded by astRBC, that was up-regulated in the 
mutant (Hummerjohann et al., 2000). This data showed that the mutation in fusA1 caused 
a global up-regulation of sulfur uptake and metabolism, most likely via the key regulator 
CysB. CysB then provided a link between iron and sulfur homeostasis as it has been found 
to directly, and positively, regulate PvdS (Imperi et al., 2010).  
 Interestingly, the tonB2-exbB1-exbD1 operon is strongly up-regulated in response 
to sulfur starvation, along with several putative TonB-dependent receptors, and was 
significantly up-regulated in FUS443. TonB1 is characterised as a key player in the iron-
response system whilst the role of TonB2 in iron uptake appears to be far more 
redundant (Cornelis et al., 2009). However, the involvement of tonB2 in sulfur 
metabolism is consistent with its position within a “sulfur island” containing a number of 
genes involved in sulfate-ester metabolism (Tralau et al., 2007), and may play a role in 
the importation of sulfur into the cell. This may explain the rise in tonB2-exbB1-exbD1 
expression whereas tonB1 was relatively unaffected in FUS443. Co-regulating iron and 
sulfur homeostasis ensures that intracellular pools of each element are available for the 
biogenesis of [Fe-S] clusters, and is also a way of preventing the toxicity of accumulating 
sulfur and the wastage of free iron (Imperi et al., 2010). 
 
5.12.6 Heat shock proteins and the oxidative stress response 
Across eukaryotic and prokaryotic species, the heat shock response is 
characterised by the rapid expression of HSPs to prevent damage induced by thermal 
stress. HSPs can also be induced by numerous non-thermal stressors such as 
antimicrobial agents, ethanol exposure, reactive oxygen species (ROS), glucose starvation 
and hyperosmolality (Allan et al., 1988; Wheeler et al., 2007). The FUS443 mutant 
exhibited an increase in the expression of HSPs at non-inducing temperatures, suggesting 
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that induction was triggered via an alternative stimulus. RpoH is one of the major sigma 
factors involved in the initiation of the heat shock response and upregulates the 
expression of numerous HSPs and molecular chaperones, including DnaK, DnaJ, GrpE, 
GroEL and GroES (Potvin et al., 2008). RpoH translation is itself thermo-regulated 
through secondary structures positioned within the rpoH mRNA. These structures 
restrict access by the ribosome under non-stress conditions but are disrupted during 
elevated temperatures, enhancing translation and increasing the abundance of the sigma 
factor in the cell. Transcription from RpoH-dependent promoters  is then increased, 
which in turn controls the expression of rpoH (Morita et al., 1999; Gunesekere et al., 
2006). The transcriptomic profiling of the FUS443 mutant revealed that the mutant strain 
was over-expressing rpoH, which explains the over-expression of HSPs. HSPs allow cells 
to adapt to stress conditions by influencing a variety of protein processing mechanisms, 
including protein folding, stabilisation, protein-complex assembly, transportation and 
protein degradation (Grudniak et al., 2018). Having affected the expression of rpoH, the 









Among the heat-shock response genes, expression of the dnaKJ-grpE chaperone 
system was up-regulated. The DnaK-DnaJ-GrpE complex targets proteins for refolding, 
degradation and disaggregation. Together they repress the heat shock response by 
targeting RpoH for degradation (Figure 5.14). However, when the cell experiences stress 
conditions DnaKJ-GrpE is recruited to the accumulating body of aggregated proteins, 
meaning that RpoH protein levels rise and initiate the heat shock response (de Bruijn, 
2016; Anglès et al., 2017). This explains how the up-regulation of both dnaKJ-grpE and 
heat shock response genes can co-exist in the FUS443 mutant, and adds to the growing 
evidence that the mutant strain has a stressed intracellular environment as a result of the 
fusA1 mutation.  
There is a strong link between the cellular redox state and the induction of the 
stress response (Wheeler and Wong, 2007). Numerous redox-active proteins were up-
regulated in FUS443 suggesting that oxidative stress may have initiated the heat shock 
response. Part of the host immune response is the release of ROS in an attempt to kill 
invading bacterial species. The bacteria themselves also generate ROS as by-products of 
respiration and for these two reasons it is highly important that the cells can protect 
themselves from oxidative damage. P. aeruginosa implement numerous methods to 
reduce oxidative damage, such as the production of antioxidants, including catalases, 
superdioxide dismutases and thiol peroxidases (Boonma et al., 2017). The increased 
transcriptional expression of redox-active proteins in FUS443 indicates that there is 
pressure to maintain a redox balance in the cell or a requirement for electron acceptors 
during the process of energy generation.  
 
5.12.7 Crosstalk between iron, sulfur and oxidative stress 
 The periplasm is a highly reducing environment within which FUS443 up-
regulated a variety of redox active molecules. Maintaining a buffered redox state is vital 
to the function of a wide variety of biological molecules in the cell. P. aeruginosa uses the 
Entner-Doudoroff pathway and TCA cycle for glucose metabolism, which is coupled with 
the reduction of nicotinamide adenine dinucleotide (NAD+) to NADH. Reduced NADH is 
utilised in the respiratory chain by transferring electrons to oxygen or nitrogen. The 
NAD+/NADH ratio can provide an indication of the redox state of the cell and can be used 
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to buffer the oxidising activities of molecules like phenazines, which are produced, among 
other reasons, for their toxic oxidising properties against competing bacteria and host 
cells (Price-Whelan et al., 2007; Cezairliyan et al., 2013). Phenazine biosynthesis genes 
were up-regulated in FUS443 and so this would increase the pressure on redox systems 
to buffer their damaging effects on the cell.  
  SoxR gene expression was down-regulated as a result of the fusA1 mutation. SoxR 
is a transcriptional regulator that senses a range of redox-cycling compounds, such as 
hydrogen peroxide, superoxide and nitric oxide. SoxR is constitutively expressed and is 
activated upon oxidation of its [2Fe-2S] cluster which causes it to de-repress promoter 
sequences, activating their transcription (Sheplock et al., 2013). Therefore, the down-
regulation of soxR in FUS443 may account for the increased expression of a variety of 
oxidoreductases and alkyl hydroperoxide reductases. Interestingly, SoxR has also been 
reported to positively regulate the mexGHI-opmD operon, and therefore its down-
regulation may have contributed to the down-regulation of mexGHI-opmD in FUS443. So 
far this is the first redox-responsive Mex system to be identified but its role in the 
oxidative stress response is unclear (Du et al., 2015). 
 Another transcriptional regulator that was affected by the fusA1 mutation was 
FinR, whose expression was transcriptionally up-regulated. FinR is under the negative 
control of SoxR through which its expression is promoted during superoxide stress 
(Yeom et al., 2010). Its up-regulation may therefore be due to the reduced expression of 
soxR or the presence of ROS. FinR regulates its neighbouring gene, fprA, and its own 
expression through their joint bi-directional promoter. FprA encodes a ferredoxin NADP+ 
reductase which catalyses the transfer of electrons between NADPH and ferredoxin, 
which is a small iron-sulfur protein that mediates electron transfer reactions for 
numerous metabolic reactions. Because of this, FprA plays an important role in 
maintaining NADP+/NADPH pools in the cell (Elsen et al., 2010; Boonma et al., 2017) and 
mutants in either finR or fprA have increased sensitivity to oxidative stress (Lewis et al., 
2013). This suggests that the FUS443 mutant would be more resistant to highly oxidative 




Figure 5.15. Oxidative stress-induced expression of the transcriptional regulator, FinR, 
and its implications on the respiratory chain and maintaining the redox-state of the cell 
by modulating NADP/NADPH pools. 
  
 FprA is also involved in cysteine biosynthesis and is induced upon sulfur-
limitation. It is postulated that FprA is associated with sulfur assimilation via an 
interaction with the sulfite reductase, CysI. Ferredoxin-dependent sulfite reductases have 
been identified in other proteobacteria and so it is also possible that FprA transfers 
electrons directly to CysI. The crosstalk between sulfur metabolism and FprA is unclear, 
and the role of FinR in this activation has not been determined. But it is possible that 
oxidised sulfur species such as sulfoxides and sulfonates could be a trigger for fprA 
induction (Lewis et al., 2013). 
 In addition to induction by oxidative stress and sulfur-limitation, fprA expression 
is also induced under iron-limited conditions (Yeom et al., 2010). [Fe-S] clusters are 
particularly sensitive to oxidative damage and dysregulation of [Fe-S] biogenesis during 
oxidative stress would have a detrimental impact on the central metabolism (Goldová et 
al., 2011; Boonma et al., 2017). The redox system also relies on iron homeostasis as the 
majority of enzymes involved in preventing the accumulation of radicals, such as 
peroxidases, catalases and some superoxide dismutases, contain iron (Messenger et al., 
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1983). Because of these links, the iron, sulfur and oxidative stress systems must be closely 
balanced through tight regulatory connections between the systems (Figure 5.16). It is 
possible that the mutated EF-G protein only affected the activity of one of the key 




Figure 5.16. The interconnecting networks of iron homeostasis, sulfur metabolism and 
oxidative stress that were affected in by mutation to EF-G.  
 
5.12.8 Secretion systems 
5.12.8.1 The type III secretion system 
 Seven secretion systems have been identified in P. aeruginosa, each with distinct 
roles in protein translocation (Mougous et al., 2006; Pukatzki et al., 2006). At least three 
of these secretion systems had been affected by mutation to fusA1. The most affected, at 
both a transcription and proteomic level, was the T3SS.  
 All of the T3SS genes detected in the transcriptomic screen were up-regulated, 
including the master regulator ExsA. The up-regulation of four genes, pcr1, pcr2, pcr3, and 
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pcr4, was also identified at a transcriptomic level. These genes are largely undefined but 
their products have been found to form interacting partners that affect the functionality 
of the T3SS. In some Yersinia and Shigella strains, these proteins come together to form 
plug or cap-like structures on the secretion tip of the injectosome to regulate 
translocation. Pcr1 was also found to bind PopN creating a T3SS repressor complex, with 
mutation to popN or pcr1 causing constitutive T3SS activation (H. Yang et al., 2007). The 
up-regulation of these genes alongside the other T3SS proteins suggests a negative 
feedback mechanism to post-translationally control the activity of the T3SS. From this 
study it is unclear if expression of the pcr1234 genes is having a negative effect on 
secretion.  
  The Gac/Rsm pathway is a global regulatory network that had been found to 
control the transcription of T3SS genes. The transcriptomic profile of FUS443 revealed 
the down-regulation of two Gac/Rsm pathway constituents; rsmY and rsmA. Small RNAs, 
rsmY and rsmZ, sequester RsmA to prevent its promotive or repressive effects on mRNA 
targets (Moscoso et al., 2014). RsmA typically promotes the expression of the T3SS and 
so the down-regulation of rsmA suggests that T3SS expression in FUS443 is a result of 
activation by a Gac/Rsm-independent mechanism. However, this pathway cannot be 
completely disregarded as the simultaneous downregulation of rsmY transcripts may 
increase the abundance of “free” RsmA, even during low level rsmA transcription. 
 The expression of another transcriptional regulator, PsrA, was down-regulated in 
the FUS443 mutant strain. There are contradictory studies relating to repression or 
induction of T3S by PsrA (Shen et al., 2006; Gooderham et al., 2008). Kang et al. (2009) 
proposed that PsrA possesses a dual regulatory role, dependent upon the presence of 
long chain fatty acids (LCFAs). It was noted that LCFA-bound-PsrA caused de-repression 
of fadAB, which encodes a complex for fatty acid degradation. These genes were up-
regulated in FUS443, supporting the notion that PsrA activity was lower in the mutant. 
Kang et al. then found that regulation of exsCEBA functioned in a similar LCFA-dependent 
manner, with de-repression in the presence of LCFAs.  The abundance of LCFA in FUS443 
is unclear, but this model suggests that the down-regulation of PsrA may have 
contributed to the up-regulation of ExsA in the mutant strain.  
 The host environment is purposely limited in iron to prevent bacterial invasion. 
Because of this, bacteria not only adopt a number of processes to overcome iron 
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limitation but iron abundance becomes an environmental signal for the presence of 
competing bacteria or host cells, which in turn induces the expression of virulence 
factors. (Bronstein et al., 2008; Chakraborty et al., 2011; Kurushima et al., 2012). The link 
between iron availability and T3S has been thoroughly documented in several bacterial 
species, including Bordetella, Salmonella, Shigella, Edwardsiella, Vibrio and Yersinia 
species (Wilderman et al., 2004; Bronstein et al., 2008; Gode-Potratz et al., 2010; 
Chakraborty et al., 2011; Kurushima et al., 2012; H. K. Miller et al., 2014). In these cases, 
Fur is considered to act as a simple repressor of T3SS genes in the presence of iron. To 
investigate if the up-regulation of T3S in FUS443 was due to iron limitation, cultures were 
grown under iron-rich conditions. Unexpectedly, this led to an increase in T3S in the 
mutant whilst the progenitor and complemented strain were unaffected.  
There is limited research on the relationship between Fur and T3S in  
P. aeruginosa, however, in the plant pathogen P. syringae, the addition of iron was found 
to suppress siderophore biosynthesis and induce genes involved in T3S and other 
proteins that use iron as a co-factor (Bronstein et al., 2008). Whilst this observation was 
not reflected perfectly in FUS443, my findings do support the inducive properties of iron. 
From these investigations it appeared that the induction of T3S by iron, in FUS443 under 
standard conditions, may be linked to the up-regulation of pyochelin and pyoverdine-iron 
acquisition systems, leading to an increase in intracellular iron. This phenotype is then 
exaggerated under iron-rich conditions causing a further increase in T3SS expression as 
the mutant strain appears to be unable to maintain iron homeostasis.  The precise 
mechanism by which iron acts on T3S is currently unclear, but is likely to act 
independently of Fur which is repressive during iron-repletion.  
From these findings, I was able to determine that the mutation in fusA1 affected 
the expression of the T3SS via the altered expression of the master regulator ExsA, which 
may have been influenced by PsrA.  The cause of this up-regulation was linked to the 
dysregulation of iron acquisition systems that occurred in the cell as a result of the 






5.12.8.2 The type II secretion system 
 The T2SS is very structurally similar to T4P and is comprised of an outer 
membrane complex, inner membrane complex, ATPase and pseudopilus. The 
pseudopilus is composed of numerous pilin-like proteins known as pseudopilins, which 
polymerise to form a piston-like structure through which secreted proteins are pushed 
from the cell (Durand et al., 2003). Out of all the secretion systems, the T3SS and T2SS are 
the major secretors of toxins, with the T2SS secreting exotoxin A, LasA and LasB, type IV 
protease, and phospholipase H (Jyot et al., 2011). P. aeruginosa encodes two main T2SSs; 
the Xcp system and the Hxc system. In FUS443, only the expression of the hxc cluster was 
affected by the mutation in fusA1. The hxc gene cluster consist of genes hxcP-Z which 
represent homologs to all of the xcp genes and produce characteristically similar proteins. 
Despite their similarity the two homologous sets do not have overlapping functions and 
will not substitute one another in the case of mutation. This helps to explain why only one 
of the T2SS clusters was affected by the fusA1 mutation (Ball et al., 2002). The hxc gene 
cluster is involved in the secretion of alkaline phosphatases and expression is induced 
upon phosphate limitation (Jyot et al., 2011).  
 The fusA1 mutation induced the down-regulation of the hxc T2SS. This suggests 
that the mutant strain may be more efficient at acquiring phosphate from its 
surroundings or, as with iron homeostasis, the phosphate response system has become 
dysregulated. Inorganic phosphate in the environment is sensed by the two component 
system PhoB/PhoR which promotes the expression of a large set of genes involved in 
phosphate acquisition, including the Pst phosphate-uptake system (Blus-Kadosh et al., 
2013; Faure et al., 2013). Neither phoAR nor pstBACS were affected on a transcriptional 
or proteomic level indicating that the downregulation of the hxc cluster is independent of 
phosphate availability.  
 
5.12.8.3 The type VI secretion system 
 The T6SS is the most recently identified secretion system. P. aeruginosa encodes 
three potential T6SSs, via three Hcp Secretion Islands (HSI-I, HSI-II, HIS-III) (Casabona et 
al., 2014). T6S is used to kill competing bacterial cells and can be used to discriminate 
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between same-species and non-pseudomonas bacteria. It is used as defence against 
same-species cells and has been implicated in a phenomenon known as ‘T6SS duelling’ 
involving the back and forth retaliation of attacks between neighbouring P. aeruginosa 
cells. Because of the direct contact between adjacent cells, the T6SS is often used in dense 
biofilms and during surface growth, when the cells are less motile. It has also been 
implicated in the formation of biofilm structures and the HSI-I cluster is in fact  
co-regulated with several biofilm-associated genes including as psl and pel, for 
exopolysaccharide synthesis, via the Gac/Rsm pathway (Hood et al., 2010). However, 
during planktonic growth the system is expressed at a low level (Alteri and Mobley, 2016) 
which meant that the up-regulation of the HSI-I cluster in FUS443 in planktonic culture 
was highly unusual. This could, however, be linked to the observed increase in 
exopolysaccharide production. The up-regulation of this system was also not reflected in 
any enhanced killing of E. coli during co-culture, putting the activity of the T6SS under 
question. 
 Several mechanisms are in place to regulate the T6SS, some of which respond to 
environmental conditions such as iron limitation, temperature and osmotic stress.  
Transcriptional regulation has been recognised through the activating properties of 
RpoN, and negative control by Fur and RetS (Mougous et al., 2006; Hachani et al., 2011; 
Alteri et al., 2016), none of which were modulated in FUS443. A second level of regulation 
occurs post-translationally via a threonine phosphorylation cascade orchestrated by the 
kinase PpkA. PpkA phosphorylates Fha1, to activate the Fha1-ClpV1 complex which 
induces the export of effector proteins through the T6SS (Figure 5.17) (Casabona et al., 
2014; Chen et al., 2015). Both PpkA and the phosphatase PppA were up-regulated as a 
result of the fusA1 mutation and are likely to be involved in the activity of the T6SS at a 






Figure 5.17. Regulation of the T6SS by PpkA and PppA threonine phosphorylation 
cascade. 
 
 The T3SS and T6SS are typically mutually exclusive phenotypes due to 
antagonistic regulation by the Gac/Rsm pathway (Line Lucchetti-Miganeh et al., 2014).  
RsmA positively regulates the T3SS but negatively regulates ppkA, leading to a down-
regulation of the T6SS (Chen et al., 2015). Each secretion system has a distinct role from 
the other; T3S is linked to pathogenicity in planktonic cultures and typically targets 
eukaryotic cells, whereas the T6SS promotes interspecies bacterial competition (as well 
as targeting eukaryotic cells), and has a more prominent role in persistence and biofilm-
associated antibiotic resistance (Zhang et al., 2011; Green et al., 2016). This study 
identified the complete dysregulation of the T3SS/T6SS resulting in activation of the two 
systems simultaneously in the FUS443 mutant strain. One study investigating clinical 
isolates of P. aeruginosa identified a similar phenomenon, whereby the level of T6SS 
proteins and transcripts did not correlate with rsmY/Z levels, resulting in the expression 
of T6SS during planktonic growth but not during biofilm formation (Line Lucchetti-
Miganeh et al., 2014). In addition to this, the T3SS and T6SS of Burkholderia pseudomallei 
was found to be co-expressed via the T6SS positive regulator, BsaN, located within a T3SS 
gene cluster (Chen et al., 2011). P. aeruginosa has no clear homologue to BsaN, however, 
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all of these findings point toward the presence of a Gac/Rsm independent regulatory 
system for either the T3SS or T6SS causing their simultaneous up-regulation.  
 
5.12.9 Conclusion 
 This chapter developed upon the phenotypic and proteomic findings to provide a 
more in depth understanding of how the fusA1 mutation in FUS443 affected particular 
biological processes. In most cases, the transcriptomic data reflected the main findings of 
the proteomic analysis, confirming that the T3SS and iron homeostasis were severely 
impacted by the mutated EF-G protein. Central metabolism was also affected by the 
mutation, as well as sulfur metabolism and the oxidative stress response, which are likely 
to be linked with the disruption to iron homeostasis via interconnecting networks. 
Dysregulation of iron acquisition is also likely to be a causal factor for the increased 
activity of the T3SS, through a currently undefined mechanism.  
 The molecular mechanisms behind several characteristics of FUS443 still remain 
unclear, such as the cause of motility or chemotaxis perturbation, the up-regulation of 
exopolysaccharide production, and the simultaneous expression of the T6SS and T3SS. 
The most likely explanation for these occurrences is that the mutated EF-G protein is 














6. Final Conclusions 
Acquisition of P. aeruginosa by the CF lung occurs, on average, at one-year-old and 
if left untreated chronic infections can lead to the development of bronchiectasis and 
respiratory failure (Silva Filho et al., 2013). Biofilm formation is closely associated with 
chronic infection and often coincides with increased antibiotic resistance, immune 
evasion and persistence within the host environment, making biofilm formation in  
P. aeruginosa the subject of intense study. Being able to eradicate early stage colonisation 
would prevent the progression into chronicity and improve the prognosis of the patient. 
Planktonic cells, which are associated with the initial acute infection, also come with their 
own detrimental characteristics, as the virulent nature of planktonic cells means that the 
host is damaged at a considerable rate.  Despite this, planktonic growth proves to be a 
susceptible window in which infection can be successfully treated with antimicrobials.  
Understanding the biological processes underpinning planktonic growth is key to 
improving the effectiveness of treatment before infection progresses into a chronic 
phase.  
During this study, a SNP was identified in the EF-G encoding gene, fusA1. This 
mutation occurred spontaneously most likely as a result of the antibiotic selection 
pressure in place during the transposon mutagenesis screening of P. aeruginosa strains. 
Having identified that the SNP in fusA1 was having pleiotropic effects on the cell, the first 
objective of this study was to identify how this mutation affected the structure of EF-G.  
I found that the resulting non-synonymous mutation caused minor conformational 
changes in EF-G which is likely to have affected the way in which the protein interacted 
with the ribosome or associating proteins, therefore disrupting the efficiency at which it 
coordinated translational elongation. The mutation did not, however, affect the adjacent 
fusidic acid binding pocket in a way that prohibited fusidic acid binding. 
As this project started as an investigation into the regulation of biofilm formation, 
my second objective was to identify if the mutated EF-G protein had any implications in 
the formation of biofilms or in the inverse expression of virulence factors. The 
involvement of EF-G in biofilm formation had not been documented before in  
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P. aeruginosa, but initial screenings showed FUS443 to exhibit decreased expression of 
the key biofilm matrix component, CdrA. Further analysis showed that the mutated EF-G 
also affected the biosynthesis of exopolysaccharides, although the overall level of biofilm 
formation remained unchanged. Although the FUS443 mutant was less relevant in biofilm 
formation, the phenotypic analysis began to unveil the large effect that the mutated EF-G 
protein had on virulence. This included an effect on cell motility, QS and the secretion of 
exoenzymes. It also became evident that the mutated EF-G protein was inducing various 
changes to antibiotic sensitivity. The fusA1 mutation caused the emergence 
aminoglycoside resistance to kanamycin and gentamicin, and also introduced sensitivity 
to fusaric acid. Many of the characteristics that were altered by the mutated EF-G protein 
are controlled independently of one another and so it was of great interest to have 
identified a SNP in one gene which had such widespread effects across the cell.  
I was able to analyse both the transcriptomic and the proteomic profile of the 
FUS443 mutant strain to produce a global representation of the cellular changes that had 
occurred as a result of the fusA1 mutation. This was the third objective of this study, and 
I was able to support many of the findings that had been observed in the phenotypic 
analysis, as well as identify numerous other characteristics that had previously gone 
undetected. For example, the collective data sets provided evidence that antibiotic 
resistance had emerged through the up-regulation of the mexXY efflux system, and the 
increased production of exopolysaccharides was a result of the increased expression of 
pel and psl biosynthesis genes and proteins.  
By far, one of the most notable characteristics of FUS443 that emerged from the 
transcriptomic and proteomic data was the up-regulation of the virulence determinant, 
the T3SS. This up-regulation included the T3SS master regulator, ExsA, whose positive 
feedback is likely to have provided the initial induction of this system. Other systems that 
were affected at a global level included proteins involved in iron homeostasis, sulfur 
metabolism and the oxidative stress response, all of which are likely to have been induced 
by a common regulator. In a similar way, cell morphology, altered growth rate and 
changes in the expression of ribosomal proteins are likely to have derived from a common 
mechanism influenced by the mutated EF-G protein.  
The precise molecular mechanism by which the mutated EF-G protein affected 
gene expression and protein abundance was less clear, as it appeared that the activity of 
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a diverse range of regulatory factors were modulated by the mutation. It is most likely 
that the mutation in EF-G affected gene expression indirectly due to its altered protein 
structure which led to a change in the efficiency of protein synthesis. The majority of 
proteins in the cell can withstand small adjustments in abundance without having large 
downstream effects on their cellular role. However, proteins that play regulatory roles, 
such as transcription factors, sigma factors and post-translational regulators, can be 
highly sensitive to such changes, causing large downstream effects on the expression of 
target genes or the activity of target proteins.  
The role of EF-G in translation has long been established across a diverse variety 
of bacterial species. This study revealed a novel involvement for EF-G in numerous 
biological processes, including T3S, iron and sulfur homeostasis, cell motility, cell 
division, the oxidative and heat stress responses, cell communication and central 
metabolism. These systems were all sensitive to the minor functional alteration that had 
occurred in the mutated EF-G protein and, whilst the impact on these systems was most 
likely to be indirect, the study highlights the dynamic downstream effects that can be 
brought about by just a single SNP in fusA1.  
FusA1 is located within the core genome (approximately 82% of the total genome) 
(Ozer et al., 2014), within which the average rate of nucleotide substitution is low due to 
the importance of core genes in cell survival  (Morales et al., 2004). Changes in the 
function or expression of these core genes can have damaging implications to cell 
viability, making mutations such as the one identified in this study relatively rare. Core 
genes include members of the pvd operon, for pyoverdine biogenesis, as well as those 
encoding the T3SS secreted proteins, exoT, exoY, exoU and exoS (Valot et al., 2015). The 
FUS443 mutant provides a perfect example as to the broad changes that can occur when 
the expression of these core genes is altered.  
The up-regulation of the T3SS in FUS443 is of particular relevance to CF infection 
models, as T3S plays a prominent role in colonisation and acute infection of the 
respiratory tract. Individuals with CF produce antibodies against the T3S effector 
proteins as an infection progresses and so the T3SS in P. aeruginosa is suppressed during 
chronic infection to evade the host immune system and promote colony persistence. 
Consistent with this, isolates from the CF airways also develop mutations in genes that 
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are essential for T3S, such as cyaB, vfr, and exsA, to prevent activation of the host immune 
response (Hauser, 2009; Kruczek et al., 2016).  
As the FUS443 mutant continually expressed T3S it could provide a useful tool for 
understanding how T3S is activated, aside from the two known inducers; calcium and 
host contact. Identifying how to promote the continual expression of T3S during infection 
may encourage the host immune system to target P. aeruginosa and enhance bacterial 
killing. Promoting T3S could also prolong the ‘susceptible’ acute infection stage and, in 
combination with antimicrobial therapies, would improve P. aeruginosa eradication and 
reduce the survival of persister cells within the lung. Alternatively, numerous 
pharmacological inhibitors are being identified which impair T3S to reduce the severity 
of the infection, elevate symptoms and lower the level of damage caused during acute 
infection (Anantharajah et al., 2016). The exaggerated T3SS expression in FUS443 could 
therefore provide a beneficial model for current research that is looking to target the 
regulatory network behind T3S, the T3SS itself, the effector proteins or the assessment 
of molecules that counteract their toxic effects.   
 Whilst virulence factors are generally not essential for survival, using known 
virulence determinants as therapeutic targets may decrease pathogenicity and assist in 
slowing disease progression.  In modern-day medicine, iron chelators are being used to 
treat numerous disorders, including neurodegenerative diseases and β-thalassemia, and 
more and more research is going into investigating the potential antimicrobial effects of 
iron chelation (Thompson et al., 2012). It is clear that the disruption to iron homeostasis 
in FUS443 reduced cell fitness and potentially caused the emergence of sensitivity to 
fusaric acid. Further investigation is required to identify how the mutated EF-G protein 
could be used to disrupt cellular iron balance, but this may provide a potential mechanism 
to reduce cell survival or induce antimicrobial sensitivity. As iron is also an essential 
cofactor in eukaryotic cells, toxicity of metal chelators used in antimicrobial therapy 
would need to be assessed. 
The emergence of antibiotic resistance in FUS443 would also benefit its survival 
within a host environment. Aminoglycosides have been in use since the 1940s (Gad et al., 
2011) and have been implemented in the management of acute exacerbations in CF 
patients. FusA1 is not typically considered an antibiotic resistance gene but more and 
more studies are identifying its importance in resistance to aminoglycosides. Mutation to 
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the fus genes have been identified in CF aminoglycoside-resistant isolates, with the 
implication that the mutated EF-G directly disrupts antibiotic-ribosomal binding (Greipel 
et al., 2016; López-Causapé et al., 2017). The documented mutations in fusA1 are 
commonly located in the mRNA-interacting domain (domain IV), or in the GTP hydrolysis 
domain, (domain I), none of which map near the P443L transition identified in this study. 
With this I have been able to provide evidence of another region within the protein that 
is sensitive to viable structural alterations and elicits an antibiotic resistance-inducing 
phenotype upon mutation.  Going beyond the published works on  
EF-G mutations, the use of transcriptomic analysis and proteomic analysis provided a 
greater insight into the mechanism behind this resistance and suggested that resistance 
occurred through the modulation of the aminoglycoside efflux system, MexXY. Adaptive 
mutations in mexXYZ genes have also been identified in CF isolates and demonstrate how 
the use of aminoglycosides in antimicrobial therapy is placing high evolutionary pressure 
on this system, directly or indirectly, as seen in this study via fusA1 (López-Causapé et al., 
2017; Prickett et al., 2017). 
The mechanism through which the EF-G mutant protein influenced the cell could 
not be determined comprehensively from this study. The main reason behind this was 
the dependency of transcription factors and regulatory proteins on post-translational 
regulation. It is possible that the mutated EF-G only affects a relatively small number of 
transcriptional factors whose modulation causes a dynamic upset across the cell. 
Focusing in on specific regulators and altering their expression could help to underpin 
their involvement and impact, downstream of the mutated EF-G.  
FusA1 shares a sequence identity of around 40% with eukaryotic mitochondrial 
EF-G, and around 24% with cytosolic EF-2 (Bielecki et al., 2012). This makes P. aeruginosa 
EF-G an unfavourable target for antibacterial therapeutics as any effect on host EF-G 
homologs could have damaging effects on the patient’s own cells. But, by identifying 
which regulatory proteins are mediating the changes in FUS443, these could be used to 
target specific biological processes to reduce the viability of P. aeruginosa cells within the 
host. Increased focus into these areas could therefore help in the development of new 






  Transcriptomic data Proteomic data 
  FUS443 FUS443C FUS443 FUS443C 
Gene name Locus log2 FC P-value log2 FC P-value log2 FC P-value log2 FC P-value 
The type II secretion system 
hxcW PA0677 -1.129 0.000 0.021 0.934     
hxcU PA0678 -0.895 0.095 -0.425 0.446     
hxcP PA0679 -0.742 0.004 -0.327 0.194     
hxcV PA0680 -0.883 0.008 0.112 0.692     
hxcT PA0681 -1.046 0.001 0.007 0.983     
hxcX PA0682 -1.264 0.000 0.036 0.893     
hxcY PA0683 -0.345 0.585 -0.198 0.797     
hxcZ PA0684 -1.320 0.158 -0.169 0.838     
hxcQ PA0685 -1.285 0.000 -0.175 0.611     
hxcR PA0686 -1.231 0.030 -0.261 0.645     
lapA PA0688 -0.961 0.000 -0.220 0.303     
lapB PA0689 -1.142 0.000 -0.034 0.885     
toxA PA1148 0.347 0.135 0.450 0.121 0.688 0.147 -0.232 0.938 
xqhB PA1382 -1.318 0.000 0.134 0.605     
xcpZ PA3095 -0.547 0.010 -0.255 0.232     
xcpY PA3096 -0.537 0.215 -0.510 0.229     
xcpX PA3097 -0.634 0.298 -0.404 0.518     
xcpW PA3098 -0.437 0.449 -0.175 0.757     
xcpV PA3099 -0.037 0.968 -0.217 0.801     
xcpU PA3100 0.396 0.547 -0.128 0.868     
xcpT PA3101 0.348 0.133 -0.090 0.703     
xcpS PA3102 -0.158 0.777 -0.209 0.712 0.109 0.701 0.377 0.743 
xcpR PA3103 -0.210 0.488 -0.288 0.351 0.473 0.156 0.197 0.915 
xcpP PA3104 -1.214 0.000 -0.037 0.895 -1.211 0.016 0.044 0.987 
xcpQ PA3105 -0.084 0.740 0.108 0.673 0.562 0.032 0.044 0.976 
lasB PA3724 0.664 0.066 -0.602 0.072 0.297 0.751 0.027 0.995 
The type III secretion system 
exoT PA0044 3.863 0.000 -0.440 0.073 2.836 0.000 0.138 0.861 
vfr PA0652 0.521 0.058 0.376 0.173 -0.101 0.556 0.192 0.819 
pscP PA1695 3.961 0.000 -0.292 0.575 4.178 0.000 -0.179 0.953 
pscO PA1696 4.718 0.000 0.061 0.964     
pscN PA1697 5.101 0.000 0.078 0.903     
popN PA1698 5.536 0.000 0.253 0.470 4.187 0.001 0.172 0.973 
pcr1 PA1699 5.026 0.000 -0.072 0.898     
pcr2 PA1700 4.057 0.000 -0.330 0.529     
pcr3 PA1701 4.723 0.000 -0.139 0.811     
pcrG PA1705 3.729 0.000 -0.643 0.015 3.211 0.000 -0.502 0.729 
pcrV PA1706 4.411 0.000 -0.429 0.053 2.143 0.000 -0.305 0.738 
pcrH PA1707 4.173 0.000 -0.816 0.276 3.262 0.000 -0.352 0.777 
popB PA1708 4.051 0.000 -0.875 0.004 3.151 0.000 -0.055 0.973 
popD PA1709 3.827 0.000 -0.885 0.001 3.895 0.000 -0.113 0.903 
exsC PA1710 1.689 0.000 -0.714 0.005 2.358 0.000 -0.019 0.993 
exsE PA1711 1.976 0.000 -0.275 0.272 2.401 0.000 -0.162 0.945 
exsB PA1712 1.913 0.000 -0.536 0.022     
exsA PA1713 1.697 0.000 0.388 0.201 0.894 0.000 0.068 0.925 
exsD PA1714 2.236 0.000 -0.062 0.814 0.846 0.000 -0.036 0.973 
pscB PA1715 2.642 0.000 0.326 0.524 2.349 0.000 -0.017 0.987 
pscC PA1716 2.196 0.000 0.019 0.944 2.133 0.000 -0.076 0.962 
pscD PA1717 1.928 0.000 0.525 0.065 0.382 0.291 0.199 0.926 
pscE PA1718 2.395 0.000 0.183 0.789 1.982 0.000 -0.300 0.769 
pscF PA1719 3.466 0.000 1.275 0.000 2.507 0.000 -0.304 0.855 
pscG PA1720 2.987 0.000 0.848 0.128 2.205 0.000 -0.189 0.861 
pscH PA1721 2.358 0.000 0.361 0.545     
pscI PA1722 2.579 0.000 0.693 0.275     
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pscJ PA1723 2.383 0.000 0.730 0.074 0.758 0.002 0.027 0.980 
pscL PA1724 2.119 0.000 0.454 0.231     
PscL PA1725 1.157 0.000 0.364 0.207 5.873 0.000 2.458 0.008 
exoY PA2191 4.057 0.000 -0.207 0.344 3.266 0.000 -0.193 0.881 
ptrA PA2808 0.557 0.038 -0.245 0.390     
psrA PA3006 -1.060 0.000 0.153 0.556 -0.111 0.530 -0.025 0.984 
exoS PA3841 3.879 0.000 -0.479 0.070 3.261 0.000 0.157 0.861 
spcS PA3842 4.461 0.000 0.370 0.106 3.263 0.000 -0.156 0.866 
The type VI secretion system 
tagQ1 PA0070 3.473 0.000 0.514 0.040 0.167 0.556 -0.240 0.868 
tagS1 PA0072 1.121 0.679 0.158 0.864     
tagT1 PA0073 1.274 0.648 0.215 0.902 0.497 0.145 0.072 0.973 
ppkA PA0074 2.041 0.001 0.184 0.795 0.412 0.091 0.079 0.966 
pppA PA0075 2.597 0.000 0.668 0.007 0.101 0.661 -0.264 0.802 
tagF1 PA0076 2.468 0.028 0.295 0.770 0.427 0.010 -0.159 0.802 
tssM1 PA0077 2.213 0.000 0.102 0.739 0.359 0.319 0.002 1.000 
tssL1 PA0078 2.434 0.000 -0.083 0.709 0.929 0.018 0.095 0.973 
tssK1 PA0079 2.056 0.000 0.341 0.274 0.637 0.031 -0.039 0.983 
tssJ1 PA0080 2.032 0.000 0.799 0.014 0.387 0.286 -0.435 0.802 
fha1 PA0081 0.437 0.083 -0.095 0.691 0.980 0.001 -0.070 0.956 
tssa1 PA0082 3.195 0.000 -0.246 0.441 0.488 0.248 0.003 1.000 
tssB1 PA0083 3.195 0.000 0.964 0.002 0.207 0.260 -0.326 0.660 
tssC1 PA0084 3.005 0.000 0.959 0.008 0.224 0.176 -0.283 0.676 
hcp1 PA0085 3.717 0.000 1.554 0.000 0.587 0.014 -0.287 0.742 
tagJ1 PA0086 2.430 0.000 0.073 0.770 0.350 0.084 -0.288 0.729 
tsse1 PA0087 2.748 0.009 0.879 0.010 0.270 0.296 -0.252 0.855 
tssf1 PA0088 2.667 0.000 0.703 0.002 0.495 0.245 -0.222 0.932 
clpV1 PA0090 2.137 0.000 0.702 0.104 0.244 0.435 -0.121 0.962 
vgrG1 PA0091 2.229 0.000 0.882 0.003 -0.163 0.595 -0.180 0.915 
hcpA PA1512 1.124 0.002 0.785 0.031 1.007 0.008 0.215 0.897 
hsiA2 PA1656 -0.448 0.046 0.081 0.736     
hsiB2 PA1657 1.273 0.000 0.858 0.005 -0.901 0.292 0.523 0.915 
hsiC2 PA1658 1.334 0.000 0.789 0.008 -0.430 0.577 0.797 0.842 
hsiF2 PA1659 0.923 0.000 0.467 0.093     
hsiG2 PA1660 0.303 0.271 0.179 0.536     
hsiH2 PA1661 0.301 0.447 0.074 0.864     
clpV2 PA1662 0.308 0.189 0.053 0.831 -0.646 0.354 0.722 0.848 
sfa2 PA1663 0.557 0.009 -0.153 0.512 -0.227 0.656 0.495 0.855 
orfX PA1664 1.203 0.007 -0.655 0.202     
fha2 PA1665 1.308 0.000 0.311 0.209     
lip2 PA1666 0.819 0.155 0.014 0.986 -0.873 0.011 0.449 0.703 
hsiJ2 PA1667 0.363 0.153 0.032 0.898 -0.030 0.951 0.675 0.711 
dotU2 PA1668 0.840 0.000 0.195 0.421     
icmF2 PA1669 0.773 0.044 0.223 0.630     
stp1 PA1670 0.340 0.688 0.272 0.741 -1.324 0.030 0.050 0.990 
stk1 PA1671 -0.796 0.136 0.103 0.836     
hsiB3 PA2365 1.355 0.000 0.638 0.030 -0.252 0.481 -0.199 0.923 
hsiC3 PA2366 0.587 0.032 0.343 0.317 -0.467 0.100 -0.249 0.860 
hcp3 PA2367 0.974 0.000 0.470 0.135 -1.355 0.008 -0.620 0.712 
hsiF3 PA2368 0.169 0.838 -0.202 0.830 -1.939 0.000 -0.329 0.742 
hsiG3 PA2369 0.210 0.536 -0.233 0.560 -0.920 0.008 -0.163 0.915 
hsiH3 PA2370 -0.500 0.349 -0.618 0.316     
clpV3 PA2371 -0.517 0.043 -0.433 0.148 -0.916 0.017 -0.222 0.903 
 PA2372 -0.081 0.740 0.115 0.700 -1.304 0.000 -0.576 0.115 
vgrG3 PA2373 -0.091 0.706 -0.093 0.704 0.061 0.667 0.088 0.907 
tseF PA2374 -0.936 0.000 -0.299 0.162     
tse2 PA2702 1.046 0.000 0.340 0.117 0.758 0.122 -0.403 0.870 
tse3 PA3484 1.091 0.000 0.324 0.276 -2.548 0.004 -0.428 0.903 
vgrG5 PA5090 0.355 0.299 -0.071 0.847     
Ribosomal and translation associated proteins 
tRNA-Met PA0574.1 -0.402 0.260 0.302 0.368     
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alaS PA0903 1.494 0.000 0.498 0.065     
relA PA0934 0.583 0.046 -0.011 0.970 0.357 0.194 0.086 0.971 
proS PA0956 1.032 0.001 0.157 0.560     
ycfB PA1678 0.560 0.012 0.000 0.998 0.891 0.001 0.155 0.847 
fusA2 PA2071 0.298 0.321 -0.316 0.273 0.624 0.009 -0.025 0.985 
pheS PA2740 1.389 0.000 0.344 0.184 0.706 0.014 0.166 0.901 
rplT PA2741 -0.285 0.511 -0.365 0.416 0.845 0.008 0.276 0.828 
deaD PA2840 2.011 0.000 0.757 0.004 0.878 0.002 0.250 0.794 
efp PA2851 2.011 0.000 0.757 0.004 0.224 0.167 0.045 0.973 
gltX PA3134 1.537 0.000 0.449 0.078 0.574 0.036 0.228 0.858 
recQ PA3344 0.162 0.534 0.014 0.958 0.466 0.059 0.368 0.703 
tyrS PA4138 2.977 0.000 0.004 0.987 2.240 0.001 0.426 0.802 
rpsK PA4240 1.703 0.000 0.753 0.013 0.489 0.004 0.015 0.985 
rpsM PA4241 1.108 0.000 0.584 0.058 0.786 0.010 0.300 0.802 
rplR PA4247 1.681 0.000 0.692 0.014 0.716 0.004 0.269 0.727 
rplX PA4252 1.247 0.000 0.627 0.044 1.712 0.001 0.380 0.743 
rplB PA4260 1.607 0.000 0.456 0.171 0.872 0.006 0.324 0.764 
rplW PA4261 2.006 0.011 0.840 0.222 0.454 0.007 0.145 0.828 
rplD PA4262 1.923 0.000 0.563 0.140 0.832 0.013 0.338 0.802 
rplC PA4263 1.720 0.000 0.554 0.067 0.825 0.007 0.311 0.775 
fusA1 PA4266 1.657 0.000 0.000 1.000 0.495 0.006 2.269 0.000 
rpsG PA4267 1.767 0.000 0.307 0.284 0.736 0.012 0.263 0.828 
rplA PA4273 1.601 0.001 0.359 0.413 0.863 0.008 0.382 0.729 
rplK PA4274 1.713 0.003 0.357 0.515 0.579 0.009 0.172 0.855 
 PA4277.1 -3.017 0.000 -1.306 0.000     
 PA4430 1.567 0.001 0.894 0.049     
rpsI PA4432 1.940 0.000 0.952 0.000 0.392 0.082 0.080 0.962 
trpS PA4439 1.616 0.000 0.520 0.029 0.78 0.000 -0.014 0.985 
rpsT PA4563 1.970 0.000 1.023 0.000 0.892 0.001 0.182 0.830 
rplU PA4568 0.671 0.013 0.205 0.433 0.854 0.004 0.331 0.729 
rtcB PA4583 3.214 0.000 -0.246 0.441 1.263 0.001 -0.340 0.743 
rtcA PA4585 2.372 0.000 -0.265 0.496 0.993 0.013 -0.347 0.841 
rplY PA4671 1.663 0.000 0.297 0.270 0.703 0.001 0.080 0.897 
dksA PA4723 1.406 0.000 0.924 0.000 0.211 0.244 0.134 0.895 
 PA4746.1 -2.417 0.000 -0.399 0.269     
smpB PA4768 -0.161 0.464 0.205 0.360 0.839 0.001 0.236 0.703 
rplI PA4932 1.571 0.000 0.472 0.114 0.813 0.001 0.220 0.742 
rpsR PA4934 2.022 0.000 0.850 0.003 0.560 0.002 0.037 0.969 
rpsF PA4935 1.749 0.000 0.649 0.022 0.578 0.001 0.049 0.950 
rpmE PA5049 1.072 0.000 0.684 0.008 1.248 0.268 1.098 0.855 
tRNA-Thr PA5160.1 -1.731 0.069 -0.446 0.492     
rpmG PA5315 1.801 0.000 0.789 0.010 1.643 0.006 0.165 0.964 
 PA5470 3.346 0.000 0.329 0.541 0.502 0.006 0.139 0.855 
Biofilm associated genes 
rsmY PA0527.1 -1.925 0.000 0.148 0.501     
rsmA PA0905 1.339 0.000 -0.006 0.985 0.201 0.271 0.078 0.950 
gacS PA0928 -0.321 0.193 -0.268 0.284 -0.177 0.640 0.163 0.950 
pslG PA2237 -0.342 0.618 -0.361 0.597 1.317 0.009 -0.906 0.486 
gacA PA2586 -0.104 0.694 0.194 0.463 -0.460 0.003 -0.065 0.914 
pelF PA3059 -0.321 0.404 0.301 0.450 1.439 0.000 -0.304 0.537 
pelA PA3064 -0.387 0.206 0.120 0.707 2.725 0.000 -0.166 0.923 
hptB PA3345 -0.660 0.004 0.302 0.171 -0.688 0.007 -0.185 0.858 
rsmz PA3621.1 -0.359 0.112 0.588 0.015     
ladS PA3974 -0.441 0.072 -0.045 0.858     
retS PA4856 -0.078 0.766 -0.410 0.123 -0.018 0.880 -0.006 0.994 
Motility and Chemotaxis 
cheB2 PA0173 -0.167 0.467 -0.320 0.168 -0.474 0.289 -0.057 0.985 
cheD PA0174 -0.136 0.580 -0.517 0.037 -0.054 0.887 -0.035 0.988 
cheR2 PA0175 0.166 0.443 -0.858 0.000 0.001 0.996 -0.138 0.933 
aer2 PA0176 -0.653 0.015 -0.512 0.056 -0.294 0.118 0.105 0.915 
cheW2 PA0177 -0.733 0.287 0.012 0.988 -1.313 0.003 -0.034 0.987 
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cheA2 PA0178 -1.427 0.000 -0.073 -0.133 0.074 0.776 0.227 0.858 
cheY2 PA0179 -1.227 0.000 0.231 0.460 -1.260 0.001 0.052 0.973 
fliY PA0314 0.611 0.008 0.043 0.846 -2.241 0.001 -0.160 0.956 
pilG PA0408 -0.112 0.662 0.193 0.454 -0.972 0.000 -0.041 0.966 
pilH PA0409 0.275 0.232 0.280 0.227 -1.274 0.000 -0.150 0.743 
pilI PA0410 0.128 0.558 -0.053 0.811 -0.251 0.360 -0.001 1.000 
pilJ PA0411 0.841 0.002 0.163 0.565 0.446 0.091 0.573 0.480 
pilK PA0412 0.214 0.353 -0.173 0.490 0.316 0.035 -0.135 0.855 
chpA PA0413 -0.041 0.904 -0.369 0.345 0.140 0.558 0.123 0.932 
chpB PA0414 0.099 0.467 -0.431 0.755 -0.170 0.134 0.006 0.993 
chpC PA0415 0.581 0.793 0.028 0.975 0.000  0.000  
chpD PA0416 0.650 0.004 0.553 0.015 0.000  0.000  
chpE PA0417 1.370 0.000 0.172 0.471 0.000  0.000  
flgB PA1077 1.133 0.000 0.067 0.765 0.000  0.000  
flgC PA1078 1.342 0.000 0.190 0.384 0.000  0.000  
flgD PA1079 1.116 0.000 0.147 0.539 0.002 0.994 -0.182 0.882 
flgE PA1080 0.411 0.164 -0.418 0.141 0.650 0.022 -0.487 0.574 
flgF PA1081 0.827 0.000 -0.143 0.521 0.000  0.000  
flgG PA1082 1.045 0.000 -0.064 0.803 1.226 0.014 -0.574 0.743 
flgH PA1083 0.933 0.000 -0.094 0.700 0.427 0.294 0.035 0.991 
flgI PA1084 0.754 0.002 -0.245 0.297 -0.022 0.952 -0.062 0.973 
flgJ PA1085 0.648 0.014 -0.349 0.157 0.000  0.000  
flgK PA1086 0.530 0.069 -0.599 0.029 0.774 0.001 -0.106 0.897 
flgL PA1087 0.630 0.025 -0.397 0.136 0.752 0.001 0.058 0.956 
fleq PA1097 0.479 0.104 -0.261 0.364 -0.076 0.511 0.037 0.970 
fleS PA1098 0.556 0.028 -0.045 0.852 0.000  0.000  
fleR PA1099 0.979 0.000 -0.343 0.178 0.562 0.002 0.046 0.962 
fliE PA1100 0.595 0.006 0.214 0.337 0.000  0.000  
fliF PA1101 0.340 0.168 -0.159 0.512 -0.196 0.146 0.043 0.969 
fliG PA1102 0.243 0.338 -0.291 0.246 0.268 0.051 0.033 0.973 
 PA1103 -0.663 0.045 -0.397 0.270 0.108 0.424 -0.065 0.940 
fliI PA1104 -0.921 0.020 -0.155 0.689 0.056 0.676 -0.040 0.973 
fliJ PA1105 -1.533 0.000 -0.062 0.794 -0.372 0.030 -0.085 0.923 
fliM PA1443 -0.056 0.831 -0.438 0.097 0.223 0.143 -0.121 0.881 
flhB PA1449 -1.137 0.000 -0.204 0.351 0.000  0.000  
cheY PA1456 0.415 0.090 0.157 0.511 -0.708 0.001 -0.104 0.897 
cheZ PA1457 -0.127 0.628 -0.262 0.319 -0.373 0.017 -0.058 0.950 
cheA PA1458 0.179 0.574 -0.137 0.667 -0.365 0.029 -0.281 0.630 
cheB PA1459 -0.051 0.845 -0.268 0.309 -0.560 0.002 -0.126 0.841 
motC PA1460 -0.258 0.257 -0.222 0.329 0.000  0.000  
motD PA1461 -0.755 0.001 -0.333 0.152 -0.569 0.002 -0.340 0.973 
orf1 PA1462 0.222 0.364 -0.283 0.246 -0.332 0.103 -0.034 0.980 
orf2 PA1463 0.236 0.372 -0.294 0.258 -0.159 0.143 -0.077 0.897 
cheW PA1464 0.093 0.735 -0.233 0.391 -1.103 0.000 -0.359 0.450 
 PA1608 1.011 0.000 0.509 0.043 0.000  0.000  
 PA2652 1.683 0.000 0.058 0.819 0.254 0.391 0.295 0.855 
 PA2654 1.012 0.000 0.328 0.223 0.060 0.853 0.366 0.802 
bswR PA2780 -1.086 0.011 -0.305 0.485 0.000  0.000  
 PA3341 -1.292 0.000 -0.340 0.215 0.005 0.975 0.167 0.848 
hsbD PA3343 -0.944 0.000 0.006 0.979 0.000  0.000  
hsbR PA3346 -1.044 0.000 -0.206 0.436 -0.256 0.124 -0.094 0.915 
hsbA PA3347 -0.287 0.255 0.041 0.877 -1.157 0.000 -0.207 0.742 
cheR1 PA3348 -0.526 0.075 -0.016 0.956 -1.205 0.000 -0.180 0.696 
 PA3349 -0.109 0.727 -0.125 0.697 -0.242 0.232 -0.021 0.987 
 PA3350 -0.749 0.004 -0.719 0.006 -0.159 0.575 0.032 0.987 
flgM PA3351 0.706 0.018 0.126 0.656 -0.030 0.831 -0.128 0.855 
 PA3352 0.557 0.039 0.001 0.996 -0.560 0.002 -0.088 0.888 
 PA3353 -0.177 0.514 -0.217 0.424 -0.243 0.106 -0.245 0.689 
wspR PA3702 -0.367 0.127 -0.122 0.617 0.048 0.711 0.005 0.995 
wspF PA3703 -0.815 0.181 -0.651 0.241 -0.577 0.002 -0.015 0.986 
wspE PA3704 -0.116 0.815 -0.753 0.157 0.022 0.889 0.002 0.999 
wspD PA3705 0.288 0.739 -0.594 0.568 0.000  0.000  
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wspC PA3706 -0.095 0.880 -0.462 0.462 -0.209 0.144 0.050 0.964 
wspB PA3707 -0.290 0.712 -0.340 0.652 -0.346 0.020 0.118 0.858 
wspA PA3708 -0.333 0.201 -0.274 0.301 -0.005 0.989 0.557 0.689 
pctC PA4307 0.033 0.883 0.413 0.074 -1.741 0.002 0.575 0.738 
pctB PA4310 1.475 0.000 0.081 0.753 0.676 0.198 0.567 0.828 
rpoN PA4462 -0.023 0.937 -0.352 0.209 0.086 0.528 -0.100 0.897 
pilA PA4525 1.375 0.000 0.291 0.401 -0.016 0.971 0.458 0.802 
clpB PA4542 1.460 0.000 -0.942 0.003 0.405 0.008 -0.036 0.973 
pilS PA4546 -0.101 0.646 0.065 0.766 -0.149 0.863 -0.297 0.962 
pilR PA4547 0.118 0.615 0.142 0.556 0.185 0.149 -0.175 0.743 
cupE4 PA4651 1.266 0.000 -0.129 0.575 -0.712 0.103 0.066 0.982 
ctpL PA4844 -1.036 0.000 0.089 0.685     
motB PA4953 -0.076 0.749 0.189 0.433 -0.206 0.277 0.049 0.973 
motA PA4954 0.611 0.009 0.155 0.505     
 PA5072 1.263 0.000 0.550 0.022     
algR PA5261 -0.203 0.483 -0.021 0.944 0.159 0.511 -0.205 0.867 
fimS PA5262 -0.756 0.005 -0.477 0.082     
Antibiotic resistance 
mexR PA0424 -0.821 0.001 -0.539 0.026 -0.340 0.009 -0.097 0.858 
mexA PA0425 -0.452 0.104 -0.281 0.318 -0.050 0.855 0.136 0.926 
mexB PA0426 -0.539 0.089 -0.707 0.028 0.127 0.587 0.334 0.741 
oprM PA0427 -0.898 0.003 -0.956 0.002 -0.359 0.137 -0.150 0.907 
oprD PA0958 2.230 0.000 0.952 0.001 -0.119 0.648 0.017 0.992 
sigX PA1776 -1.268 0.000 -0.825 0.009 -0.443 0.044 -0.077 0.962 
mexY PA2018 0.981 0.000 -0.345 0.156 1.929 0.001 0.170 0.942 
mexX PA2019 1.365 0.000 -0.161 0.468 1.830 0.000 0.110 0.915 
mexZ PA2020 0.128 0.586 -0.294 0.221 1.183 0.001 0.055 0.973 
mexE PA2493 -0.149 0.538 0.424 0.072     
mexF PA2494 -0.654 0.013 -0.090 0.726     
oprN PA2495 -0.371 0.375 -0.251 0.569     
oprP PA3279 -1.171 0.000 0.013 0.953     
mexG PA4205 -1.922 0.000 0.150 0.585     
mexH PA4206 -1.946 0.000 -0.282 0.304 0.007 0.993 1.256 0.561 
mexI PA4207 -1.215 0.000 -0.387 0.244     
opmD PA4208 -0.429 0.296 -0.418 0.398     
pprA PA4293 -1.272 0.000 -0.152 0.512     
pprB PA4296 0.378 0.149 -0.012 0.960 -0.104 0.621 0.320 0.712 
oprJ PA4597 -0.656 0.003 -0.103 0.629     
mexD PA4598 -0.630 0.004 -0.196 0.369     
mexC PA4599 0.080 0.751 0.014 0.953     
opmH PA4974 1.076 0.000 0.028 0.908 1.282 0.001 -0.134 0.903 
armZ PA5471 3.309 0.000 0.003 0.993 2.106 0.000 0.022 0.985 
Iron homeostasis 
tonB2 PA0197 2.465 0.000 0.475 0.051     
exbB1 PA0198 2.808 0.000 0.357 0.112     
exbD1 PA0199 1.389 0.000 0.454 0.046     
fiuA PA0470 -1.061 0.000 -0.266 0.323 -0.268 0.319 -0.615 0.480 
fiuR PA0471 -1.116 0.010 -0.359 0.419 -0.204 0.501 0.150 0.938 
fiuI PA0472 -0.715 0.129 -0.184 0.718 0.648 0.107 -0.207 0.926 
bioB PA0500 0.901 0.002 0.514 0.069 1.286 0.001 0.506 0.492 
aprX PA1245 -0.145 0.729 -1.194 0.007 2.798 0.001 0.452 0.880 
aprD PA1246 -0.512 0.234 -1.617 0.000 -0.099 0.646 0.284 0.743 
aprE PA1247 -0.790 0.306 -1.557 0.041 -0.330 0.341 0.514 0.738 
aprF PA1248 -1.011 0.001 -1.644 0.000 0.270 0.126 0.065 0.962 
aprA PA1249 0.237 0.610 -1.617 0.001 2.755 0.007 0.679 0.869 
aprI PA1250 -0.155 0.537 -0.712 0.005 -1.026 0.001 -0.077 0.940 
 PA1271 1.297 0.000 0.234 0.295 -0.023 0.940 0.058 0.973 
 PA1365 1.243 0.000 0.424 0.089 -0.034 0.852 -0.226 0.744 
 PA2134 -2.533 0.001 -0.474 0.858 -2.533 0.001 -0.474 0.858 
pvdA PA2386 1.310 0.010 0.112 0.827 -0.054 0.862 -0.076 0.973 
fpvI PA2387 -0.430 0.049 -0.318 0.153 -0.447 0.008 -0.001 1.000 
201 
 
fpvR PA2388 -0.244 0.354 -0.087 0.744 -0.262 0.341 0.163 0.915 
pvdT PA2390 -0.369 0.423 -0.147 0.760 -0.334 0.160 0.065 0.973 
opmQ PA2391 -0.421 0.116 -0.318 0.267 0.646 0.010 -0.024 0.986 
pvdP PA2392 1.416 0.000 0.452 0.175 0.207 0.643 0.436 0.855 
pvdN PA2394 2.033 0.000 0.799 0.014 0.473 0.010 -0.026 0.980 
pvdO PA2395 2.089 0.000 0.925 0.009 -1.797 0.007 -0.242 0.940 
pvdF PA2396 1.726 0.000 0.498 0.177 -0.267 0.222 -0.128 0.915 
pvdS PA2426 0.938 0.006 0.227 0.475 0.370 0.140 0.243 0.855 
foxI PA2466 0.120 0.639 -0.199 0.424 -0.102 0.609 -0.396 0.561 
foxR PA2467 -0.351 0.198 -0.010 0.971 -0.067 0.846 -0.140 0.950 
foxI PA2468 -0.644 0.024 -0.702 0.014     
 PA2469 -1.116 0.000 -0.328 0.451 -0.314 0.178 0.174 0.888 
pvdR PA2807 -0.833 0.008 -0.062 0.821 -2.471 0.000 -0.667 0.470 
 PA3268 1.349 0.000 0.445 0.051 0.835 0.002 0.048 0.973 
fprA PA3397 1.320 0.000 0.365 0.261 -0.055 0.794 0.329 0.703 
fptA PA4221 0.603 0.266 -0.023 0.964 1.106 0.006 0.851 0.384 
pchI PA4222 0.000 1.000 0.000 1.000 1.552 0.046 1.672 0.470 
pchH PA4223 0.000 1.000 0.000 1.000 1.836 0.028 1.884 0.428 
pchG PA4224 0.000 1.000 0.000 1.000 2.312 0.004 1.483 0.442 
pchF PA4225 0.000 1.000 0.000 1.000 1.810 0.006 1.050 0.536 
pchE PA4226 0.000 1.000 0.000 1.000 2.441 0.003 1.321 0.470 
pchR PA4227 -0.043 0.898 -0.108 0.744 -0.025 0.905 -0.120 0.908 
pchR PA4227 -0.043 0.898 -0.108 0.744 -0.025 0.905 -0.120 0.908 
pchD PA4228 1.199 0.247 0.039 0.966 1.888 0.001 0.657 0.532 
pchD PA4228 1.199 0.247 0.039 0.966 1.888 0.001 0.657 0.532 
pchC PA4229 1.050 0.655 -0.019 0.970 0.414 0.538 0.403 0.915 
pchC PA4229 1.050 0.655 -0.019 0.970 0.414 0.538 0.403 0.915 
pchB PA4230 0.882 0.641 -0.046 0.979 1.241 0.016 0.986 0.480 
pchB PA4230 0.882 0.641 -0.046 0.979 1.241 0.016 0.986 0.480 
pchB PA4231 0.599 0.505 -0.309 0.731 1.398 0.016 0.562 0.808 
pchA PA4231 0.882 0.641 -0.046 0.979 1.398 0.016 0.562 0.808 
feoC PA4357 -2.061 0.031 -1.145 0.460 -1.425 0.034 -0.642 0.841 
feoB PA4358 -1.972 0.000 -0.533 0.063     
feoA PA4359 -1.498 0.000 -0.440 0.052 -1.573 0.014 -0.526 0.855 
fprB PA4615 -1.299 0.000 -0.317 0.251 -0.153 0.360 -0.013 0.991 
chtA PA4675 1.693 0.000 0.421 0.077 0.681 0.016 0.070 0.973 
fur PA4764 0.679 0.010 0.109 0.681 0.068 0.557 -0.058 0.938 
 PA5505 1.945 0.000 0.618 0.026 -2.467 0.002 -0.109 0.973 
tonb1 PA5531 -0.744 0.020 -0.083 0.792 -0.878 0.001 -0.368 0.529 
Cell shape defining proteins 
minD PA3244 1.349 0.000 0.445 0.051 -0.338 0.034 -0.084 0.915 
rodA PA4002 -1.208 0.000 -0.363 0.118     
ftsZ PA4407 0.528 0.129 -0.351 0.301 -0.072 0.686 -0.224 0.777 
spoOJ PA5562 1.01364 0.000 0.129 0.589 -0.108 0.360 -0.080 0.903 
Sulfur metabolism 
cysA PA0280 5.141 0.000 -0.285 0.195 1.074 0.007 0.745 0.470 
ssuB2 PA3347 -0.287 0.255 0.041 0.877 -1.157 0.000 -0.207 0.742 
ssuF PA3441 3.419 0.000 PA3441 2.654 1.353 0.013 1.298 0.381 
ssuB PA3442 4.518 0.000 PA3442 1.495     
ssuC PA3443 6.198 0.000 PA3443 2.463     
ssuD PA3444 6.766 0.000 PA3444 3.540 2.519 0.002 1.811 0.262 
 PA3445 5.675 0.000 PA3445 3.929 0.130 0.824 1.292 0.470 
ssuE PA3446 5.544 0.000 PA3446 3.060 0.829 0.008 0.122 0.938 
 PA3447 1.784 0.000 PA3447 0.499     
 PA3448 2.018 0.000 PA3448 0.999 1.091 0.000 0.324 0.276 
iscR PA3815 -0.672 0.014 -0.099 0.709 0.030 0.888 0.424 0.492 
tauD PA3935 3.989 0.000 1.293 0.000 1.998 0.000 1.273 0.081 
tauC PA3936 4.118 0.000 1.675 0.001     
tauB PA3937 5.322 0.000 3.023 0.000 2.398 0.003 1.636 0.364 
tauA PA3938 5.042 0.000 3.342 0.000 -0.442 0.443 1.136 0.574 
cysD 
 
PA4443 3.754 0.000 2.141 0.000 1.031 0.000 0.331 0.502 
202 
 
Heat shock response 
rpoH PA0376 1.031 0.002 0.040 0.890 -0.203 0.455 0.191 0.899 
rpoD PA0576 1.125 0.001 0.173 0.578 0.175 0.262 0.082 0.932 
 PA1068 1.443 0.000 0.169 0.481 0.863 0.008 0.174 0.903 
htpG PA1596 2.827 0.000 -0.487 0.098 0.278 0.025 -0.044 0.956 
ibpA PA3126 1.987 0.000 -1.318 0.000 0.498 0.034 -0.034 0.981 
rpoA PA4238 1.576 0.000 0.449 0.191 0.428 0.022 0.138 0.868 
groES PA4386 1.554 0.000 -1.203 0.000 0.356 0.011 -0.015 0.985 
dnaJ PA4760 1.491 0.000 -0.784 0.004 0.174 0.557 0.047 0.981 
dnaK PA4761 1.618 0.000 -1.020 0.005 0.269 0.032 -0.006 0.993 
grpE PA4762 2.019 0.000 -0.942 0.000 -0.372 0.047 0.082 0.940 
hslV PA5053 2.442 0.000 -0.803 0.000 0.171 0.360 0.046 0.973 
hslU PA5054 2.231 0.000 -0.732 0.005 0.394 0.018 -0.017 0.986 
Redox active proteins and proteins of the oxidative stress response 
coxB PA0105 -1.249 0.000 -0.208 0.520 -0.380 0.128 -0.185 0.888 
ahpF PA0140 1.375 0.000 0.087 0.713 0.740 0.001 0.000 1.000 
cttP PA0180 0.166 0.524 -0.175 0.507 0.098 0.740 -0.199 0.899 
 PA0840 1.096 0.000 0.314 0.150 0.266 0.038 -0.078 0.903 
ccoO2 PA1556 -1.590 0.000 0.267 0.242     
ccoN2 PA1557 -1.590 0.000 0.109 0.685     
 PA1856 -1.076 0.000 -0.164 0.478     
 PA2477 -1.179 0.011 -0.328 0.451     
 PA2482 -1.402 0.000 -0.148 0.694 0.419 0.327 -0.036 0.991 
 PA3331 2.763 0.000 0.745 0.168 -0.282 0.672 0.180 0.973 
fprA PA3397 1.320 0.000 0.365 0.261 -0.055 0.794 0.329 0.703 
finR PA3398 1.109 0.000 0.039 0.887 0.232 0.044 0.104 0.855 
 PA3795 1.160 0.000 0.162 0.536 -0.380 0.118 -0.239 0.853 
 PA4061 1.616 0.000 -0.268 0.283 0.615 0.001 -0.049 0.944 
 PA4621 -1.343 0.000 0.057 0.843 1.209 0.001 0.157 0.904 
grx PA5129 1.382 0.000 0.402 0.080 -0.382 0.092 -0.109 0.938 
Metabolism 
 PA0220 -1.214 0.000 -0.284 -0.284 0.000  0.000  
metK PA0546 1.891 0.000 0.439 0.232 0.665 0.002 0.202 0.743 
 PA1325 6.180 0.000 0.166 0.754 3.667 0.000 -0.086 0.973 
ilvA2 PA1326 6.746 0.000 0.451 0.067 2.206 0.000 0.013 0.991 
ggt PA1338 1.371 0.000 -0.020 0.935 0.379 0.076 0.097 0.940 
aatJ PA1339 2.020 0.000 -0.152 0.698 -0.547 0.007 -0.628 0.173 
aatM PA1340 2.176 0.001 -0.281 0.623     
aatP PA1341 2.596 0.001 0.031 0.963     
aatQ PA1342 1.901 0.000 0.125 0.677 -1.509 0.003 -0.022 0.993 
opdO PA2113 -1.182 0.000 -0.388 0.116     
aroP1 PA3000 -1.150 0.000 0.086 0.704     
 PA3035 -1.211 0.000 -0.073 0.743 -1.070 0.001 -0.170 0.855 
 PA3865 -0.410 0.058 -0.307 0.163 -2.955 0.001 -0.248 0.938 
narX PA3878 -0.923 0.003 -0.216 0.491     
narL PA3879 -0.563 0.171 -0.001 0.999 -0.698 0.001 -0.214 0.668 
 PA3965 1.249 0.000 0.436 0.065 0.088 0.508 -0.153 0.807 
 PA4192 4.213 0.000 0.822 0.283     
 PA4193 1.673 0.004 0.214 0.626     
glyA3 PA4602 1.729 0.000 0.520 0.036 0.642 0.003 0.010 0.992 
arcD PA5170 -2.625 0.000 -0.393 0.223 0.374 0.034 -0.242 0.727 
crc PA5332 -0.062 0.807 0.164 0.530 0.093 0.454 -0.074 0.915 
Disulfide bond formation 
dsbB PA0538 0.225 0.308 -0.577 0.012     
dsbD2 PA2478 -0.294 0.445 -0.181 0.650 -1.681 0.005 0.158 0.964 
dsbC PA3737 0.324 0.141 0.406 0.075 -0.133 0.535 -0.014 0.992 
trxA PA5240 0.760 0.008 -0.103 0.717 -1.395 0.000 -0.255 0.492 
dsbA PA5489 0.646 0.021 -0.021 0.938 -1.455 0.001 0.038 0.982 
Hypothetical proteins and miscellaneous 
 PA0149 -1.172 0.001 0.157 0.677 0.222 0.357 -0.255 0.841 
 PA0200 -2.134 0.000 -0.491 0.031     
203 
 
 PA0270 -0.473 0.035 -0.751 0.001 -2.768 0.006 -0.601 0.888 
dnr PA0527 -1.495 0.000 -0.500 0.024 -0.202 0.221 -0.084 0.933 
 PA0618 0.123 0.775 -0.017 0.972 1.680 0.000 0.088 0.950 
 PA0620 0.229 0.494 0.216 0.556 2.613 0.000 0.275 0.861 
 PA0622 -0.034 0.910 0.007 0.982 1.267 0.002 -0.018 0.993 
 PA0630 -0.521 0.290 0.085 0.878 2.688 0.001 -0.070 0.982 
 PA0718 -1.882 0.000 -0.980 0.000 0.000  0.000  
cbpD PA0852 1.190 0.004 -0.252 0.536 -1.868 0.001 -0.037 0.987 
 PA1414 -2.427 0.000 -0.377 0.167 1.234 0.000 -0.045 0.969 
anr PA1544 0.405 0.135 -0.373 0.158 -0.637 0.007 -0.092 0.938 
 PA1673 -2.120 0.000 0.178 0.466 -2.178 0.000 -0.477 0.729 
modC PA1861 -1.047 0.000 -0.070 0.776 0.000  0.000  
modB PA1862 -0.713 0.001 0.171 0.458 0.000  0.000  
modA PA1863 -0.476 0.043 -0.152 0.511 -2.259 0.001 -0.194 0.944 
exaB PA1983 0.179 0.569 1.497 0.000 -3.154 0.000 -0.097 0.950 
 PA2050 1.892 0.001 0.327 0.481 0.000  0.000  
 PA2202 3.856 0.000 0.675 0.005 0.000  0.000  
 PA2274 -2.345 0.000 0.224 0.339 0.000  0.000  
 PA2328 2.829 0.000 0.136 0.810 -0.367 0.474 0.823 0.703 
 PA2329 3.357 0.000 0.414 0.517 -0.169 0.322 -0.049 0.973 
 PA2565 -1.247 0.011 -0.539 0.340 -0.007 0.967 0.005 0.995 
 PA2781 -0.980 0.006 -0.253 0.487 -2.278 0.000 -0.066 0.969 
 PA3318 -0.085 0.698 0.074 0.739 -2.291 0.001 -0.660 0.660 
 PA3430 -2.045 0.000 1.092 0.001 -0.877 0.029 0.071 0.973 
 PA3431 -2.071 0.000 0.361 0.401 0.000  0.000  
 PA3576 -0.355 0.117 -0.551 0.017 -1.901 0.000 0.488 0.030 
glpF PA3581 -1.901 0.000 0.488 0.030 0.000  0.000  
 PA3661 1.151 0.000 1.001 0.001 4.004 0.002 -0.452 0.923 
 PA3785 0.632 0.003 0.634 0.009 -2.947 0.000 -0.288 0.899 
 PA4063 0.926 0.002 -0.411 0.184 -2.300 0.067 -1.098 0.858 
prpL PA4175 -0.897 0.005 -1.098 0.003 -0.257 0.673 0.548 0.858 
olsA PA4351 -2.166 0.000 -0.460 0.403 0.000  0.000  
 PA4352 -2.188 0.000 -0.388 0.276 -0.729 0.003 0.024 0.985 
 PA4364 -1.882 0.000 -0.244 0.376 0.000  0.000  
 PA4523 -2.235 0.000 -0.385 0.275 -0.559 0.002 0.002 0.998 
 PA4697  0.354 0.100 -0.031 0.887 -2.409 0.001 -0.180 0.962 
 PA5027 -2.300 0.000 -0.741 0.005 0.000  0.000  
 PA5086  -1.154 0.000 -0.552 0.014 -3.088 0.000 -1.481 0.222 
 PA5087 -1.133 0.000 -0.383 0.079 0.000  0.000  
 PA5088  -1.129 0.000 -1.198 0.000 -2.205 0.000 -1.478 0.032 
 PA5330  -0.538 0.076 0.035 0.912 -2.240 0.001 -0.201 0.944 
 PA5359  -0.469 0.067 -0.505 0.052 -2.366 0.000 -0.514 0.689 
 PA5475 -2.875 0.000 -0.439 0.107 -1.550 0.001 -0.426 0.741 
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